Samatvam Endocrinology Diabetes Center

Samatvam-Logo-01

NGO – “Not  For Profit”

Jki-facebook-line Icon-instagram-1 Map-marker-alt Youtube

Diabetes: Answer is in your hands | Samatvam : Always there to help you

+91-9148971472
Get in Touch
Samatvam-Logo-01

NGO – “Not For Profit”

+91-9148971472
Get In Touch

Research & Publications

  • Home
  • Research & Publications
  1. Samatvam Science and Research Center
  2. Samatvam: Research Achievements
  3. Landmark discoveries and scientific contributions [Selected from more than 1000 international publications and presentations]:
  4. N Eng J Med 1981; 304(19):1175-1176; 
  5. N Engl J Med. 1983 Feb 10;308(6):322-5; 
  6. Ann Int Med 1983; 99:320-326;   
  7. Trans Assoc Amer Phys. 1984; XCVII: 80-87;   
  8. Lancet.1984;(1):1176-1177;   
  9. N Engl J Med 1985; 313:461-464; 
  10. N Eng J Med 1985; 313:893-894; 
  11. Diabetes. 1986 Mar;35(3):300-5; 
  12. Mol biol and Med 1986; 3:113-127; 
  13. N Engl J Med 1986; 315:920-294; 
  14. Clin Chem. 1986 Oct;32(10 Suppl):B7-18; 
  15. Diabetes. 1986 Mar;35(3):300-5;  
  16. J Clin Endocrinol Metab. 1987 Jan;64(1):43-50; 
  17. J Clin Invest 79(3): 934, 1987; 
  18. Diabetes Care. 1987 Sep-Oct;10(5):645-56;  
  19. Immunol Invest. 1995 May;24(4):573-82; 
  20. Nature. 2013 Mar 7;495(7439):103-6; 
  21. Sci Rep. 2017 Feb 7; 7:420-31; 
  22. Indian J Endocrinol Metab. 2015 Apr;19(Suppl 1): S58-63; 
  23. Kidney Int Rep. 2018 Jun 2;3(5):1110-1118; 
  24. Diabet Med. 2018 Jun;35(6):760-769
  25. Publications: Original Reports
  26. Srikanta S, Ahuja, NMS, Malaviya AN, Mehra NK, Vaidya MC. Type 1 (Insulin-dependent) diabetes mellitus in North India: HLA and autoimmunity. N Eng J Med.1981; 304(19):1175-1176.
  27. Srikanta S. Malaviya AN, Mehra NK, Vaidya MC, Geevarghese PJ, Ahuja MMS.  Autoimmunity in type I (insulin –dependent) diabetes mellitus in North India.J
  28. Srikanta S, Mehra NK, Vaidya MC, Malaviya AN, Ahuja NMS, HLA. AntigensIn type I (insulin –dependent) diabetes mellitus in North India. Metabolism.1981;30(10):992-993
  29. Srikanta S, Malaviya AN, Rajagopalan P, Bhuyan U, Ahuja NMS, Associationof Type I diabetes mellitus, antinuclear antibody, autoimmunity and membrano-proliferative glomerulonephritis.  Diabetes Care. 1983; 6:71-74.
  30. Srikanta S, Ganda OP, Eisenbarth GS, Soeldner JS.  Islet-cell antibodies and beta-cell function in monozygotic triplets and twins initially discordant for Type I diabetes mellitus. N Engl J Med. 1983 Feb 10;308(6):322-5
  31. Srikanta S, Ganda OP, Jackson RA, Gleason RE, Kaldany A, Garovoy MR, Milford EL, carpenter CB, Soleldner JS, Eisenbarth GS. Type I diabetes mellitus: chronic progressive beta cell dysfunction. Ann int Med. 1983; 99:320-326.
  32. Srikanta S, Ganda OP, Jackson RA, Gleason RE Kaldany A, Garovoy MR, Milford EL, carpenter CB, Soleldner JS, Eisenbarth GS. Type I diabetes mellitus: Chronic progressive beta cell dysfunction. Ann int Med. 1983; 99:320-326.
  33. Ganda OP, Srikanta S, Brink SJ, Morris MA, Gleason RE, Soeldner JS, Eisenbarth GS, Differential sensitivity to beta cells secretagogues in “early”Type I diabetes mellitus. Diabetes. 1984,33(6):516-521.
  34. Srikanta S, Eisenbarth GS, Disappearing anti-islet antibodies Lancet.1984;(1):1176-1177.
  35. Srikanta S, Ganda OP, Gleason RE, Jackson RA, Soeldner JS, Eisenbarth GS Pre- Type I diabetes; Linear Loss of beta cell respons to intravenous glucose.  Diabetes 1984; 33(8):717-720.
  36. Srikanta S, Ganda OP, Jackson RA, Brink SJ, Fleischnick E, Yunis E, Alper, C,Soeldner JS, Eisenbath GS.Pre-type I (insulin-dependent) diabetes: commonendocrinological course despite immunological and imunogenetic heterogeneity.Diabetologia 1984;27(suppl):146-148.
  37. Bhuyan UN, Dash SC, Srikanta S, Malaviya AN, Malhotra KK. Occurrence ofglomerulonephritis and auto antibodies in diabetes mellitus J Assoc Phys India.1984; 32 (2):171-175.
  38. Sutherland DER, Sibley R, Xu XZ, Mechael A, Srikanta S, Taub F, Najarian J, Goetz FC. Twin to twin pancreas transplantation: reversal and reenactment of the pathogenesis of Type I diabetes Trans Assoc Amer Phys. 1984; XCVII: 80-87.
  39. Srikanta S, Rabizadeh A, Omar MAK, Eisenbarth GS, Assay for islet cellAntibodies; Evidence that the target antigen is a sialo-glycoconjugate. Diabetes1985; 34(6):617-619.
  40. Nayak RC, Omar MAK, Rabizadeh A, Srikanta S, Eisenbarth. ‘Cytoplasmic’ islet cell antibodies: Evidence that the target antigen is a sialo-glycoconjugate.  Diabetes 1985; 34(6):617-619.
  41. Eisenbarth GS, Srikanta S, Fleischnick E, Ganda OP, Jackson RA, Brink SJ,Soeldner  JS, Yunis E, Alper C. Progressive autoimmune beta cell insufficieny inthe absence of high risk HLA alleles DRJ, DR4.  Diabetes Care 185;8(5):477-480
  42. Srikanta S, Ganda OP, Rabiadeh A, Soeldner JS, Eisenbart GS.  First degreeRelatives of patients with Type I diabetes: islet cell antibodies and abnormal inslin secretion.  N Engl J Med 1985; 313:461-464.
  43. Soeldner JS, Tuttleman M, Srikanta S, Ganda OP, Eisenbarth GS. Insulin –Dependent diabetes and beta cell failure.  N Eng J Med 1985; 313:893-894.
  44. Eisenbarth GS, Srikanta S, Jackson RA, Rabinowe SL, Dolinar R, Aoki T, Morris MA. Anti-thymocyte Globulin and prednisone immunotherapy of recent onset Type I diabetes mellitus.  Diabetes Research 1985; 2:271-276.
  45. Srikanta S; Ricker At, McCulloch DK, Soeldner JS, Eisenbarth GS, palmer UP Autoimmunity to insulin, beta cell dysfunction and development  of insulin-Dependent diabetes mellitus.  Diabetes 1986; 139-142.
  46. Eisenbarth GS, Srikanta S, Rabinowe SL, Jackson RA, Ganda OP, Soeldner JSRestoration of rist phase insulin secretion by daily prednisone in two islet cell antibody positive non-diabetic individals.  Transplantation Proceedings 1985; XVIII(4) : 305-808.
  47. Srikanta S, Eisenbarth GS, Islet cell antigens: initial studies of their biology andFunctions.  Mol biol and Med 1986; 3:113-127.
  48. Rabinowe SL, Srikanta S, Jackson RA, Nayak RC, Ganda OP Soeldner JS, Eisenbarth GS “prediction” of overt type I diabetes and pilot trials ofimmunomodulation. Proceedings of the 12th Congress of the InternationalDiabetes Federation, Madrid, Spain, Elsevier Science Publishers, BV Amsterdam,The Netherlands 1985;pp
  49. Srikanta S, Krisch K, Eisenbarth GS. Islet cell proteins defined by monoclonalislet cell antibody HISL-19. Diabetes 1986; 35(3):300-305.
  50. Krisch K, Buxbaum P, Horvat G, Krisch I, Neuhold N, Ulrich W, Srikanta S, Monoclonal antibody HISL-19 as an immunocytochemical probe for neuro-Endocrine differentiation.  Its application in diagnostic pathology.  Am J Pathol1986; 123(1):100-108.
  51. Nayak RC, Spitalnik SL, Rabizadeh A, Srikanta S, Eisenbarth GS, Zigler Islet cellsautoantigen(s) in Type I diabetes mellitus.  Preliminary biochemical characterization.  Proceedings of the second International Conference on Human tissues and organs for Research Interchange, Washington Dc, USA, 1985. Pp-
  52. Ganda OP, Srikanta S, Gleason RE, Soeldner JS, Eisenbarth GS, Alpha Cellhypofunction in the early phase of type I diabetes.  Metabolism 1986; 35(11):1074-1077, 1986.
  53. Dib S, Vardi P, Connelly, J, Eisenbarth, GS Soeldner JS. Immune changesassociated with insulin-dependent diabetes may remit without causing the disease: a study in identical twins.  Brit Med J 1986; 292:1670.
  54. Hamman RF, Berlin N (Report prepared by Chairman and Co-chairman).  International workshop on the Epidemiology of Insulin-dependent DiabetesMellitus.  Diabetes Care 1985; 8(1)1-4. (Workshop participant: Srikanta S)
  55. Bottazzo GF, Gleichmann H (Report prepared by chairperson).  Immunology andDiabetes Workshops: report of the first international workshop on the standardization of cytoplasmic islet cell antibodies.  Diabetolgia 1986; 29:125-126.(Workshop participants: S Srikanta A Rabizadesh, GS Eisenbarth).
  56. Posillico JT, Wortsman J, Srikanta S, Eisenbarth GS, Mallette LE Brown EM.Parthyroid cell surface autoantibodies that inhibit parathyroid hormone secretion from dispersed human parathyroid cells.  J Bone Min Res 1986; 1(5):475-483.
  57. Colman PG, Nayak RC, Connelly J, Rabizadeh A, Socldener JS, Eisenbarth GSIslet cell antibodies: Clinical utility and target antigen(s).  Symposium on theImmunology of Diabetes, Edmonton, Canada, Elsevier Science Publisher, BV,The Netherlands, 1986 pp.
  58. Posillico JT, Srikanta S, Eisenbarth G, Quaranta V, Brown EM binding of monoclonal antibody (4F2) to its cell surface antigen on dispersed adenomatous parathyroid cells raises cytosolic calcium and inhibitis parathyroid hormone secretion. J Clin Endo Metab. 1987;1
  59. Kaye WA, Adri NMS, Soeldner JS, Rabinowe SL, Kaldany A, Khan CR, BistrianB, Srikanta S, Ganda OP, Eisenbarth GS.  Acquired defect in interleukin-2Production in patients with type I diabetes mellitus. N Engl J Med 1986; 315:920-294.
  60. Omar MAK, Srikanta S, Eisenbart GS, Human islet cell auto antibodies; immunoglobulin class and subclass distribution defined by monoclonal antibodies.  Diabetes Research 4 (4): 155-158, 1987.
  61. Baekkskov S, Bruining J, Srikanta S, Mandrup-poulsen T, C de Beaufort,Eisenbarth G, Nerup J, Lernmark A, antibodies to an M 64000 human islet cell protein in the prediabetes period of IDDM patients  Ann NY Acad Sci 1986; 415-417.
  62. Posillico JT, Wilson RE, Srikanta S, Eisenbarth GS, Letarte M, Quackenbush EJ, Quaranta V, Brown EM. Monoclonal antibody mediated modulation of parathyroid hormone secretion by dispersed parathyroid cells.  Archives of Surgery 1986;pp
  63. S Srikanta, M Telen, JT posillico, R Dolinar, K Krisch, BF Haynes, GS Eisenbarth.  Monoclonal antibodies to a human islet cell surface glycoprotein: 4F2 and LC7-2 Endocrinology 120: 2240-2244, 1987.
  64. Karp M, Rabizadeh A, Eisenbarth GS, (Srikanta S).   Prolonged sera incubation to improve sensitivity of the double immunofluorescent monoclonal BISL-32.  FITC protein A assay.  Diabetes Care 1986, pp.
  65. Dotta F, RC Nayak, Dib SA, E Dibella, Krisch K, Posillico JT, Ricker AT, DiMario U, Eisenbarth GS, (Srikanta S).  A novel neuroendocrine cell surface glycoprotein: identification, isolation and initial characterisation.  Endocrinology 122(4):1263-1268 1988.
  66. P Vardi, SA Dib, M Tuttleman, JE Connelly, M Grinbergs, A Rabizadeh, WJ Riley, NK Maclaren, GS Eisenbarth, JS Soeldner, (Srikanta S).  , .  Competitive insulin autoantibody assay: prospective evaluation of subjects at high risk for development of type I diabetes mellitus.  Diabetes 36: 1286-1291, 1987.
  67. Dib SA, Vardi P, Boner-Weir S, Eisenbarth GS, (Srikanta S).    Factor VIII and II antigen expression in normal pancreas.  1986 Diabetes.pp-
  68. Connelly J, Eisenbarth GS, Soeldner JS, (Srikanta S). .  Rapid intravenous glucose tolerance tests; Responses in normal and diabetes high-risk subjects.  1986 .pp
  69. Vardi P, Dib SA, Tuttleman M, Grinbergs , Reske I, (Srikanta S), Eisenbarth GS, Soleldner JS.  Insulin autoantibodies in high risk population for development of IDDM and human insulin binding specificity. 1986.pp-
  70. Krisch K, Dibella E, Buxbaum P, Horvat G, Krisch I, Neuhold N, Ulrich W, Nayak RC Srikanta S.  Islet cell proteins defined by monoclonal islet cell antibody HISL-19: Further characterisation.1986.pp-
  71. Pasquarello T, Kamalesh M, Oneil J, Appel MC, . (Srikanta S).  Islet cell antigens (ICAg):  Down-Regulation by hypoglycaemia and suppression of islet cell autoimmunity. 1986.pp-
  72. Brown FS, Kamalesh M, Adri MNS, (Srikanta S), Rabinowe SL, Adrenal medullary autoantibodies in Type I and ‘pre-type I’ diabetes mellitus: Prevalence and relationship to islet cell autoimmunity.  J Clin Endo etab 1986 PP-
  73. Krisch K, Srikanta S, Posillico JT, Eisenbarth GS.  Thyroid C-cells reactivity of monoclonal islet cell antibodies I 1986:pp-
  74. Bakkeskov S, Kristensen JK, Srikanta S, Poulsen TM, de Beaufort C, SoeldnerJS, Eisenbarth GS, Dahlquist G, Lernmark A, Antibodies to a Mr 64000 humanislet cell antigen precede the clinical onset of insulin-dependent diabetes.  J clinInvest 79(3) :934, 1987.
  75. Karasik A, Ohara C, Srikanta S, Swift M, Soeldner JS, Kahn CR, Hersokowitz RD.   Genetically programmed selective islet beta cell loss in diabetic subjects with   Wolfram’s syndrome.  Diabetes Care 1989;12(2):135-138.
  76. Herskowitz RD, Ricker A, Wolfsdorf JI, Beron M, Connelly J, Soeldner JS,             Eisenbarth GS,  (Srikanta S).  .  Transient Hyperglycaemia in childhood; identification of a subgroup with imminent hypoparathyroidism of fluctuating severity.  1986.Pp-.
  77. Posillico JT, Wortsman J, Srikanta S, Eisenbarth GS, Mallette LE, Brown EM.  Late onset autommune hypoparathyroidism of fluctuating severity. 1986. Pp-.
  78. M Catalano, IM Bernstein, RR Wolfe, S.Srikanta, E Tyzbir, EAH Sms. Subclinical abnormalities of glucose metabolism in subjects with previous gestational diabetes. Am J Obstet Gynecol 155(6):1255-1262, 1986. (2nd paper Diabetes care ICAb Protein A Monoclonal Antibody method 1990)
  79. SA Dib, PG Colman, F Dotta, M Tautkus,  (Srikanta S).  et al.  Expression of cytoplasmic islet cell antigens by rat pancreas.  Diabetes, 36() 982-98x, 1987.
  80. PG Colman, M Tautkus, A Rabizadeh, (Srikanta S).   et al. Islet cell antibody assay using rat pancreas and peroxidase protein A.  Diabetes care, 11:367, 1988.
  81. PG Colman, RC Nayak IL Campbell, GS Eisenbarth, (Srikanta S).   .  Binding of cytoplasmic islet cell antibodies is blocked by human pancreatic glycolipid extracts.  Diabetes 37:645-652, 1988.\R Moncayo, K Krisch, T Pasquarello, EF Pfeiffer, (Srikanta S).   .  Islet cell antigens: Extraction studies and ELISA analysis. Diabetes 37(8): 1137-1143, 1988.
  82. Diabetes Collaborative Study Goup, AIIMS (Srikanta S).  .  Environment and health: Madhumeh (Diabetes mellitus) and endocrine metabolic disorders. J Soc Young Scientists, 1989, pp-.
  83. Diabetes Collaborative Study Group, AIIMS(Srikanta S).   .  Serological carkers of islet cell autoimmunity. Diabetes Bulletin; 8(1):32-42, 1988.
  84. S Setia,  (Srikanta S).   Diabetes Awareness 88.  Diabetes bulletin; 9(1): 53-56, 1989.
  85. SK Garg, M Joshi,  (Srikanta S).  Camp for children and youth with diabetes Specific aims and organisation.  Diabetes Bulletin 1988;8(2):11-23.
  86. S Setia, A Mithal. (Srikanta S).    Camp for children and youth with diabetes:  Diabetes education – evaluation.  Diabetes Bulletin 1988;8(2):28-31.
  87. Brown FM, Vinik Al, Ganda OP, Adri NMS, Rabinowe SL, (Srikanta S).   . Dirrerent effects of duration on prevalence of anti-adrenal medullary and pancreatic islet cell antibodies in type I diabetes mellitus Horm Metab res 1989;21(8):434-497.
  88. Brown FM, Zuckerman M, Longway S, Rabinowe SL, (Srikanta S).   .  Adrenal Medullary fibrosis in IDDM of long duration Diabetes Care 1989;12(7):494-497.
  89. A Virmani, P Ushabala, PV Rao, (Srikanta S).    Diabetes mortality in a tertiary referral hospital in India.  Lancet; 335:1341.1990.
  90. DK Gupta, LK Verma, PK Khosla, SC Dash, (Srikanta S).    . The prevalence of microalbuminuria in diabetes; a study from North India. Diab Res Clin Practice 1991.
  91. Virmani A, Setia S, Menon SN,  (Srikanta S).  Effect of formal childhood diabetes education program on behaviour and metabolic control in a developing country.  1991
  92. Raju R, Srikanta S, Kharbanda K and Kochupillai N. Islet cell antigens and autoantigen(s) mnoclonal antibodies and further characterisation. 1991
  93. Raju R, (Srikanta S).  .Immunology and Diabetes workshops, Islet Cell Antibody Proficiency Programs, 1988 and 1989. (Participating Laboratory).
  94. Vera A, Dinda A, Sarkar C, Fotedar R, Dhawan IK, Sharma LK, Khetarpal K, Fotedar A, Srikanta S, Kochupillai N, Ahuja NMS.  Pancreatic islet transplantation Utility of ductular obstruction and exocrine atrophy model Trop gastroenterol 1990; 11(3):148-51.
  95. Ejiri K, Taniguchi H, Morimoto Y, Yamashrio Y, Baba S, Srikanta S, Eisenbarth GS. Heterogeneity of islet cell autoantibodies in terms of insulin release from rat islets and insulinoma cells.  Diabetes Res Clin act 1990;9(1):1-5.
  96. Deftos LJ, Woloszczuk W, Krisch I, Horvat G, Ulrich W, Neuhold N, Braun O, Reiner A, Srikanta S, Krisch K. medullary thyroid carcinomas express chromogranin A and a novel neuroendocrine protein recognised by monoclonal antibody HISL-19. Am J Med 1988;85(6):780-784
  97. Bordi C, Krisch K, Horvat G, Srikanta S, Immunocytochemical patterns of islet cel tumors as defined by the monoclonal antibody HISL-19.  An J Pathol 1988;132(2);249-257.
  98. R.Raju, S Srikanta, K Kharbanda, N Kochupillai.  Islet Cell antigens and autoantigen(s): Monoclonal antibodies and further charactierization, J Bioscience 17(3): 313-323, 1992.
  99. S. Kumaravelu, P Shah, S Srikanta, MC Maheshwari. Hyperglycemia, diabetes and stroke: Prognostic analysis.  Neurology
  100. SS Sidhu, P Shah, S Srikanta, PK Tandon.  Insulin requiring diabetes of the young in India:  A profile of their exocrine and endocrine 
  101. pancreatic dysfunction.  Pancreas
  102. S Srikanta.  Insulin dependent diabetes mellitus in India: “Classical versus atypical” International Journal of Diabetes in developing Countries 1993
  103. Aravind Raj Sanjeevaiah, Subbarayappa Sanjay, Tejeswini Deepak, Ardanareshwaran Sharada, Sri S. Srikanta.  Precocious Puberty and Large Multicystic Ovaries in Young Girls with Primary Hypothyroidism.      Endocrine Practice, Volume 13, Number 6 / October 2007, Pages 652-655
  104. Aravind Raj Sanjeevaiah, Gilbert Vassart, Sri S Srikanta. Follicle-stimulating hormone receptor DNA sequencing: Investigation into possible glycoprotein receptor mutation in Van Wyk-Grumbach syndrome. Endocrine practice.   Volume 14, Number 5 / July / August 2008 Pages 648-650  
  105. Cushing syndrome associated with Carney complex; Challenges and difficulties in the diagnostic and therapeutic path. Manjunath Reddy, Prakruthi Lakshman, Madan Gopal, Subbarayappa Sanjay, Tejeswini Deepak, Ardanareshwaran Sharada, Sri S. Srikanta, for the Endocrine Collaborative Study Group; Samatvam Endocrinology Diabetes Center, Bangalore, India. [manuscript under preparation]
  106. Evolution and resolution of spontaneous hypoglycemia and insulin autoimmune syndrome: Continuous glucose monitoring [CGM], Insulin secretory dynamics and immunotherapy. Madan Gopal, Manjunath Reddy, Prakruthi Lakshman, Subbarayappa Sanjay, Tejeswini Deepak, Ardanareshwaran Sharada, Sri S. Srikanta, , for the Endocrine Collaborative Study Group; Samatvam Endocrinology Diabetes Center, Bangalore, India [manuscript under preparation]
  107. Oncogenous osteomalacia [adult onset hypophosphatemic] due to a infrapubic mesenchymal tumors: Diagnostic latency and surgical remission.   Tejeswini Deepak, Deepak Shivanna, Subbarayappa Sanjay,  Ardanareshwaran Sharada, Madan Gopal, Manjunath Reddy,Prakruthi Lakshman, Sri S. Srikanta, , for the Endocrine Collaborative Study Group; Samatvam Endocrinology Diabetes Center, Bangalore, India,   [manuscript under preparation]
  108. Comparison of empagliflozin and glimepiride as add-on to metformin in patients with type 2 diabetes: a 104-week randomised, active-controlled, double-blind, phase 3 trial. Ridderstråle M1, Andersen KR2, Zeller C3, Kim G4, Woerle HJ4, Broedl UC4; EMPA-REG H2H-SU trial investigators. Dr Pushpa Ravikumar (Co Principal Investigator) Dr S Srikanta (Principal Investigator)
  109. A Study of MK-0822 in Postmenopausal Women with Osteoporosis to Assess Fracture Risk (MK-0822-018) Bone HG, Dempster DW, Eisman JA, Greenspan SL, McClung MR, Nakamura T, Papapoulos S, Shih WJ, Rybak-Feiglin A, Santora AC, Verbruggen N, Leung AT, Lombardi A. Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial. Osteoporos Int. 2015 Feb;26(2):699-712. doi: 10.1007/s00198-014-2944-6. Epub 2014 Nov 29.  Dr S Srikanta (Principal Investigator) 
  110. Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial. Barnett AH, Mithal A, Manassie J, Jones R, Rattunde H, Woerle HJ, Broedl UC; EMPA-REG RENAL trial investigators. Lancet Diabetes Endocrinol. 2014 May;2(5):369-84. doi: 10.1016/S2213-8587(13)70208-0. Epub 2014 Ja (Principal Investigator-Dr S Srikanta) 
  111. Sitagliptin Versus Glipizide in Patients with Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1) Arjona Ferreira JC, Marre M, Barzilai N, Guo H, Golm GT, Sisk CM, Kaufman KD, Goldstein BJ, Dr S Srikanta, Dr Pushpa Ravikumar (Co PI). Efficacy and safety of sitagliptin versus glipizide in patients with type 2 diabetes and moderate-to-severe chronic renal insufficiency. Diabetes Care. 2013 May;36(5):1067-73. doi: 10.2337/dc12-1365. Epub 2012 Dec 17.
  112. Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study. Taskinen MR, Rosenstock J, Tamminen I, Kubiak R, Patel S, Dugi KA, Woerle HJ. Dr A Sharda and Dr S Srikanta, [Principal Investigators)
  113. Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease. Green JB, Bethel MA, Paul SK, Ring A, Kaufman KD, Shapiro DR, Califf RM, Holman RR. Dr A Sharda and Dr S Srikanta, [Principal Investigators] Am Heart J. 2013 Dec;166(6):983-989.e7. doi: 10.1016/j.ahj.2013.09.003. Epub 2013 Oct 23.
  114.   Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR; TECOS Study Group.  Dr A Sharda and Dr S Srikanta, [Principal Investigators] N Engl J Med. 2015 Jul 16;373(3):232-42. doi: 10.1056/NEJMoa1501352. Epub 2015 Jun 8. Erratum in: N Engl J Med. 2015 Aug 6;373(6):586. PMID: 26052984 
  115. Regional, age and sex differences in baseline characteristics of patients enrolled in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS). Bethel MA, Green JB, Milton J, Tajar A, Engel SS, Califf RM, Holman RR; TECOS Executive Committee.  Dr A Sharda and Dr S Srikanta, [Principal Investigators] Diabetes Obes Metab. 2015 Apr;17(4):395-402. doi: 10.1111/dom.12441. Epub 2015 Feb 13. PMID: 25600421
  116. Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)–a randomized placebo-controlled trial. Neal B1, Perkovic V, de Zeeuw D, Mahaffey KW, Fulcher G, Stein P, Desai M, Shaw W, Jiang J, Vercruysse F, Meininger G, Matthews D. Am Heart J. 2013 Aug;166(2):217-223.e11. doi: 10.1016/j.ahj.2013.05.007. Epub 2013 Jun 24. Dr A Sharda and Dr S Srikanta, [Principal Investigators] 
  117. Efficacy and safety of canagliflozin, a inhibitor of sodium-glucose cotransporter 2, when used in conjunction with insulin therapy in patients with type 2 diabetes.  Neal B, Perkovic V, de Zeeuw D, Mahaffey KW, Fulcher G, Ways K, Desai M, Shaw W, Capuano G, Alba M, Jiang J, Vercruysse F, Meininger G, Matthews D; CANVAS Trial Collaborative Group. Dr A Sharda and Dr S Srikanta, [Principal Investigators] Diabetes Care. 2015 Mar;38(3):403-11. doi: 10.2337/dc14-1237. Epub 2014 Dec 2. PMID: 25468945 
  118. Effectiveness and Tolerability of Vildagliptin in Indian Patients with Type 2 Diabetes Mellitus: Results from Edge−A Real-World Observational Study.   Subhash K Wangnoo*, Giovanni Bader**, Apurva Gawai, , Shradhanand Singh. Dr A Sharda and Dr S Srikanta, Principal Investigators Indian Journal of Clinical Practice, Vol. 24, No. 6, November 2013 
  119. A dose range finding study of novel oral insulin (IN-105) under fed conditions in type 2 diabetes mellitus subjects. Khedkar A1, Iyer H, Anand A, Verma M, Krishnamurthy S, Savale S, Atignal A.     [Principal Investigator: Srikanta S, Diabetes Obes Metab. 2010 Aug;12(8):659-64. doi: 10.1111/j.1463-1326.2010.01213. x.
  120. Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus Benjamin M. Scirica, M.D., M.P.H., Deepak L. Bhatt, M.D., M.P.H., Eugene Braunwald, M.D., P. Gabriel Steg, M.D., Jaime Davidson, M.D., Boaz Hirshberg, M.D., Peter Ohman, M.D., Robert Frederich, M.D., Ph.D., Stephen D. Wiviott, M.D., Elaine B. Hoffman, Ph.D., Matthew A. Cavender, M.D., M.P.H., Jacob A. Udell, M.D., M.P.H., Nihar R. Desai, M.D., M.P.H., Ofri Mosenzon, M.D., Darren K. McGuire, M.D., Kausik K. Ray, M.D., Lawrence A. Leiter, M.D., and Itamar Raz, M.D., for the SAVOR-TIMI 53 Steering Committee and Investigators*   The New England journal of Medicine Oct 2013 Dr A Sharda and Dr S Srikanta, [Principal Investigators] SAVOR TIMI.
  121. Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52-week results from a randomised, double-blind, phase 3 non-inferiority trial.  Prof William T Cefalu MD Prof Lawrence A Leiter MD c, Prof Kun-Ho Yoon MD d, Prof Pablo Arias MD e f, Prof Leo Niskanen MD g, John Xie PhD h, Dainius A Balis PharmD, William Canovatchel MD h, Gary Meininger MD.  The Lancet, Volume 382, Issue 9896, Pages 941 – 950, 14 September 2013.  Dr A Sharda and Dr S Srikanta, [Principal Investigators]
  122. Adding once-daily lixisenatide for type 2 diabetes inadequately controlled by established basal insulin: a 24-week, randomized, placebo-controlled comparison (GetGoal-L). Riddle MC1, Aronson R, Home P, Marre M, Niemoeller E, Miossec P, Ping L, Ye J, Rosenstock J. Diabetes Care. 2013 Sep;36(9):2489-96. doi: 10.2337/dc12-2454. Epub 2013 Apr 29. Dr A Sharda and Dr S Srikanta, [Principal Investigators]
  123. Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)–a randomized placebo-controlled trial. Neal B1, Perkovic V, de Zeeuw D, Mahaffey KW, Fulcher G, Stein P, Desai M, Shaw W, Jiang J, Vercruysse F, Meininger G, Matthews D. Am Heart J. 2013 Aug;166(2):217-223.e11. doi: 10.1016/j.ahj.2013.05.007. Epub 2013 Jun 24. [Dr K Sumathi Co-Principal Investigator] Dr A Sharda and Dr S Srikanta, [Principal Investigators]
  124. Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes. Vilsbøll T, Rosenstock J, Yki-Järvinen H, Cefalu WT, Chen Y, Luo E, Musser B, Andryuk PJ, Ling Y, Kaufman KD, Amatruda JM, Engel SS, Katz L.. Diabetes Obes Metab. 2010 Feb;12(2):167-77. doi: 10.1111/j.1463-1326.2009.01173. Dr A Sharda and Dr S Srikanta, [Principal Investigators]
  125. Type 1 diabetes: Awareness, management and challenges: Current scenario in India. Kumar KM, Saboo B, Rao PV, Sarda A, Viswanathan V, Kalra S, Sethi B, Shah N, Srikanta S, Jain SM, Raghupathy P, Shukla R, Jhingan A, Chowdhury S, Jabbar PK, Kanungo A, Joshi R, Kumar S, Tandon N, Khadilkar V, Chadha M. Indian J Endocrinol Metab. 2015 Apr;19(Suppl 1): S6-8. doi: 10.4103/2230-8210.155339.
  126. Type 1 diabetes pathogenesis – Prevention??? Krishna CS, Srikanta S. Indian J Endocrinol Metab. 2015 Apr;19(Suppl 1): S58-63. doi: 10.4103/2230-8210.155404
  127.  
  128. The INTERPRET-DD study of diabetes and depression: a protocol. Lloyd CE, Sartorius N, Cimino LC, Alvarez A, Guinzbourg de Braude M, Rabbani G, Uddin Ahmed H, Papelbaum M, Regina de Freitas S, Ji L, Yu X, Gaebel W, Müssig K, Chaturvedi SK, Srikanta S, Burti L, Bulgari V, Musau A, Ndetei D, Heinze G, Romo Nava F, Taj R, Khan A, Kokoszka A, Papasz-Siemieniuk A, Starostina EG, Bobrov AE, Lecic-Tosevski D, Lalic NM, Udomratn P, Tangwongchai S, Bahendeka S, Basangwa D, Mankovsky B Diabet Med. 2015 Jul;32(7):925-34. doi: 10.1111/dme.12719. Epub 2015 Feb 27.
  129. Feasibility of rapid parathormone assay for enabling minimally invasive parathyroid excision. Padma KS, Lakshman K, Srikanta S. Indian J Surg. 2013 Jun;75(3):210-5. doi: 10.1007/s12262-012-0483-y. Epub 2012 Apr 18. 
  130. ‘See-saw’ expression of microRNA-198 and FSTL1 from a single transcript in wound healing. Sundaram GM, Common JE, Gopal FE, Srikanta S, Lakshman K, Lunny DP, Lim TC, Tanavde V, Lane EB, Sampath P. Nature. 2013 Mar 7;495(7439):103-6. doi: 10.1038/nature11890. Epub 2013 Feb 10.
  131. Monogenic Diabetes: Perspectives and clinical implications from pediatric to adult endocrinology.   BV Reshma, KM Chandrika, Geetha Rao, Lakshmi Reddy, Usha Rangaraj, Vasanthi Nath, Babitha D Thyagaraj, S Srikanta and the Samatvam – Jnana Sanjeevini Diabetes Collaborative Study Group.  Pediatric Diabetes [Text book: Changing Diabetes in Children], 2016 [in print]
  132. Insulin love and care: Psychological, social and economic determinants of type 1 diabetes care in India.   Nagamani Srinivas, Owais Haaq, S Malhotra, K Mamatha, BV Reshma, KM Chandrika, Geetha Rao, Lakshmi Reddy, Usha Rangaraj, Vasanthi Nath, Babitha D Thyagaraj, S Srikanta and the Samatvam – Jnana Sanjeevini Diabetes Collaborative Study Group.  Pediatric Diabetes [Text book: Changing Diabetes in Children], 2016 
  133. Effect of ranolazine on glycaemic control in patients with type 2 diabetes treated with either glimepiride or metformin. Pettus, J., Mcnabb, B., Eckel, R. H., Skyler, J. S., Dhalla, A., Guan, S., … Henry, R. H. (2016). [Principal Investigators: Dr S Srikanta, Dr A Sharda] Diabetes, Obesity and Metabolism, 18(5), 463-474. DOI: 10.1111/dom.12629
  134. Improving diabetes care for children with type 1 diabetes from poor families: Changing diabetes in children program, India. KM Prasanna Kumar [Principal Investigator: Dr S Srikanta; Co Investigator: Dr Vasanthi Nath, Dr BV Reshma, Dr Babitha D Thyagaraj] , Indian J Endocrinol Metab. 2014 Jan-Feb; 18(1): 116–117.
  135. Insulin Love and Care: Psychological, Social and Economic Determinants of Type 1 Diabetes Care in India.  Srikanta S, Kamala T, Chandraprabha S, Nath V, Ravikumar P et al. (2017) Endocrinol Metab Int J 4(6): 00108. DOI: 10.15406/emij.2017.04.00108  
  136. Educational and Psychological Aspects Prevalence and correlates of depressive disorders in people with Type 2 diabetes: Results from the International Prevalence and Treatment of Diabetes and Depression (INTERPRET-DD) study, a collaborative study carried out in 14 countries.  C. E. Lloyd , A. Nouwen, N. Sartorius, H. U. Ahmed, A. Alvarez, S. Bahendeka, D. Basangwa, A. E. Bobrov,
    S. Boden, V. Bulgari, L. Burti, S. K. Chaturvedi, L. C. Cimino, W. Gaebel, G. de Girolamo, T. M. Gondek,
    M. Guinzbourg de Braude, A. Guntupalli, M. G. Heinze, L. Ji, X. Hong, A. Khan, A. Kiejna, A. Kokoszka,
    T. Kamala, N. M. Lalic, D. Lecic Tosevski, B. Mankovsky, M. Li, A. Musau, K. Müssig, D. Ndetei, G. Rabbani, S. S. Srikanta, E. G. Starostina, M. Shevchuk, R. Taj, O. Vukovic, W. Wölwer, Y. Xin. Diabetic Medicine. 2018 DOI: 10.1111/dme.13611
  137. Prevalence and correlates of depressive disorders in people with Type 2 diabetes: results from the International Prevalence and Treatment of Diabetes and Depression (INTERPRET‐DD) study, a collaborative study carried out in 14 countries. C. E. Lloyd  A. Nouwen  N. Sartorius  H. U. Ahmed  A. Alvarez  S. Bahendeka  D. Basangwa  A. E. Bobrov  S. Boden  V. Bulgari  L. Burti  S. K. Chaturvedi  L. C. Cimino  W. Gaebel  G. de Girolamo  T. M. Gondek  M. Guinzbourg de Braude  A. Guntupalli  M. G. Heinze  L. Ji  X. Hong  A. Khan  A. Kiejna  A. Kokoszka  T. Kamala  N. M. Lalic  D. Lecic Tosevski  B. Mankovsky  M. Li  A. Musau  K. Müssig  D. Ndetei  G. Rabbani  S. S. Srikanta  E. G. Starostina  M. Shevchuk  R. Taj  O. Vukovic  W. Wölwer  Y. Xin. Diabet Med. 2018 Jun;35(6):760-769
  138. Effects of MK-0941, a Novel Glucokinase Activator, on Glycemic Control in Insulin-Treated Patients with Type 2 Diabetes. Meininger, G. E., Scott, R., Alba, M., Shentu, Y., Luo, E., Amin, H., Davies, M. J., Kaufman, K. D, Goldstein, B. J. [Dr S Srikanta, Principal Investigator] (2011). Effects of MK-0941, a novel glucokinase activator, on glycemic control in insulin-treated patients with type 2 diabetes. Diabetes care, 34(12), 2560-6.  
  139. Aza-heterocyclic Receptors for Direct Electron Transfer Hemoglobin Biosensor. Vinay Kumar, Nikhila Kashyap D.M., Suraj Hebbar, Swetha R., Sujay Prasad, Kamala T., S.S Srikanta, P.R. Krishnaswamy, and Navakanta Bhat, , Nature Sci. Rep. 7, 42031, 2017.
  140. Vinay Kumar, Suraj Hebbar, Rahila Kalam, Sachin Panwar, Sujay Prasad, S. S. Srikanta, P. R. Krishnaswamy, and Navakanta Bhat,” Creatinine-Iron Complex and Its Use in Electrochemical Measurement of Urine Creatinine”, IEEE Sensors Journal, vol. 18, no. 2, January 15, 2018.
  141. Application of a Nanotechnology-Based, Point-of-Care Diagnostic Device in Diabetic Kidney Disease. Vinay Kumar, Suraj Hebbar, Ananthram Bhat, Sachin Panwar, Madhumati Vaishnav, Kavitha Muniraj, Vasanthi Nath, Reshma Banaki Vijay, Sapna Manjunath, Babithadevi Thyagaraj, Chandraprabha Siddalingappa, Muralidharakrishna Chikkamoga Siddaiah, Indranil Dasgupta, Urmila Anandh, Thummala Kamala, S.S. Srikanta, P.R. Krishnaswamy and Navakanta Bhat.  Kidney Int Rep (2018) 
  142. Chaturvedi SK, Manche Gowda S, Ahmed HU, Alosaimi FD, Andreone N, Bobrov A, Bulgari V, Carrà G, Castelnuovo G, de Girolamo G, Gondek T, Jovanovic N, Kamala T, Kiejna A, Lalic N, Lecic-Tosevski D, Minhas F, Mutiso V, Ndetei D, Rabbani G, Somruk S, Srikanta S, Taj R, Valentini U, Vukovic O, Wölwer W, Cimino L, Nouwen A, Lloyd C, Sartorius N. More anxious than depressed: prevalence and correlates in a 15-nation study of anxiety disorders in people with type 2 diabetes mellitus. Gen Psychiatr. 2019 Aug 9;32(4):e100076. doi: 10.1136/gpsych-2019-100076. PMID: 31552386; PMCID: PMC6738670.
  143. Kumar V, Hebbar S, Bhat A, Panwar S, Vaishnav M, Muniraj K, Nath V, Vijay RB, Manjunath S, Thyagaraj B, Siddalingappa C, Chikkamoga Siddaiah M, Dasgupta I, Anandh U, Kamala T, Srikanta SS, Krishnaswamy PR, Bhat N. Application of a Nanotechnology-Based, Point-of-Care Diagnostic Device in Diabetic Kidney Disease. Kidney Int Rep. 2018 Jun 2;3(5):1110-1118. doi: 10.1016/j.ekir.2018.05.008. PMID: 30197977; PMCID: PMC6127407.
  144. Srikanta S, Kamala T, Chandraprabha S, Vibha A Rao (Madhumati Vaishnav) et al. Insulin love and care: psychological, social and economic determinants of type 1 diabetes care in India. Endocrinol Metab Int J. 2017;4(6):165-166. DOI: 10.15406/emij.2017.04.00108
  145. Omwenga VO, Madhumati V, Vinay K, Srikanta S, Bhat N. Mathematical Modelling of Combined Intervention Strategies for the Management and Control of Plasma Glucose of a Diabetes Mellitus Patient: A System Dynamic Modelling Approach. Mathematics. 2023; 11(2):306. https://doi.org/10.3390/math11020306
  146. Vaishnav MS, Kumari N, Srikanta S, Krishnaswamy PR, Balaram P, Bhat N. Differential Spectrum of Albumin Glycation, Oxidation, and Truncation in Type 2 and Type 1 Diabetes: Clinical and Biological Implications. Metab Syndr Relat Disord. 2023;21(7):397-409. doi:10.1089/met.2023.0079
  147. Eternal gratitude and best care to children and families with Type 1 Diabetes: Sharing lessons learnt with Health Care Professional colleagues. Ms Geetha S Rao, Dr Reshma Harsha Vijay and Ms Madhumati S Vaishnav. Cape News ISPAE, June 2022, Volume 26, Issue 2, page 30-32. 
  148. Hoff FW, Xing C, Simha V, Agarwal AK, Zhang X, Lekkala L, Vaishnav MS, Vuitch F, Garg A. Early-onset diabetes mellitus as a presenting feature of Werner’s syndrome in an Indian family. Mol Genet Genomic Med. 2024 Jan;12(1): e2299. doi: 10.1002/mgg3.2299. Epub 2023 Oct 10. PMID: 37815015; PMCID: PMC10767583.
  149. Akinci G, Alyaarubi S, Patni N, Alhashmi N, Al-Shidhani A, Prodam F, Gagne N, Babalola F, Al Senani A, Muniraj K, Elsayed SM, Beghini M, Saydam BO, Allawati M, Vaishnav MS, Can E, Simsir IY, Sorkina E, Dursun F, Kamrath C, Cavdar U, Chakraborty PP, Dogan OA, Al Hosin A, Al Maimani A, Comunoglu N, Hamed A, Huseinbegovic T, Scherer T, Curtis J, Brown RJ, Topaloglu H, Simha V, Wabitsch M, Tuysuz B, Oral EA, Akinci B, Garg A. Metabolic and other morbid complications in congenital generalized lipodystrophy type 4. Am J Med Genet A. 2024 Jan 17. doi: 10.1002/ajmg.a.63533. Epub ahead of print. PMID: 38234231.
  150. Madhumati S Vaishnav, Deepalakshmi PD, Sneha S Hegadi, Divya C, Kotamballi N Chidambara Murthy, Sathyanarayana Srikanta, Sujay Prasad R. Accelerated microbial identification “directly” from positive blood cultures using MALDI-TOF MS: Local clinical laboratory challenges. Diagn Microbiol Infect Dis. 2024 Apr 18;109(3):116306. doi: 10.1016/j.diagmicrobio.2024.116306.
  151. Vaishnav MS, Kumari N, Srikanta S, Simha V, Krishnaswamy PR, Balaram P, Bhat N. Albumin Oxidation and Albumin Glycation Discordance During Type 2 Diabetes Therapy: Biological and Clinical Implications. Metab Syndr Relat Disord. 2024 May 2. doi: 10.1089/met.2023.0275. Epub ahead of print. PMID: 38696648.
  152. Kumar V, Ghosh K, Chandran A, Panwar S, Bhat A, Konaje S, Das S, Srikanta S, Jaganathan L, Prasad S, Venkatesh DB, Shivaram C, Krishnaswamy PR, Bhat N. Multicentric evaluation of a novel point of care electrochemical ELISA platform for SARS-CoV-2 specific IgG and IgM antibody assay. J Virol Methods. 2021 Dec; 298:114275. doi: 10.1016/j.jviromet.2021.114275. Epub 2021 Sep 13. PMID: 34530010; PMCID: PMC8436431.

Original Articles Submitted:

  1. Pembrolizumab-Induced Autoimmune Hypophysitis with “Isolated” ACTH Deficiency: Need for Heightened Awareness and Action Among Medical Fraternity. Srushti Shankar, Sumal S Sundar, Madhumati S Vaishnav, Srikanta Sathyanarayana, et.al. AACE Clinical Case Reports. Manuscript ID: AACECCR-D-24-00075
  2. Clinical Challenges of Paraneoplastic Endocrine Metabolic Syndromes: An Illustrative Example. Srushti Shankar, Sumal S Sundar, Madhumati S Vaishnav, Srikanta Sathyanarayana, et.al. AACE Clinical Case Reports. Manuscript ID: AACECCR-D-24-00076 
  3. Management of “Hyperandrogenism” Confounded by Dermatology Biotin Prescriptions. Sumal S Sundar, Srushti Shankar, Madhumati S Vaishnav, Srikanta Sathyanarayana, et.al. AACE Clinical Case Reports. Manuscript ID: AACECCR-D-24-00077
  4. Enigmatic Spontaneous Hypoglycemia During Prolonged Complete Remission in a Child with Autoantibody-Positive Diabetes: Possible Role of Coincidental GYS2 Heterozygous Mutation. Sumal S Sundar, Srushti Shankar, Madhumati S Vaishnav, Srikanta Sathyanarayana, et.al. AACE Clinical Case Reports. Manuscript ID: AACECCR-D-24-00078

Truncated Albumins as Novel Surrogate Biomarkers in Diabetes Therapy: Epiphenomena and Potential Clinical Applications. Madhumati S Vaishnav, Namita Kumari, Sathyanarayana Srikanta, Vinaya Simha, Patnam R Krishnaswamy, and Navakanta Bhat. Metab Syndr Relat Disord. 

Original Articles Under Submission:

  1. Exploring Glycated Sites in Human Serum Albumin: Impact of Sample Processing Techniques on Detection and Analysis. Namita Kumari, Madhumati S Vaishnav, Sathyanarayana Srikanta, P. R. Krishnaswamy, Navakanta Bhat and P. Balaram. Manuscript ID: AY-ART-03-2024-000503. Analytical Methods.
  2. Diabetogenesis in Werner Syndrome: Insulin Sensitivity and Secretion and Associated Biomarkers in Family Members with The Pathogenic WRN Gene Mutation. Madhumati S Vaishnav, Suvyaktha Simha, Leena Lekkala, Kavitha Muniraj, Reshma BV, Yug Garg, Sneha KL Rao, Vinaya Simha. Metab Syndr Relat Disord.
  3. Selectively Increased C-Terminal Albumin Truncation (HSA-L) in Diabetes Chronic Kidney Disease. Madhumati S Vaishnav, Namita Kumari, Sathyanarayana Srikanta, Patnam R Krishnaswamy, Padmanabhan Balaram and Navakanta Bhat. Metab Syndr Relat Disord.
  4. Congenital Generalized Lipodystrophy, Albumin Molecular Modifications and Insulin Resistance: Nature’s Model and New Learnings. Madhumati S Vaishnav, Namita Kumari, Kavitha Muniraj, Reshma Harsha, Apoorva Govind, Leena Lekkala, Sathyanarayana Srikanta, Vinaya Simha, Abhimanyu Garg, Patnam R Krishnaswamy, Padmanabhan Balaram, and Navakanta Bhat. Metab Syndr Relat Disord.
  5. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
  6. Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, Shaw W, Law G, Desai M, Matthews DR; CANVAS Program Collaborative Group.
  7. N Engl J Med. 2017 Aug 17;377(7):644-657. doi: 10.1056/NEJMoa1611925. Epub 2017 Jun 12.
  8. PMID: 28605608 Clinical Trial.
  9. Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
  10. Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR; TECOS Study Group.
  11. N Engl J Med. 2015 Jul 16;373(3):232-42. doi: 10.1056/NEJMoa1501352. Epub 2015 Jun 8.
  12. PMID: 26052984 Clinical Trial.
  13. Prevalence and correlates of depressive disorders in people with Type 2 diabetes: results from the International Prevalence and Treatment of Diabetes and Depression (INTERPRET-DD) study, a collaborative study carried out in 14 countries.
  14. Lloyd CE, Nouwen A, Sartorius N, Ahmed HU, Alvarez A, Bahendeka S, Basangwa D, Bobrov AE, Boden S, Bulgari V, Burti L, Chaturvedi SK, Cimino LC, Gaebel W, de Girolamo G, Gondek TM, de Braude MG, Guntupalli A, Heinze MG, Ji L, Hong X, Khan A, Kiejna A, Kokoszka A, Kamala T, Lalic NM, Lecic Tosevski D, Mankovsky B, Li M, Musau A, Müssig K, Ndetei D, Rabbani G, Srikanta S, Starostina EG, Shevchuk M, Taj R, Vukovic O, Wölwer W, Xin Y.
  15. Diabet Med. 2018 Jun;35(6):760-769. doi: 10.1111/dme.13611. Epub 2018 Mar 30.
  16. PMID: 29478265 Clinical Trial.
  17. Management of anemia in patients with diabetic kidney disease: A consensus statement.
  18. Bajaj S, Makkar BM, Abichandani VK, Talwalkar PG, Saboo B, Srikanta S, Das A, Chandrasekaran S, Krishnan PV, Shah A, Abraham G, Tikku P, Kumar S.
  19. Indian J Endocrinol Metab. 2016 Mar-Apr;20(2):268-81. doi: 10.4103/2230-8210.176348.
  20. PMID: 27042425 Free PMC article. Review.
  21. Aza-heterocyclic Receptors for Direct Electron Transfer Hemoglobin Biosensor.
  22. Kumar V, Kashyap DM, Hebbar S, Swetha R, Prasad S, Kamala T, Srikanta S, Krishnaswamy PR, Bhat N.
  23. Sci Rep. 2017 Feb 7; 7:42031. doi: 10.1038/srep42031.
  24. PMID: 28169325 Free PMC article.
  25. The INTERPRET-DD study of diabetes and depression: a protocol.
  26. Lloyd CE, Sartorius N, Cimino LC, Alvarez A, Guinzbourg de Braude M, Rabbani G, Uddin Ahmed H, Papelbaum M, Regina de Freitas S, Ji L, Yu X, Gaebel W, Müssig K, Chaturvedi SK, Srikanta S, Burti L, Bulgari V, Musau A, Ndetei D, Heinze G, Romo Nava F, Taj R, Khan A, Kokoszka A, Papasz-Siemieniuk A, Starostina EG, Bobrov AE, Lecic-Tosevski D, Lalic NM, Udomratn P, Tangwongchai S, Bahendeka S, Basangwa D, Mankovsky B.
  27. Diabet Med. 2015 Jul;32(7):925-34. doi: 10.1111/dme.12719. Epub 2015 Feb 27.
  28. PMID: 25659409 Clinical Trial.
  29. Type 1 diabetes pathogenesis – Prevention???
  30. Krishna CS, Srikanta S.
  31. Indian J Endocrinol Metab. 2015 Apr;19(Suppl 1):S58-63. doi: 10.4103/2230-8210.155404.
  32. PMID: 25941654 Free PMC article.
  33. Efficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetes.
  34. Fulcher G, Matthews DR, Perkovic V, de Zeeuw D, Mahaffey KW, Mathieu C, Woo V, Wysham C, Capuano G, Desai M, Shaw W, Vercruysse F, Meininger G, Neal B; CANVAS trial collaborative group.
  35. Diabetes Obes Metab. 2016 Jan;18(1):82-91. doi: 10.1111/dom.12589. Epub 2015 Dec 8.
  36. PMID: 26450639 Clinical Trial.
  37. Type 1 diabetes: Awareness, management and challenges: Current scenario in India.
  38. Kumar KM, Saboo B, Rao PV, Sarda A, Viswanathan V, Kalra S, Sethi B, Shah N, Srikanta S, Jain SM, Raghupathy P, Shukla R, Jhingan A, Chowdhury S, Jabbar PK, Kanungo A, Joshi R, Kumar S, Tandon N, Khadilkar V, Chadha M.
  39. Indian J Endocrinol Metab. 2015 Apr;19(Suppl 1):S6-8. doi: 10.4103/2230-8210.155339.
  40. PMID: 25941655 Free PMC article.
  41. Safety and efficacy of ranirestat in patients with mild-to-moderate diabetic sensorimotor polyneuropathy.
  42. Polydefkis M, Arezzo J, Nash M, Bril V, Shaibani A, Gordon RJ, Bradshaw KL, Junor RW; Ranirestat Study Group.
  43. J Peripher Nerv Syst. 2015 Dec;20(4):363-71. doi: 10.1111/jns.12138.
  44. PMID: 26313450 Clinical Trial.
  45. Application of a Nanotechnology-Based, Point-of-Care Diagnostic Device in Diabetic Kidney Disease.
  46. Kumar V, Hebbar S, Bhat A, Panwar S, Vaishnav M, Muniraj K, Nath V, Vijay RB, Manjunath S, Thyagaraj B, Siddalingappa C, Chikkamoga Siddaiah M, Dasgupta I, Anandh U, Kamala T, Srikanta S, Krishnaswamy PR, Bhat N.
  47. Kidney Int Rep. 2018 Jun 2;3(5):1110-1118. doi: 10.1016/j.ekir.2018.05.008. eCollection 2018 Sep.
  48. PMID: 30197977 Free PMC article.
  49. Pre-hyperglycemic diabetes mellitus.
  50. Soeldner JS, Srikanta S, Eisenbarth GS, Gleason RE.
  51. Clin Chem. 1986 Oct;32(10 Suppl):B7-18.
  52. PMID: 3530543 Review. No abstract available.
  53. More anxious than depressed: prevalence and correlates in a 15-nation study of anxiety disorders in people with type 2 diabetes mellitus.
  54. Chaturvedi SK, Manche Gowda S, Ahmed HU, Alosaimi FD, Andreone N, Bobrov A, Bulgari V, Carrà G, Castelnuovo G, de Girolamo G, Gondek T, Jovanovic N, Kamala T, Kiejna A, Lalic N, Lecic-Tosevski D, Minhas F, Mutiso V, Ndetei D, Rabbani G, Somruk S, Srikanta S, Taj R, Valentini U, Vukovic O, Wölwer W, Cimino L, Nouwen A, Lloyd C, Sartorius N.
  55. Gen Psychiatr. 2019 Aug 9;32(4):e100076. doi: 10.1136/gpsych-2019-100076. eCollection 2019.
  56. PMID: 31552386 Free PMC article.
  57. Islet cell autoantibodies: pathobiology and clinical applications.
  58. Vardi P, Dibella EE, Pasquarello TJ, Srikanta S.
  59. Diabetes Care. 1987 Sep-Oct;10(5):645-56. doi: 10.2337/diacare.10.5.645.
  60. PMID: 3315517 Review.
  61. Disappearing anti-islet antibodies?
  62. Srikanta S, Eisenbarth GS.
  63. Lancet. 1984 May 26;1(8387):1176-7. doi: 10.1016/s0140-6736(84)91414-4.
  64. PMID: 6144892 No abstract available.
  65. ‘See-saw’ expression of microRNA-198 and FSTL1 from a single transcript in wound healing.
  66. Sundaram GM, Common JE, Gopal FE, Srikanta S, Lakshman K, Lunny DP, Lim TC, Tanavde V, Lane EB, Sampath P.
  67. Nature. 2013 Mar 7;495(7439):103-6. doi: 10.1038/nature11890. Epub 2013 Feb 10.
  68. PMID: 23395958
  69. Feasibility of rapid parathormone assay for enabling minimally invasive parathyroid excision.
  70. Padma KS, Lakshman K, Srikanta S.
  71. Indian J Surg. 2013 Jun;75(3):210-5. doi: 10.1007/s12262-012-0483-y. Epub 2012 Apr 18.
  72. PMID: 24426429 Free PMC article.
  73. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
  74. Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, Ray KK, Leiter LA, Raz I; SAVOR-TIMI 53 Steering Committee and Investigators.
  75. N Engl J Med. 2013 Oct 3;369(14):1317-26. doi: 10.1056/NEJMoa1307684. Epub 2013 Sep 2.
  76. PMID: 23992601 Clinical Trial.
  77. Follicle-stimulating hormone receptor DNA sequencing: investigation into possible glycoprotein receptor mutation in Van Wyk-Grumbach syndrome.
  78. Sanjeevaiah AR, Vassart G, Srikanta S.
  79. Endocr Pract. 2008 Jul-Aug;14(5):648. doi: 10.4158/EP.14.5.648.
  80. PMID: 18753112 No abstract available.
  81. Genetically programmed selective islet beta-cell loss in diabetic subjects with Wolfram’s syndrome.
  82. Karasik A, O’Hara C, Srikanta S, Swift M, Soeldner JS, Kahn CR, Herskowitz RD.
  83. Diabetes Care. 1989 Feb;12(2):135-8. doi: 10.2337/diacare.12.2.135.
  84. PMID: 2649325
  85. Effect of anti-IL-1β antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo-controlled trial.
  86. Rissanen A, Howard CP, Botha J, Thuren T; Global Investigators.
  87. Diabetes Obes Metab. 2012 Dec;14(12):1088-96. doi: 10.1111/j.1463-1326.2012.01637.x. Epub 2012 Jul 
  88. PMID: 22726220 Clinical Trial.
  89. Burden of neuropathic pain in Indian patients attending urban, specialty clinics: results from a cross sectional study.
  90. IndINeP Study Group.
  91. Pain Pract. 2008 Sep-Oct;8(5):362-78. doi: 10.1111/j.1533-2500.2008.00208.x. Epub 2008 May 29.
  92. PMID: 18513226
  93. Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial.
  94. Bergenstal RM, Wysham C, Macconell L, Malloy J, Walsh B, Yan P, Wilhelm K, Malone J, Porter LE; DURATION-2 Study Group.
  95. Lancet. 2010 Aug 7;376(9739):431-9. doi: 10.1016/S0140-6736(10)60590-9. Epub 2010 Jun 26.
  96. PMID: 20580422 Clinical Trial.
  97. 24.Assay for islet cell antibodies. Protein A–monoclonal antibody method.
  98. Srikanta S, Rabizadeh A, Omar MA, Eisenbarth GS.
  99. Diabetes. 1985 Mar;34(3):300-5. doi: 10.2337/diab.34.3.300.
  100. PMID: 2579003
  101. 25. Substrate for islet cell antibody assays.
  102. Raju R, Srikanta S, Kochupillai N.
  103. Diabetes Res Clin Pract. 1994 Jun;24(2):121. doi: 10.1016/0168-8227(94)90029-9.
  104. PMID: 7956709 No abstract available.
  105. 26.Immunocytochemical patterns of islet cell tumors as defined by the monoclonal antibody HISL-19.
  106. Bordi C, Krisch K, Horvat G, Srikanta S.
  107. Am J Pathol. 1988 Aug;132(2):249-57.
  108. PMID: 2840831 Free PMC article.
  109. 27.Precocious puberty and large multicystic ovaries in young girls with primary hypothyroidism.
  110. Sanjeevaiah AR, Sanjay S, Deepak T, Sharada A, Srikanta S.
  111. Endocr Pract. 2007 Oct;13(6):652-5. doi: 10.4158/EP.13.6.652.
  112. PMID: 17954423
  113. 28.Occurrence of glomerulonephritis and autoantibodies in diabetes mellitus.
  114. Bhuyan UN, Dash SC, Srikanta S, Malaviya AN, Malhotra KK.
  115. J Assoc Physicians India. 1984 Feb;32(2):171-5.
  116. PMID: 6235208 No abstract available.
  117. 29.Factors associated with the onset of major depressive disorder in adults with type 2 diabetes living in 12 different countries: results from the INTERPRET-DD prospective study.
  118. Lloyd CE, Sartorius N, Ahmed HU, Alvarez A, Bahendeka S, Bobrov AE, Burti L, Chaturvedi SK, Gaebel W, de Girolamo G, Gondek TM, Guinzbourg M, Heinze MG, Khan A, Kiejna A, Kokoszka A, Kamala T, Lalic NM, Lecic-Tosevski D, Mannucci E, Mankovsky B, Müssig K, Mutiso V, Ndetei D, Nouwen A, Rabbani G, Srikanta S, Starostina EG, Shevchuk M, Taj R, Valentini U, van Dam K, Vukovic O, Wölwer W.
  119. Epidemiol Psychiatr Sci. 2020 Jun 2;29:e134. doi: 10.1017/S2045796020000438.
  120. PMID: 32484148 Free PMC article.
  121. 30.Heterogeneity of islet cell autoantibodies in terms of insulin release from rat islets and insulinoma cells.
  122. Ejiri K, Taniguchi H, Morimoto Y, Yamashiro Y, Baba S, Srikanta S, Eisenbarth GS.
  123. Diabetes Res Clin Pract. 1990 Apr;9(1):1-5. doi: 10.1016/0168-8227(90)90002-b.
  124. PMID: 2161728
  125. 31.HLA antigens in type I (insulin-dependent) diabetes mellitus in North India.
  126. Srikanta S, Mehra NK, Vaidya MC, Malaviya AN, Ahuja MM.
  127. Metabolism. 1981 Oct;30(10):992-3. doi: 10.1016/0026-0495(81)90098-6.
  128. PMID: 7024726
  129. 32.I-45 islet cell antigen is a 68kD neuroendocrine protein.
  130. Raju R, Srikanta S, Shah P, Kochupillai N.
  131. Immunol Invest. 1995 May;24(4):573-82. doi: 10.3109/08820139509066858.
  132. PMID: 7622195
  133. 33.Autoimmunity in type I (insulin-dependent) diabetes mellitus in North India.
  134. Srikanta S, Malaviya AN, Mehra NK, Vaidya MC, Geevarghese PJ, Ahuja MM.
  135. J Clin Immunol. 1981 Jul;1(3):169-73. doi: 10.1007/BF00922759.
  136. PMID: 7037829
  137. 34.Medullary thyroid carcinomas express chromogranin A and a novel neuroendocrine protein recognized by monoclonal antibody HISL-19.
  138. Deftos LJ, Woloszczuk W, Krisch I, Horvat G, Ulrich W, Neuhold N, Braun O, Reiner A, Srikanta S, Krisch K.
  139. Am J Med. 1988 Dec;85(6):780-4. doi: 10.1016/s0002-9343(88)80021-4.
  140. PMID: 3195602
  141. 35.Type I (insulin-requiring) diabetes mellitus in North India: HLA and autoimmunity.
  142. Srikanta S, Ahuja MM, Malaviya AN, Mehra NK, Vaidya MC.
  143. N Engl J Med. 1981 May 7;304(19):1175-6. doi: 10.1056/NEJM198105073041918.
  144. PMID: 7012621 No abstract available.
  145. 36.Chronic calcific pancreatitis of the tropics (CCPT): spectrum and correlates of exocrine and endocrine pancreatic dysfunction.
  146. Sidhu SS, Shah P, Prasanna BM, Srikanta S, Tandon RK.
  147. Diabetes Res Clin Pract. 1995 Feb;27(2):127-32. doi: 10.1016/0168-8227(94)01021-q.
  148. PMID: 760705
  149. Binding of monoclonal antibody (4F2) to its cell surface antigen on dispersed adenomatous parathyroid cells raises cytosolic calcium and inhibits parathyroid hormone secretion.
  150. Posillico JT, Srikanta S, Eisenbarth G, Quaranta V, Kajiji S, Brown EM.
  151. J Clin Endocrinol Metab. 1987 Jan;64(1):43-50. doi: 10.1210/jcem-64-1-43.
  152. PMID: 3782435
  153. Islet cell antigens. Initial studies of their biology and function.
  154. Srikanta S, Eisenbarth GS.
  155. Mol Biol Med. 1986 Apr;3(2):113-27.
  156. PMID: 2426556
  157. “Cytoplasmic” islet cell antibodies. Evidence that the target antigen is a sialoglycoconjugate.
  158. Nayak RC, Omar MA, Rabizadeh A, Srikanta S, Eisenbarth GS.
  159. Diabetes. 1985 Jun;34(6):617-9. doi: 10.2337/diab.34.6.617.
  160. PMID: 2989050
  161. Prevalence & significance of pancreatic islet cell & adrenal antibodies in patients with Graves’ disease.
  162. Goswami R, Srikanta S, Kochupillai N.
  163. Indian J Med Res. 1995 May;101:201-6.
  164. PMID: 7601498
  165. Monoclonal antibody HISL-19 as an immunocytochemical probe for neuroendocrine differentiation. Its application in diagnostic pathology.
  166. Krisch K, Buxbaum P, Horvat G, Krisch I, Neuhold N, Ulrich W, Srikanta S.
  167. Am J Pathol. 1986 Apr;123(1):100-8.
  168. PMID: 3515956 Free PMC article.
  169. Monoclonal antibodies to a human islet cell surface glycoprotein: 4F2 and LC7-2.
  170. Srikanta S, Telen M, Posillico JT, Dolinar R, Krisch K, Haynes BF, Eisenbarth GS.
  171. Endocrinology. 1987 Jun;120(6):2240-4. doi: 10.1210/endo-120-6-2240.
  172. PMID: 243689743.
  173. Acquired defect in interleukin-2 production in patients with type I diabetes mellitus.
  174. Kaye WA, Adri MN, Soeldner JS, Rabinowe SL, Kaldany A, Kahn CR, Bistrian B, Srikanta S, Ganda OP, Eisenbarth GS.
  175. N Engl J Med. 1986 Oct 9;315(15):920-4. doi: 10.1056/NEJM198610093151502.
  176. PMID: 353185044.
  177. Islet-cell antibodies and beta-cell function in monozygotic triplets and twins initially discordant for Type I diabetes mellitus.
  178. Srikanta S, Ganda OP, Eisenbarth GS, Soeldner JS.
  179. N Engl J Med. 1983 Feb 10;308(6):322-5. doi: 10.1056/NEJM198302103080607.
  180. PMID: 6337325 No abstract available.
  181.  
  182. 45.
  183. Pre-type I diabetes. Linear loss of beta cell response to intravenous glucose.
  184. Srikanta S, Ganda OP, Gleason RE, Jackson RA, Soeldner JS, Eisenbarth GS.
  185. Diabetes. 1984 Aug;33(8):717-20. doi: 10.2337/diab.33.8.717.
  186. PMID: 6378696
  187. 46.Insulin-dependent diabetes mellitus and autoimmunity: islet-cell autoantibodies, insulin autoantibodies, and beta-cell failure.
  188. Soeldner JS, Tuttleman M, Srikanta S, Ganda OP, Eisenbarth GS.
  189. N Engl J Med. 1985 Oct 3;313(14):893-4. doi: 10.1056/NEJM198510033131417.
  190. PMID: 3897867 No abstract available.
  191. 47.Type I diabetes mellitus in monozygotic twins: chronic progressive beta cell dysfunction.
  192. Srikanta S, Ganda OP, Jackson RA, Gleason RE, Kaldany A, Garovoy MR, Milford EL, Carpenter CB, Soeldner JS, Eisenbarth GS.
  193. Ann Intern Med. 1983 Sep;99(3):320-6. doi: 10.7326/0003-4819-99-3-320.
  194. PMID: 6351687
  195. Diminished A-cell secretion in the early phase of type I diabetes mellitus.
  196. Ganda OP, Srikanta S, Gleason RE, Soeldner JS, Eisenbarth GS.
  197. Metabolism. 1986 Nov;35(11):1074-7. doi: 10.1016/0026-0495(86)90046-6.
  198. PMID: 3534518
  199. 49.Islet cell proteins defined by monoclonal islet cell antibody HISL-19.
  200. Srikanta S, Krisch K, Eisenbarth GS.
  201. Diabetes. 1986 Mar;35(3):300-5. doi: 10.2337/diab.35.3.300.
  202. PMID: 3512340
  203. 50.Anti-thymocyte globulin and prednisone immunotherapy of recent onset type 1 diabetes mellitus.
  204. Eisenbarth GS, Srikanta S, Jackson R, Rabinowe S, Dolinar R, Aoki T, Morris MA.
  205. Diabetes Res. 1985 Nov;2(6):271-6.
  206. PMID: 3878262
  207. 51.Progressive autoimmune beta cell insufficiency: occurrence in the absence of high-risk HLA alleles DR3, DR4.
  208. Eisenbarth GS, Srikanta S, Fleischnick E, Ganda OP, Jackson RA, Brink SJ, Soeldner JS, Yunis EJ, Alper C.
  209. Diabetes Care. 1985 Sep-Oct;8(5):477-80. doi: 10.2337/diacare.8.5.477.
  210. PMID: 3876922
  211. 52.Human islet cell antibodies: immunoglobulin class and subclass distribution defined by monoclonal antibodies.
  212. Omar MA, Srikanta S, Eisenbarth GS.
  213. Diabetes Res. 1987 Apr;4(4):155-7.
  214. PMID: 3304781
  215. 53.Autoimmunity to insulin, beta cell dysfunction, and development of insulin-dependent diabetes mellitus.
  216. Srikanta S, Ricker AT, McCulloch DK, Soeldner JS, Eisenbarth GS, Palmer JP.
  217. Diabetes. 1986 Feb;35(2):139-42. doi: 10.2337/diab.35.2.139.
  218. PMID: 3510920
  219. 54.Pre-type 1 (insulin-dependent) diabetes: common endocrinological course despite immunological and immunogenetic heterogeneity.
  220. Srikanta S, Ganda OP, Jackson RA, Brink SJ, Fleischnick E, Yunis E, Alper C, Soeldner JS, Eisenbarth GS.
  221. Diabetologia. 1984 Jul;27 Suppl:146-8. doi: 10.1007/BF00275674.
  222. PMID: 6383919
  223. 55.First-degree relatives of patients with type I diabetes mellitus. Islet-cell antibodies and abnormal insulin secretion.
  224. Srikanta S, Ganda OP, Rabizadeh A, Soeldner JS, Eisenbarth GS.
  225. N Engl J Med. 1985 Aug 22;313(8):461-4. doi: 10.1056/NEJM198508223130801.
  226. PMID: 3894969
  227. 56.Subclinical abnormalities of glucose metabolism in subjects with previous gestational diabetes.
  228. Catalano PM, Bernstein IM, Wolfe RR, Srikanta S, Tyzbir E, Sims EA.
  229. Am J Obstet Gynecol. 1986 Dec;155(6):1255-62. doi: 10.1016/0002-9378(86)90155-9.
  230. PMID: 3538877
  231. 57.Monoclonal antibody-mediated modulation of parathyroid hormone secretion by dispersed parathyroid cells.
  232. Posillico JT, Wilson RE, Srikanta S, Eisenbarth GS, Letarte M, Quackenbush EJ, Quaranta V, Kajaji S, Brown EM.
  233. Arch Surg. 1987 Apr;122(4):436-42. doi: 10.1001/archsurg.1987.01400160062009.
  234. PMID: 3551881
  235. 58.Pancreatic islet transplantation: utility of ductular obstruction and exocrine atrophy model?
  236. Verma A, Dinda A, Sarkar C, Fotedar R, Dhawan IK, Sharma LK, Khetarpal K, Fotedar A, Srikanta S, Kochupillai N, et al.
  237. Trop Gastroenterol. 1990 Jul-Sep;11(3):148-51.
  238. PMID: 2267673
  239. 59.Association of type I (insulin-dependent) diabetes mellitus, autoimmunity, antinuclear antibody, and membranoproliferative glomerulonephritis.
  240. Srikanta S, Malaviya AN, Rajagopalan P, Bhuyan UN, Ahuja MM.
  241. Diabetes Care. 1983 Jan-Feb;6(1):71-4. doi: 10.2337/diacare.6.1.71.
  242. PMID: 6220878
  243. 60.
  244. Twin-to-twin pancreas transplantation: reversal and reenactment of the pathogenesis of type I diabetes.
  245. Sutherland DE, Sibley R, Xu XZ, Michael A, Srikanta AM, Taub F, Najarian J, Goetz FC.
  246. Trans Assoc Am Physicians. 1984;97:80-7.
  247. PMID: 6398950 No abstract available.
  248. 61.Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes.
  249. Baekkeskov S, Landin M, Kristensen JK, Srikanta S, Bruining GJ, Mandrup-Poulsen T, de Beaufort C, Soeldner JS, Eisenbarth G, Lindgren F, et al.
  250. J Clin Invest. 1987 Mar;79(3):926-34. doi: 10.1172/JCI112903.
  251. PMID: 3546382 Free PMC article.
  252. 62.Differential sensitivity to beta-cell secretagogues in “early,” type I diabetes mellitus.
  253. Ganda OP, Srikanta S, Brink SJ, Morris MA, Gleason RE, Soeldner JS, Eisenbarth GS.
  254. Diabetes. 1984 Jun;33(6):516-21. doi: 10.2337/diab.33.6.516.
  255. PMID: 6373458
  256. Parathyroid cell surface autoantibodies that inhibit parathyroid hormone secretion from dispersed human parathyroid cells.
  257. Posillico JT, Wortsman J, Srikanta S, Eisenbarth GS, Mallette LE, Brown EM.
  258. J Bone Miner Res. 1986 Oct;1(5):475-83. doi: 10.1002/jbmr.5650010512.
  259. PMID: 3332555
  260. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study. McClung MR, O’Donoghue ML, Papapoulos SE, Bone H, Langdahl B, Saag KG, Reid IR, Kiel DP, Cavallari I, Bonaca MP, Wiviott SD, de Villiers T, Ling X, Lippuner K, Nakamura T, Reginster JY, Rodriguez-Portales JA, Roux C, Zanchetta J, Zerbini CAF, Park JG, Im K, Cange A, Grip LT, Heyden N, DaSilva C, Cohn D, Massaad R, Scott BB, Verbruggen N, Gurner D, Miller DL, Blair ML, Polis AB, Stoch SA, Santora A, Lombardi A, Leung AT, Kaufman KD, Sabatine MS; LOFT Investigators. Lancet Diabetes Endocrinol. 2019 Dec;7(12):899-911. doi: 10.1016/S2213-8587(19)30346-8. Epub 2019 Oct 31. PMID: 31676222.
  261. Multicentric evaluation of a novel point of care electrochemical ELISA platform for SARS-CoV-2 specific IgG and IgM antibody assay. Kumar V, Ghosh K, Chandran A, Panwar S, Bhat A, Konaje S, Das S, Srikanta S, Jaganathan L, Prasad S, Venkatesh DB, Shivaram C, Krishnaswamy PR, Bhat N. J Virol Methods. 2021 Dec; 298:114275. doi: 10.1016/j.jviromet.2021.114275. Epub 2021 Sep 13. PMID: 34530010; PMCID: PMC8436431.
  262. Publications: Books / Chapters
  263. Book Chapters (Under Print): 
  264. Diabetes Care for The Bottom of The Socioeconomic Pyramid: Four Decades of Science, Medicine, Creativity and Empathy (Samatvam – India Model). Kavitha Krishnamurthy Muniraj, Madhumati S Vaishnav and Satyanarayana Srikanta, et.al Cardiometabolic Diseases: Molecular Basis, Early Detection of Risks, and Management. Life Science Elsevier. (Under Print)
  265. Diabetes and comorbid depression – Two stories from India: Societal values and challenges, and the healing power of indomitable human Spirit. Thummala Kamala, Kavitha Krishnamurthy Muniraj, Madhumati S Vaishnav, Sathyanarayana Srikanta, et.al (Under Print)
  266. Type 2 Diabetes and Depression in India: Care, Culture, Science and Lessons from INTERPRET-DD. Thummala Kamala, Kavitha Krishnamurthy Muniraj, Madhumati S Vaishnav and Sathyanarayana Srikanta, et.al (Under Print)
  267. Publications: Abstracts
  268. Mehra NK, Srikanta S, Ahuja MS, Vaidya MC, Malaviya AN.  HLA antigens in type I (insulin-dependent) diabetes mellitus in North India.  Indian immunology Society 1980; 44:78A.
  269. Srkanta S, Malaviya AN, Mehra NK, Vaidya MC, Ahuja MMS, Verghese G, Autoimmunity in Type I (insulin dependent) diabetes mellitus in North India.  Assoc Phys India 1981;18.
  270. Srikanta S Mehra NK, Vaidya MC, Malaviya AN, Ahuja MMS. HLA antigens in type I (insulin-dependent) diabetes mellitus in North India.  Assoc Phys India 1981; 18.
  271. Srikanta S, Manjunath N, Balaya S, Malaviya AN, Ahuja MMS. Coxsackie B virus antibodies in type I (insulin –dependent) Diabetes Mellitus in North India.  Assoc Phys India 1981;18.
  272. Srikanta S, Dolinar R, Eisenbarth GS.  Identification of islets on sections of human pancreas with murine monoclonal antibody 4F2; and aid in to determination of human anti-islet antibodies.  Diabetes 1981 ;31(suppl 2):48A..   
  273. Jackson R, Dolinar R, Srikanta S, Morris MA, eisenbarth GS.  Prednisone therapy in early Type I diabetes: immunologic effects.  Diabetes 1982; 31 (suppl 2): 48A.
  274. Buse J, Srikanta S, Rabizadeh A, Powers AC, Jackson RA, Eisenbarth GS. Production of monoclonal antibody from BB rat lymphocytes. American Diabetes Association, Massachusetts Affiliate 1982;6.
  275. Srikanta S, Ganda OP, Eisenbarth GS, Soeldner JS.  Islet cell antiodies and beta cell function in monozygotic triplets and twins:  a longitudinal study.  American Diabetes Association, Massachusetts affiliate 1982;6. 
  276. Srikanta S, Ganda OP, gleason RE, Soedner JS, Eisenbarth GA.  Islet cell antibodies and chronic progressive beta cell dysfunction in monozygotic twins.  Clin Res 1982;31(2):397A. 
  277. Eisenbarth GS, Srikanta S, Jackson R, Dolinar R, Morris MA.  Immunotherapy of recent onset Type I Diabetes mellitus.  Clin Res 1983;31(2):500A. 
  278. Jackson RA, Srikanta S, Morries MA, Dolinar R, Aoki T, Eisenbarth GS.  Immunologic subgroups of Type I Diabetes: 92% of adults have la positive T cells.  Clin Res  1983;31(2):388A. 
  279. Buse JB, Srikanta S, Haynes BF, Eisenbarth GS. Type I diabetes mellitus:  monoclonal human and autoantibodies reacting with subsets of thymic endocrine epithelium.  Clin Res 1983; 31(2): 388A.
  280. Srikanta S, Ganda OP. Chronic progressive beta cell dysfunction in relatives of patients with type I Diabetes 1983;32(1):51A.
  281. Ganda OP, Srikanta S, gleason RE, Soeldner JS, Eisenbarth GS. Selective absence of intravenous glucose stimulated insulin secretion in early phase and following immunotherapy of type I diabetes mellitus.  Diabetes 1983;32(1):50A.
  282. Srikanta S, Ganda OP, Jackson R, Soeldner JS, Eisenbarth GS.  Pre-Type I diabetes; chronic progressive deterioration of insulin secretory dynamics.  American Diabetes Association, Massachusetts Affiliate 1983;13.
  283. Ricker A, Rabizadeh A, Eisenbarth GS, Srikanta S, Monoclonal antiman islet cell antibodies: probes for the study of unique islet ell antigens.  Immunology in diabetes 84, International Symposium, Rome, Italy 1984; 97.
  284. Srikanta S, Ganda OP, soeldener JS, Gleason RE, Brink SJ, Jackson RA, Ricker A, Eisenbarth GS.  Pre-Type I diabetes: delineation with 3-minute intravenous glucose tolerance test, islet cell cytoplasmic anatibodies and I a positive T cells.  Immunology in diabetes 84, International Symposium, Rome, Italy 1984; 109.
  285. Srikanta S, Ricker A, Rabizadeh A, Eisenbarth GS. Isolation and characterization of a novel (p 100) human islet cell surface protein. Clin Res 1984; 32(2):409A.
  286. Rabinowe SL, Jackson RA, Morris MA, Srikanta S, Eisenbarth GS. Differential immunologic effects of horse anti-thymocyte globulin (ATGAM) as compared to monoclonal antibody T 12 in the therapy of recent onset type I diabetes.  Clin Res 1984; 32(2): 356A.
  287. Srikanta S, Ganda OP, soeldener JS, Gleason RE, Brink SJ, Rabizadeh A, Eisenbarth GS. Prediction of overt diabetes in relatives of Type I diabetis. Clin Res 1984; 32(2):409A.
  288. Sutherland, DER, Sibley R, Chinn P. Michael A, Srikanta S, Taub F, Najarian J, Goetz Fc. Twin to twin pancreas transplantation (Tx) : reversal and reenactment of the pathogenesis of type I diabetes.  Clin Res 1984; 32(2):561A.
  289. Srikanta S, Ricker A, Rabizadeh A, Eisenbarth GS. Monoclonal human islet cell antibodies: endocrine cell cross-reactivity. 7t International congress of Endocrinology, Quebec, Canada. Excerpts Medica 1984; 1825: 1173.
  290. Ganda OP, Srikanta S, gleason RE, Soeldner JS, Eisenbarth GS.  Lack of A-cell hyperresponsiveness in the early phase of type I diabetes.  7th International congress of Endocrinology Quebec, Canada Excerpts Medica 1984; 705 : 613.
  291. Srikanta S, Ganda OP, Kaldany A, Fleischnick E, Yunis E, Alper C, Eisenbarth GS, Pre-type I diabetes: identical endocrinologic course independent of HLA-DR type or presence of cytoplasmic islet cell antibodies (A).  Diabetes 1984; 33(suppl 1) 145:37A.
  292. Ganda OP, gleason RE, Srikanta S,  Soeldner JS. B-cell secretary response in monozygotic twins  of HLA-DR4 Type I diabetes is not increased.  Diabetes 1984;3 (suppl 1) 145:37A.
  293. Sutherland DER, Sibley R, Chinn P. Michael A, Srikanta S, Taub F, Najarian J, goetz FC.  Recurrence of islet cell inflammation in grafts done in identical twins.  6th International Belinson Symposium on Future Trends in Juvenile Diabetes, Tel Aviv, Israel 1985.
  294. Brink SJ, Fleischnick E, Srikanta S, Jackson RA, Ganda OP, Yunis E, alper C, Soeldner JS, Eisenbarth GS.  Pre-Type I diabetes Mellitus detected in a screening program.  6th International belinson symposium on future trends in Juvenile Diabetes, Tel Aviv, Israel 1985.
  295. Srikanta S, Krisch K, Eisenbarth GS.  Novel islet cell proteins defined by monoclonal islet cell antibody HISL-19: Identification, isolation and characterization.  American Diabetes Association, Massachusetts Affiliate 1984;8.
  296. Srikanta S, Ganda OP, Soeldener JS, Eisenbarth GS. Joslin pre-Type I diabetes study – an update 1984.  Assoc Phys ndia annual Meeting, Bangalore, India 1985.
  297. Nayak RC, Omar MAK, Rabizadeh A, Srikanta S, Eisenbarth GS. Evidence that the major “cytoplasmic” islet cell autoantigen is a glycolipid. FASEB 1985.
  298. Eisenbarth GS, Jackson RA, Srikanta S, Buse JB, Nayak RC, Ganda OP, Soeldner JS Type I Diabetes Mellitus (DM): Chronic progressive autoimmune beta cell destuction.  FASEB 1985.
  299. Srikanta S, Rabizadeh A, Ganda OP, Soeldner JS, Eisenbarth GS.  Prospective screening of first degree relatives of patients with Type I diabetes: Islet cell antibodies and abnormal insulin secretion.  Clin Res 1985; 33(2):445A.
  300. Srikanta S, Krisch K, Nayak RC, Elsenbarth GS.  Affinity purification of islet cell proteins defined by monoclonal islet cell antibody HISL-19. Clin Res 1985;33(2): 445 A.
  301. Posillico JT, Srikanta S, Brown EM, Eisenbarth GS. AF2 cell surface protein modulates intracellular calcium.  Clin res 1985;33(2):385A.
  302. Eisenbarth GS, Omar MAK, Rabizadeh A, Srikanta S, Nayak RC.  Initial biochemical characterization of the major “Prognostically significant” islet autoantigen.  Clin Res 1985;33(2):568A.
  303. Posillico JT, Srikanta S, Eisenbarth GS, Brown EM. Modulation of partyroid cell secretary function by anti-cell surface monoclonal antibodies.  Clin res 1985;33(2):573A.
  304. Ganda OP, Srikanta S, Eisenbarth GS, ICA+ relatives of patients with type I DM: Defective insulin secretion and restoration of rist phase insulin release by low dose prednisone.  Diabetes 1985; 34(suppl 1) : 258, 65A.
  305. Nayak RC, Omar MAK, Rabizadeh A, Srikanta S, Islet cytoplasmic” autoantigen has the biochemical properties of a complex ganglioside distinct from other oraga specific autoantigens.  Diabetes 1985; 34 (suppl I) : 258,65A.
  306. Posillico JT, Srikanta S, Eisenbarth GS, Brown EM. Monoclonal antibodies which react with boving parathyroid cells: Effects on hormone creation.  67th annual meeting of the endocrine society, Baltimore, MD, USA 1985; 337A.
  307. Nayak RC, Omar MAK,  Srikanta S, Eisenbarth GS.  Evidence that the major “cytoplasmic” islet cell autoantigen is a glycolipid.  Third Milano International meeting on diabetes, University Degli Studi Di Milano . Supp. 1985;40:5,
  308. Eienbarth GS, Buse JB, Srikanta S, Seidman ZJG, Jackson RA. Type I diabetes; Autoimmunity and immunodeficiency.  Immunology Mid-winter Symposium, Assilomar, California 1985.
  309. Nayak RC, Omar MAK, Rabizadeh A, Srikanta S, Eisenbarth GS. Islet cell autoantigen (s) in type I diabetes mellitus: Preliminary biochemical characterization.  National diabetes Research Interchange: Second International conference on Human tissues and organs for research and Transplantation, Washington, DC 1985.
  310. Srikanta S, Ganda OP, Jackson RA,Rabinowe SL, Kaye WA, Adri MNS, Rabizadeh A, George KL, Soeldner JS, Eisenbarth GA.Characteristics of the preclinical phase of Type I diabetes mellitus: Autoimmunity and slow beta cell destruction.  XII congress of the international Diabetes Federation, Madrid, Spain, Diabetes Research and Clinical Practice 1985; (suppl 1) : 1386A.
  311. Srikanta S, Krisch K, Posillico  JT, Rabizadeh A, Omar MAK, Nayak RC, Brown EM, Eisenbarth GS.  Molecular characterization of islet cell antigens (IC Ag).  XII congress of the international Diabetes Federation, Madrid, Spain, Diabetes Research and Clinical Practice 1985; (suppl 1): 1387 A.
  312. Srikanta S, Krisch K, Posillico  JT, Rabizadeh A, Omar MAK, Nayak RC, Brown EM, Eisenbarth GS.  Molecular characterization of islet cell antigens (IC Ag).  International Symposium on Monoclonal Antibodies-Basic principles, Experimental and Clinical Application in Endocrinology, Florence, Italy 1985.
  313. Eisenbarth GS, Srikanta S, Jackson RA, Rabinowe SL, Nayak RC, Krisch K, Crump A, Powers AC, Posillico JT, Brown EM, Haynes B, Monoclonal antibodies: Probes for studying the structure, function and pathophysiology of endocrine and “neoendocrine” differentiation molecules.  International Symposium on Monoclonal Antibodies-basic Principles, Experimental and clinical Application in endocrinology, Florence, Italy 1985.
  314. Posillico JT, Srikanta S, Eisenbarth GS, BrownEN.  The 4F2 cell surface antigen: Evidence for its role in signal recognition/transduction mechanisms in human adenomatous parathyroid cells.  International Symposium an Monoclonal Antibodies-Basic Principles, Experimental and Cinical Applications in Endocrinology, Florence, Itly1985.
  315. Jackson RA, Hattori M, Buse JB, Nayak RC, Rabinowe SL, Srikanta S, Eisenbarth GS. Type I diabetes- BB rat, NOD mouse and man: multigenic inheritance “recessive: with MHC genes leading to progressive beta cell destruction.  International Meeting on Immunogenetics and Endocrine Disorders, St. John’s, Newfoundland, Canada 1985.
  316. Eisenbarth GS, Srikanta S, Nayak RC, Jackson RA, Hattori M, Buse JB, abinowe SL, Soeldner JS.  Type I diabetes: A genetically “programmed” chronic autoimmune disease.  The second International Symposium on Treatment of Diabetes Mellitus – Recent Trends in Manageemnt of Diabetes Mellitus, Nagoya, Japan 1985.
  317. Yeo PPB, Eisenbarth GS, Srikanta S, Like AA, Ingbar SH.  Autoantibodies in the BB/W diabetic rats immunoprecipitate subcellular antigens from a cloned rat beta cell line (RINm5F cells).  XII Congress of the International Diabetes Federation, Madrid, Spain, Diabetes Research and Clinical Practice 1985, (suppl 1): 1605A.
  318. Eisenbarth GS, Srikanta S, Ganda OP, Connelly J, Rabizadeh A, Soeldber JS.  Loss of first phase insulin secretion: prediction of months to overt diabetes in both islet cell antibody positive and negative individuals.  First International Workshop on the Standardization of Cytoplasmic Islet Cell Antibodies, Monte Carlo, Monaco, 1985.
  319. Palmer JP, Srikanta S, Ricker AT, McCulloch DK, Soeldner JS, Eisenbarth GS, Autoimunity to insulin islet cell antibodies and the development of insulin dependent diabetes mellitus.  11th Annual meeting of the International Study Group for Diabetes in Children and Adolescents (ISGD), EL Escorial, Madrid, Spain, 1985.
  320. Catalano PM, Bernstein IM, Wolfe RR, Srikanta S, Sims EAH subclinical abnormalities of glucose metabolism in former gestational diabetic subjects.  Society for Gynaecologic Investigation, March 1986, Toronto, Canada.
  321. Srikanta S, Palmer JP, Ricker At, McCulloch DM, Ganda OP, Eisenbarth GS, Soeldner JS. Autoimmunity to insulin, beta cell dysfunction and development of insulin-dependent diabetes mellitus. ADA, Massachusetts Affiliate, 1985.
  322. Srikanta, S, DiBella E, Krisch K, Posillico JT, Rabizadeh A, Nayak RC, Brown EM, Eisenbarth GS.  Islet cell antigens (ICAg): initial studies of their biology and function.  ADA, Massachusetts Affiliate, 1985.
  323. Posillico JT, Wortsman J, Srikanta S, Eisenbarth GS, Brown EM. Parathyroid cell surface autoantibodies inhibit parathyroid hormone secretion from human parathyroid cells.  Clin Res 1986.
  324. Vardi P, Tuttleman M, Grinbergs M, Connelly J, Srikanta S, Eisenbarth GS, Soeldner JS, Spontaneous insulin autoantibodies in pre-insulin dependent diabetes: use of a competitive insulin autoantibody (CIAA) radioassay.  Clin Res 1986.
  325. Ricker AT, Herskowitz R, Wolfsdorf JI, Connelly J, Beron M, Srikanta S, Eisenbarth GS, Prognostic factors in children and young adults presenting with transient hyperglycemia or impaired glucose tolerance.  Diabetes 1986;35(suppl).
  326. Vardi P, Tuttleman M, Grinbergs M, Connelly J, Srikanta S, Eisenbarth GS, Soeldner JS, Constancy of anti-islet autoimmunity in “pre-type I diabetes” and genetically susceptible subjects: evidence form an ultrasensitive competitive insulin autoantibody (CIAA) radioimmunoassay.  Diabetes 1986; 35(suppl).
  327. Eisenbarth GS, Jackson RA, Srikanta S, Rabinowe SL, Ricker AT, Nayak RC, Vardi P, Ikegami H, Bhatia E, Dib S, Soeldener JS.  Type I diabetes of the BB rat, NOD mouse and man: multigenic contribution to chronic autoimmune beta cell destruction. The Endocrine Society, Anaheim, CA, USA 1986.
  328. Rabinowe SL, Ravnikar V, Srikanta S; Dib SA, Adri MNS, George KL, Dluhy RG.  Monoclinal antibody defined T lymphocyte abnormalities and antiovarian antibodies in premature menopuse.  The endocrine society, Anaheim, CA USA, 1986.
  329. Connelly J, eron M, Smith TM, Grinbergs M, Rabizadeh A, Srikanta S, Soeldner JS, Eisenbarth GS, Autoimmunity, genetic susceptibility and beta cell dysfunction in pre-insulin dependent diabetes mellitus.  International symposium on the immunology of diabetes, Edmonton, Canada 1986.  Pancreas 1986.
  330. Krisch K, DiBella E, Buxbaum P, Horvat G, Krisch I, Neuhold N, Ulrich U, Nayak RC, Srikanta S.  Islet cell proteins defined by monoclonal islet cell antibody HISL-19: further characterisation.  International symposium on the immunology of diabetes, Edmontion, Canada 1986.  Pancreas 1986.
  331. Vardi P, Dib SA, Tuttleman M, Grinbergs M, Connelly J, Srikanta S, Eisenbarth GS, Soeldner JS.  Competitive insulin autoantibodies (CIAA):  Reflection of the rate of beta cell destruction?  International symposium on the immunology of diabetes, Edmonton, Canada 1986. Pancrease 1986.
  332. DiMario U, Dotta F, DiBella E, Dib SA, Srikanta S, Eisenbarth GS. Anti-human pancreatic islet monoclonal antibody HISL-5: reactivity to human tissues and diabetic serum factors.  Annual congress of the European Association for the study of diabetes, Rome, Italy 1986.
  333. Kaye WA, Adri MNS, Kaldany A, Soeldner JS, Eisenbarth GS. Interleukin – s (IL-2) deficiency in type I diabetes mellitus.  Clin Res. 33:434A, 1985.
  334. Soeldber JS, Eisebnarth GS, Srikanta S, Ganda OP: Defects of insulin secretion: A clinical laboratory approach.  Proceedings of 9th Annual Arnold O. Beckman Conference, Saddlebrook, Florida, USA, January 1986; pp5-8.
  335. Gleichmann H. Comparison of various assays on the determination of cytoplasmic islet cell antibodies.  Diabetes 1986, 35 (suppl 1) page 183 A (abst #702).
  336. Gleichmann H, Bonifacio E, Bottazzo GF.  Comparison of various assays in the determination of cytoplasmic islet cell antibodies.  International symposium on the immunology of Diabetes, Edmonton, Canada, 1986.  Pancreas 1986 (Workshop participants: S Srikanta, A Rabizadeh, GS Eisenbarth).
  337. Moncayo R, Eisenbarth G, Pfeiffer EF.  Use of Monoclonal antibodies directed against beta cells to characterise different fractions of whole human pancreas.  International symposium on the immunology of diabetes, Edmontion, Canada 1986.  Pancreas 1986.
  338. Kamalesh M, Karasik A, Srikanta S.  Immunofluorescence assay for islet cell antibodies.  Practical Cardiology 986;12(10):21.
  339. Posillico JT, Wilson RE, Srikanta SS, Eisenbarth GS, Letarte M, Quackenbush EJ, Quaranta V, Brown EM.  Monoclonal antibody mediated modulation of parathyroid hormone secretion from dispersed parathyroid cells.  Annual Meeting of the New England Surgical Society, Dixville Notch, NH, 1986:12A.
  340. Posillico JT, Brown EM, Srikanta S, Leiden JM, Barbosa JA. Role of 4F2 cell surface antigen in the modulation of cytosolic calcium: studies with mouse L cells that express the gene encoding for the human 4 F2 antigen.  IX International Conference on Calcium regulating Hormones, Nice, France, 1986:24A.
  341. Pasquarello T, Kamalesh M, O’Neil J, Appel MC. Islet Cell antigens (ICAg): Downregulation by hypoglycaemia and suppression of islet cell autoimmunity.  American Diabetes Association, Masschusetts affiliate 1986.
  342. Vardi P, Connelly J, Soeldner JS, Eisenbarth GS. Actuarial Analysis of progressive endocrine abnormalities in islet cell and/or insulin autoantibody positive relative.  American diabetes Association, Masschusetts Affiliate 1986.
  343. Dib SA, Vardi P, Bonner-Weir S, Eisenbarth GS.  Factor VIII(F8) and class II antigens of normal pancreas.  American Diabetes Association, Masschusetts Affiliate, 1986.
  344. Keller R, Vardi P, Dib SA, IP S, Soeldner JS, Jackson RA. Assay of serum interleukin-2 receptors (IL2-R): A potential marker for more rapid regression to overt diabetes.   American Diabetes Association, Assachusetta Affiliate, 1986.
  345. Karasik A, O ‘Hara C, Srikanta S, Kahn CR, Soeldner JS, herskowitz RD.  Wolfram (DIDMOAD) syndrome: a model for genetically mediated beta cell loss.   American Diabetes Association, Masschusetts Affiliate, 1986.
  346. Krisch K, DiBella E, Buxbaum P, Horvat G, Krisch I, Neuhold N, Ulrich W, Nayak RC, Srikanta S.  Islet cell proteins defined by monoclonal islet cell antibody HISL-19: further characterisation.  Federation of the American Society of Experimental Biologists, 2nd, Summer Research Conference on Autoimmunity, Saxton River, Vermont, USA 1986.
  347. Brennan M, Kitabchi A, Reshbaum WM, Eisenbarth GS, Peterson CM.  Human Fetal islet transplantation in man.  2nd Annual Meeting of the European Association for Study of Diabetes. Rome, Italy, 1986.
  348. P Vardi, SA Dib, J Connelly, JS Soeldner, GS Eisenbarth.  Differential rates of progression to overt type I diabetes:  correlation with age and concentration of insulin autoantibodies.  Clin Res 35: 628A, 1987
  349. RC Nayak, PG Colman, PA Halban, GS Eisenbarth.  Identification and purification of islet ganglioside antigen 3G5 and islet cell autoantigen from human pancreas.  Diabetes 36 (suppl 1): 64A, 1987.
  350. F Dotta, U Dimario, C Tiberti et al.  Ganglioside expression in whole pancreas and isolated islets.  Diabetologia: 515A, 1987.
  351. PG Colman, A Rabizadeh, U Dimario.  Prediction of future insulin dependent diabetes (IDD): direct comparison of two islet cell antibody (ICA) assays.  Diabetes, 36 (suppl 1): 178A, 1987.
  352. P Vardi, S Dib, RD Herskowitz, JI Wolfsdorf, JS Soeldner, GS Eisenbarth. Multiparamenter prediction of months to overt diabetes in ICA positive first degree relatives.  Diabetes 37 (suppl): 6A. 1988 (International Research Symposium on Immunology of Diabetes, October 1987, Woods Hole, MA USA).
  353. PG Colman, F Dotta, RC Nayak,  DiMario, GS Eisenbarth.  Extraction and further characterisation of an iselt cell autoantigen from human pancreas.  Diabetes 37 (suppl): 4A, 1988.
  354. P Vardi, R Keller, SA Dib, GS Eisenbarth, JS Soeldner.  Log-liner correlation  of CIAA with age in new onset Type I diabetics.  Diabetes 37 (suppl):28A, 1988.
  355. PG Colman, S Fujii, SA Dib, F Dotta, M Tautkus, A Rabizadeh, GS Eisenbarth.  Development of a cytoplasmic islet cell antibody assay using rat pancreas.  Diabetes 37 (suppl): 29A, 1988.
  356. L Crisa, D Andreani, A Candela, L Campea, JS Soeldner, U DiMario.  Anti-immunoglobulin antibodies in the early stages of Type I diabetes: a newly found immunopathological factor. Diabetes 37 (suppl):31A, 1988.
  357. F Brown, A Vinik, OP Ganda, MNS Adri, SL Rabinowe.  Prevalence of anti-adrenal medullary antibodies in Type I diabetes mellitus of varying duration.  Diabetes 37 (suppl): 32A, 1988.
  358. SL Rabinowe, F Brown, MNS Adri, OP Ganda.  Anti-sympathetic ganglia antibodies in Type I diabetes ad patients at high risk for type I diabetes.  Diabtes (suppl): 32A, 1988.
  359. R Jackson, P Vardi, R Herskowitz et al.  Dual parameter linear model for prediction of onset of Type I diabetes in islet cell antibody positive relatives. Clin Res, XXA, 1988.
  360. Diabetes Collaborative Study Group, AIMS.  Towards standardization of immunoassays for islet cell autoimmunity, and data in Indian diabetics.  Research Society for Study of Diabetes in India, Annual Scientific Meeting, January 1988, Pune, India.
  361.  
  362. Society of Young scientists, AIIMS.  Underutilization of scientific and technological talent, and internal and external brain drain.  Symposium of Society for Technology and National Development, arch1988, New Delhi, India, STAND Newsletter, 1 (1) : 4, 1988.
  363.  
  364. Diabetes collaborative study group AIIMS, Environment ad health:  Madhumeh (Diabetes Mellitus) and endocrine metabolic disorders.  National Seminar on Impact of Environment on Health, June 1988, New Delhi, India, J Soc Young Scientists, (suppl 2): 15, 1988.
  365.  
  366. Diabetes Collaborative Study Group, AIIMS.  Serological markers of islet cell autoimmunity in India.  13th Congress of International Diabetes Federation, November 1988, Sydney, Australia.  Diabetes Research and clinical Practice; 5 (suppl 1): S 339, 1988.Diabetes Collaborative Study Group, AIIMS.  Serological markers of islet cell autoimmunityin India.  13th Congress of International Diabetes Federation, November 1988, Sydney, Australia.  Diabetes Research and clinical Practice; 5 (suppl 1): S 339, 1988.
  367.  
  368. Islet Cell Transplant Study Group, AIIMS.  Pancreatic islet transplantation:  Utility of the ductular obstruction and exocrine atropy model?  13th Congress of International Diabetes Federation, November 1988, Sydney, Australia.  Diabetes Research and Clinical practice; 5 (suppl 1): SXXX, 1988.
  369.  
  370. Diabetes Collaborative Study Group, AIIMS.  Perspectives in diabetogenesis.  Continuing Medical Education in Diabetes, Indo-US Diabetes Association, December 1988, New Delhi, India, Diabetes Bulletin 8(3): 17, 1988.
  371.  
  372. A Virmani , P Shah, PSN Menon. Camps for diabetic children: medical and health educational experience.  International Symposium on pediatric Endocrinology, February 1989, Bombay, India.
  373.  
  374. R Raju, M Joshi, P Shah, A Virmani, PSN Menon, N Kochupillai, Pathogenesis of Diabetes of young in India.  Annual scientific meeting, Indian Academy of Pediatrics, October 1989, Agra, India.
  375.  
  376. PSN Menon, A Virmani, P Shah, M Joshi, R Raju, S Setia, A Sethi, N Kochupillai, MMS Ahuja.  Childhood onset diabetes mellitus in North India:  Clinical profile and immunological studies.  Annual scientific meeting, Research Society for Study of Diabetes in India, October 1988, Madras India.  Diabetes Bulletin 9 (suppl 1): 8, 1989.
  377.  
  378. M Joshi, MMS Ahuja.  Childhood diabetes registry, Delhi, North India: Ditial observations.  Annual scientific meeting, Research Society for study of Diabetes in India, October 1988, Madras, India.  Diabetes Bulletin 9(suppl 1): 10-11, 1989.
  379.  
  380. A Virmani, S Setia, PSN Menon.  Effects on positive behaviour and metabolic control of a formal childhood diabetes patient education programme.  Annual scientific meeting, Research Society for study of Diabetes in India, October 1988, Madras, India.  Diabetes Bulletin 9 (suppl 1): 11-12, 1989.
  381.  
  382. S Setia. Experiences with self home blood glucose monitoring (SHBGM) in an economically developing society. Annual scientific meeting, Research Society for study of Diabetes in India, October 1988, Madras, India.  Diabetes Bulletin 9 (suppl 1): 13-14, 1989.
  383.  
  384. DK Gupta, PK Khosla, LK Verma, VS Thakur, SC Dash.  Prevalence and correlates of microalbuminuria in childhood diabetes.  Annual scientific meeting, Research Society for study of Diabetes in India, October 1988, Madras, India. Diabetes Bulleting 9 (suppl 1): 13-14, 1989.
  385.  
  386. G Rustagi, R Raju, DK Gupta, SC Dash, N Kochupillai, R Sharma.  Evaluation of a simple dye binding method for measurement of microproteinuria in diabetic patients, and its correlation with microalbuminuria (turbidi-immunoassay) and clinical parameters. Annual scientific meeting, Research Society for study of Diabetes in India, October 1988, Madras, India.  Diabetes Bulletin 9 (suppl 1):16-17, 1989.
  387.  
  388. A Virmani, P Ushabala, PV Rao, Mortality in IDDM observed in a tertiary referral hospital in India.  Annual scientific meeting, Research Society for Study of Diabetes in India, October 1988, Madras, India. Diabetes Bulletin 9 (suppl 1): 18-19, 1989.
  389.  
  390. Virmani A, Menon PSN, Setia S. Childhood diabetes: changes in knowledge and self-care with a formal patient education program (1988-89).  Annual Meeting, International Study Group of Diabetes in Children and Adolescents (ISGD), Oslo Norway, Sept 90.  Diabetes in the young, 1990, 24:30.
  391.  
  392. Virmani A, Menon PSN, Samal KC, Venkataraman S, Mohan V, Abraham A .(Research Society for study of Diabetes in India). Profile of child diabetes mellitus in India: regional, ethnic and social variations.  Annual Meeting, ISGD, Oslo, Sept 1990.
  393.  
  394. Shah P, Virmani A, Gupta N, Joshi M, Raju R, Setia S, Memon PSN, Kochupillai N, Ahuja MMS.  Childhood diabetes in India: resitual B-cell function and islet cell autoimmunity.  Annual Meeting, ISGD, Oslo, Sept 90 Diabetes in the young, 1990, 24:30
  395.  
  396. Rustagi GK, Virmani A, Gupta DK, Raju R, Kochupillai N, Dash SC. Microproteinuria by a simple dye binding assay: correlation with microalbuminuria and clinical & nutritional factors in childhood diabetes.  Annual Meeting, ISGD, Oslo, Sept 1990.  Diabetes in the   young, 1990, 24:26-7.
  397.  
  398. Raju R, Srikanta S, Kochupillai N. Islet cell antibodies and antigens: Antigen heat stability and further characterisation.  26th annual Meeting, European Association for the Study of Diabetes, September 1990; Diabetologia, Sept 1990 (Suppl.): Abstract P 706, A 191.
  399.  
  400. Shah P, Gupta N, Srikanta SS, Virmani A, Raju R, Setia S, Kocupillai N, Ahuja MMS.  Clinical profile of ‘diabetes of young’ in India.  India – USA Symposium & Workshop on Endocrinology, Metabolism & Diabetes, All India Institute of Medical Sciences, New Delhi, December 1990, p80.
  401.  
  402. Srikanta S, Raju R, Kochupillai N.  On the nature of Islet cell autoantibodies and antigens.  India USA Symposium and workshop on Endocrinology Metabolism and Diabetes.  All India Institute of Medical Sciences, New Delhi, December 1990, p86.
  403.  
  404. S Srikanta, R Raju, Monoclonal antibodies: Applications in endocrine biology.  India USA Symposium and workshop on Endocrinology Metabolism and Diabetes. All India Institute of Medical Sciences, New Delhi, December 1990, 
  405.  
  406. Raju R. Monoclonal antibodies probes for endocrine autoimmunity; Immoassays for islet cell antibodies.  India. USA Symposium and workshop on endocrinology Metabolism and Diabetes.  All India Institute of Medical Sciences, New Delhi December 1990.
  407.  
  408. Virmani A, Dheer A, Gupta DK, Rustagi G, Srikanta SS.  Assays for protein glycation and incipient diabetic nephropathy:  Technology Update in India-USA symposium & Workshop on Metablolism & Diabetes, All India Institute of Medical Sciences, New Delhi, December 1990.
  409.  
  410. Rustagi GK, Dheer AK, Naik RG, Raju R, Srikanta S, Gupta DK, Dash SC, Kochupillai, N Microproteinuria – its determination by a simple dye binding assay, and risk factor evaluation.  India USA Symposium and work on Endocrinology Metabolism and Diabetes.  All India Institute of Medical Sciences, New Delhi, December 1990, p69.
  411.  
  412. AK Dheer, A Virmani, GK Rustagi, RG Naik, MMS Ahuja, Protein glycation and glycemic control in diabetes mellitus: filter paper dried blood spot assay.  India USA Symposium and workshop on Endocrinology Metabolism and Diabetes.  All India Institute of Medical Sciences, New Delhi, December 1990, p94.
  413.  
  414. Setia S. Innovative education and training programs for the care of children and youth with diabetes.  India USA Symposium and workshop on Endocrinology Metabolism and Diabetes.  All India Institute of Medical Sciences, New Delhi, December 1990, p73.
  415.  
  416. Shah P, Gupta N, Srikanta S, Srivastava AK, Virmani A, Joshi M, Raju R, Setia S, Memon PSN, Kochupullai N, Ahuja MMS. Correlates of Residual beta  cell function in diabetes of young.  14th International Diabetes Federation Congress, Washington, USA June 1991 (Accepted).
  417.  
  418. Kochupillai , Shah P, Gupta N, Srikanta S. Spectrum of the Beta cell Dysfunction in Chronic Calcific Pancreatitis of the tropics.  14th International Diabetes Federation Congress, Washington, USI June 1991 (Accepted)
  419.  
  420. R Raju, S Srikanta, N.Kochupillai.  Islet cell antibodies and antigens: heat stability and further characterisation; 14th International Diabetes Federation Congress, Washington, USA June 1991 (Accepted)
  421.  
  422. Virmani A, Menon PSN, Samal KC, Venkataraman S, Mohan V, Abraham A.  profile of childhood diabetes mellitus in India: Regional, ethnic and social variations. 14th International Diabetes Federation Congress, Washington, USA June 1991 (Accepted)
  423.  
  424. S Kumar, NMS Ahuja.  Correlation of glycated hemoglobin (GHb) with outcome of acute myocardial infarction (AMI) in diabetics.  14th International Diabetes Federation Congress, Washington, USA June 1991 (Accepted)
  425.  
  426. U Dhiman. Challenge of economic impoverishment and illiteracy in diabetes education and care in India: the JDS/DFI experience.  14th International Diabetes Federation Congress, Washington, USA June 1991 (Accepted)
  427.  
  428. R.Vijay. Camps for children and youth with diabetes in India: Social experimentation and health outcome. 14th International Diabetes Federation Congress, Washington, USI June 1991 (Accepted)
  429.  
  430. Diabetes Collaborative Study Group.  Diabetes epidemiology in developing countries; cost-effective and socially relevant technologies.  Epidemiology of Diabetes and its complications, 14th IDF Satellite, Williamsburg, Virginia, USA June 1991 
  431.  
  432. Diabetes Collaborative Study Group.  Chldhood diabetes millitus (CDM) in India: progile variations and “deaths before diagnosis”?   Epidemiology of Diabetes and its complications, 14th IDF Satellite, Williamsburg, Virginia, USA June 1991 
  433.  
  434. Raju R, Srikanta S and Kochpillai N.  Islet cell glycoconjugates: potential targets in the autoimmunity of type I diabetes. Abstract submitted to 11th International Symposium on Glycoconjugates, Toronto, Canada June 29-July 5, 1991 
  435.  
  436. SS Sidhu, P Shah, S Srikanta, RK Tandon.  Insulin requiring diabetes of the young in India: A profile of their exocrine and endocrine pancreatic dysfunction.  33rd Annual Conference of the Indian Society of Gastroenterology, November 1992, New Delhi, India.  Indian Journal of Gastroenterology 11 (Suppl.1): G8, A19, 1992.
  437.  
  438. R Raju, S Srikanta, Shah, N Kochupillai.  I-45: A noval islet/neuroendocrine protein distinct from glutamic acid decarboxylase (GAD).  Annual Conference of Endocrine Society of India, November 1992, Puri, India.
  439.  
  440. TK Jagdish, A Gupta, P Shah, S Srikanta, N Kochupillai Diabetic peripheral Vascular disease (PVD) in India.  Annual Conference of Endocrine Society of India, November 1992, Puri, India.
  441.  
  442. V Mishra, P shah, S Srikanta, ML Khurana, A Juneja, V Dev, HS Wasir, N Kochupillai.  Metabolic and hormonal correlates of myocardial damage/disfunction in acutemyocardial infarction (AMI).  VI World Congress on Diabetes in the tropics and Developing Countries, Bombay, India, January, 1993.
  443.  
  444. TK Jagdish, P Shah, N Gupta, U Gupta, SS Srkanta, JP Wall, N Kochpillai.  Islet beta cell dysfunction (BCD) in humans: The pentamidine model (PEN) model.  VI World congress on Diabetes in the tropics and Developing countries, Bombay, India, January, 1993.
  445.  
  446. P Shah, RG Naik, SA godbole, N Gupta, S Srikanta, N Kochupillai.  Diabetes mellitus (DM) with coexisting autoimune thyroid disease (AITD): Residnal beta cell function (BCF) and autoimmunity.  VI World Congress on Diabetes in the Tropics and Developing Countries, Bombay, India, January, 1993.
  447.  
  448. SA Godbole, TK Jagdish, P Shah, S Srikanta, N Kochupillai.  Severe diabetic autonomic neropathy: Correlates and relationship to peripheral vascular disease.  VI World Congress on Diabetes in the Tropics and Developing Countries, Bombay, India, January, 1993.
  449.  
  450. R Raju, S Srikanta, P Shah, N Kochupillai.  I-45: A novel islet/neuroendocrine protein distinct from glutamic and decarboxylase (GAD).  V World Congress on Diabetes in the Tropics and Developing Countries, Bombay, India, January 1993.
  451.  
  452. TK Jagdish, A Gupta, P Shah, S Srikanta, N Kochupillai Diabetic peripheral Vascular disease (PVD) in India.  VI World Congress on diabetes in the Tropics and Developing Countries, Bombay, India, January 1993.
  453.  
  454. S Srikanta, R Raju, Endocrinology Collaborative Study Group.  Neuroendocrine differentiation: Molecular markers and newer cell types.  75th annual meeting of the Endocrine Society, Las Vegas, USA, June 1993. 1311:A378.
  455.  
  456. S Srikanta – Diabetes Collaborative Study Group.  A unique human model of islet beta cell injury and regeneration.  75th Annual meeting of the Endocrine Society, Las Vegas, USA, June 1993.232:A725.
  457.  
  458. S Srikanta – Diabetes Collaborative StudyGroup. Project “DOSTI” (friendship) To help them help themselves.  53rd annual meeting of American Diabetes Association, Las Vegas, USA, June 1993. 685-214A.  
  459.   
  460. SS Sidhu, P Shah, S Srikanta, RK Tandon.  Insulin requiring diabetes of the young in India: A profile of their exocrine and endocrine pancreatic dysfunction.  33rd Annual Conference of the Indian Society of Gastroenterology, November 1992, New Delhi, India.  Indian Journal of Gastroenterology 11 (Suppl.1): G8, A19, 1992.
  461.  
  462. R Raju, S Srikanta, Shah, N Kochupillai.  I-45: A novel islet/neuroendocrine protein distinct from glutamic acid decarboxylase (GAD).  Annual Conference of Endocrine Society of India, November 1992, Puri, India.
  463.  
  464. TK Jagdish, A Gupta, P Shah, S Srikanta, N Kochupillai Diabetic peripheral Vascular disease (PVD) in India.  Annual Conference of Endocrine Society of India, November 1992, Puri, India.
  465.  
  466. V Mishra, P shah, S Srikanta, ML Khurana, A Juneja, V Dev, HS Wasir, N Kochupillai.  Metabolic and hormonal correlates of myocardial damage/dysfunction in acute myocardial infarction (AMI).  VI World Congress on Diabetes in the tropics and Developing Countries, Bombay, India, January, 1993.
  467.  
  468. TK Jagdish, P Shah, N Gupta, U Gupta, SS Srkanta, JP Wall, N Kochpillai.  Islet beta cell dysfunction (BCD) in humans: The pentamidine model (PEN) model.  VI World congress on Diabetes in the tropics and Developing countries, Bombay, India, January, 1993.
  469.  
  470. P Shah, RG Naik, SA Godbole, N Gupta, S Srikanta, N Kochupillai.  Diabetes mellitus (DM) with coexisting autoimune thyroid disease (AITD): Residnal beta cell function (BCF) and autoimmunity.  VI World Congress on Diabetes in the Tropics and Developing Countries, Bombay, India, January, 1993.
  471.  
  472. SA Godbole, TK Jagdish, P Shah, S Srikanta, N Kochupillai.  Severe diabetic autonomic neropathy: Correlates and relationship to peripheral vascular disease.  VI World Congress on Diabetes in the Tropics and Developing Countries, Bombay, India, January, 1993.
  473.  
  474. M.G.Mamatha, G.S.Narayan, A.S.Vinaya, B.S.Sdha, D.V.Rama, J.Srikanth, S.Nagabushan, N.Nagesh, S.Krishna Murthy, S. Colaco, A.Sharda and S Srikanta. “Dirty” Vs “Pure” insulins: relevance, Recommendations and requests from a developing country.  16th international Diabetes Federation Congress-Helsinki, Finland, 1997.
  475.  
  476. A. Sharda, G.S.Narayan, A.S.Vinaya, M.G.Mamatha, B.S.Sudha, D.V.Rama, J.Srikanth, Nagabushan, N.Nagesh, S.Krishna Murthy, S.Colaco, and S.S.Srikanta.  Dyslipidemia and coronary heart disease in native Asian Indians with NIDDM.  16th International Diabetes Federation Congress-Helsinki, Finland, 1997.
  477.  
  478. G.S.Narayan, M.G.Mamatha, A.S.Vinaya, B.S.Sudha, D.V.Rama, J.Srikanth, S.Nagabushan, N.Nagesh, S.Krishna Murthy, S.Colaco, A.Sharda and S.S.Srikanta.  Is Vegetarian protein diet (VDP) renoprotective?  16th International Diabetes Federation Congress-Helsinki, Finland 1997..
  479.  
  480. A.S.Vinaya, G.S.Narayan, M.G.Mamatha, B.S.Sudha, D.V.Rama, J.Srikanth, S.Nagabushan, N. Nagesh, S.Krishna Murthy, S.Colaco, A.Sharda and S.S. Srikanta.   “Holistic” versus “ Blood Sugar” counselling in diabetes, 16th IDF Congress-Helsinki, Finland, 1997 International Diabetes Federation .
  481.  
  482. G.S.Narayan, M.G.Mamatha, A.S.Vinaya, B.S.Sudha, D.V.Rama, J.Srikanth, S.Nagabushan, N.Nagesh, S.Krishna Murthy, S.Colaco, A.Sharda and S.S.Srikanta. Day camps for mass diabetes health education and care: Social experiments in a developing country.  16th International Diabetes Federation Congress=Helsinki Finalnd, 1997.
  483.  
  484. N. Isharath, M.Uma, S.Rajesh, A.H.Mamatha, J.Srikanth, S.Vidyanand, U.Dayashankar, b.S.Sudha, G.S.Narayan, .Ashalakshmi, A.S.Vinaya, S.Krishnaiengar, A.Sharda, S.S.Srikanta.  Foot Self Care (FSC) in Diabetes: Health knowledge (HK) Behavior (HB) and Foot Status (FS).  Published in Diabetes Bulletin: International Journal of Diabetes in Developing Countries) 1998.
  485.  
  486. J.Srikanth, S.Vidyanand, Z Farah Zeba, M.V.Asha, S.Srinivas, B.L.Shashibushan, D.V.Rama, G.S.Narayan, B.S.Sudha, A.S.Vinaya, P.Ashalakshmi, A.Sharda, S.S.Srikanta. Weight Reduction (WR) and maintenance (WM) in Diabetes: Experience from A structured Health Education Counselling Program. 8th International Congress on Obesity, Paris) 1998.
  487.  
  488. S.S.Srikanta, S.Krishnaiengar, A.H.Mamatha, A.S.Vinaya, M.Uma, N.Ishrath, S.Vidyanad, G.S.Narayan, B.S.Sudha, U.Dayashankar, P.Ashalakshmi, S.Rajesh, D.V.Rama, M.A.Srilakshmi, A.Sharda, J.Srikanth.  Lower Extremity arterial disease (Lead) in Asian Indians with Niddm: Prevallence, profile, risk factors and association with micro Albuminuria and Ischemic Heart Disease IHD).  Annual Meeting of the British Diabetic Association, Glasgow-April 1999.
  489.  
  490. A.H.Mamatha, N.Ishrath, G.S.Narayan, M.Uma, S.Rajesh, J.Srikanth, S.Vidyanand, S.Krishnaiengar, U.Dayashankar, B.S.Sudha, D.V.Rama, P.Ashalakshmi, M.A.Srilakshmi, A.S.Vinaya, A.Sharda, S.S. Srikanta.  Foot self care in Diabetes in Asian Indians: Health knowledge, Health behaviour and foot status.  Annual Meeting of the British Diabetic Association, Glasgow-April 1999.53:p80
  491. A.Sharda, A.H.Mamatha, S.Krishnaiengar, G.S.Narayan, M.Uma, S.Vidyaand, U.Dayashankar, B.S.Sudha, , D.V.Rama, A.S.Vinaya, N.ishrath, P.Ashalakshi, S.S.Srikanta, Deleterious effect of Diabetic Nephropathy (DN) on Dyslipidemia (DL) is further grossly amplified by non-vegetarian diet:  Additional plea for vegetarianism.  Annual Meeting of the British Diabetic Association.  Glasgow-April 1999. 91: P 206.
  492. J.Srikanth, A.H.Mamatha, S.Krishnaiengar, G.S.Narayan, M.Uma, S.Vidyanand, U.Dayashankar, B.S.Sudha, D.V.Rama, A.S.Vinaya,N.Ishrath, P.Ashalakshi, A.Sharda, S.S.Srikanta. Loss of Protective sensation (LOPS) and lower extremity Arterial Disease (LEAD)  in Asian Indians wit Niddm.  Annual Meeting of the British Diabetic Association, Glasgow-April 1999. 65:P122.
  493. A.H.Mamatha, S.Krishnaiengar, G.S.Narayan, M.Uma, J.Srikanth, S.Vidyanand, U.Dayashankar, B.S.Sudha, D.V.Rama, A.S.Vinaya, N.Ishrath, P.Ashalakshmi, A.Sharda, S.S.Srikanta. Display poster series for patient, family and Public Diabetes Health Education:  A native Asian Indian Experiment.  Annual Meeting of the British Diabetic Association, Glasgow- April 1999. 55:P89
  494. S.R.Krishnaiengar, S.Sma, J.Hegde, N.C.Basavaraju, D.V.Rama, M.A.Srilakshmi, S.Joshi, A.S.Vinaya, G.S.narayan, U.Dayashankar, B.S.Sudha, A.H.Mamatha, G.Raja, T.Kalpana, N.Sumithra, N.Ishrath,.Srikanth, B.A.Mahesh, S.S.Srikanta and A.Sharda.  Loss of Protective Sensation (LOPS) in NIDDM: Pathogenetic Association with Atherosclerosis and Nephropathy.  17th International Diabetes Federation Congress Mexico 2000.
  495. S.Suma, S.R.Krishnaiengar, J.Hegde, N.C.Basavaraju, D.V.Rama, M.A.Srilakshmi, S.Joshi, A.S.Vinaya, G.S.Narayan, U.Dayashankar, B.S.Sudha, A.H.Mamatha, G.Raja, T.Kalpana, N.Sumithra, N.Ishrath, J.Srikanth, B.A.Mahesh, S.S.Srikanta and A.Sharda.  Optimal and Maximal Eulipidemic Therapy in Diabetes. “Tailored” Drug Combinations and Estrogen Replacement.  17th International Diabetes Federation Congress, Mexico 2000.
  496. S.S. Srikanta, S.R.Krishnaiengar, S.Suma, J.Hegde, N.C.Basavaraju, D.V.Rama, M.A.Srilakshmi, S.Joshi, A.S.Vinaya, G.S.Narayan, U.Dayashankar, B.S.Sudha, A.H.Mamatha, G.Raja, T.Kalpana, N.Sumithra, N.Ishrath, J.Srikanth, L.Punitha, C.G.Sreelatha, B.A.Mahesh and A.Sharda. “Highest” International Prevalence of Incipient Diabetic Nephropathy 9IDN) in Asian Indians with NiDDM: genetic Predisposition versus Social Deficiencies in Diabetes Care? 1th International Diabetes Federation Congress, Mexico 2000.
  497. Display poster series for patient, family and Public Diabetes Health Education. G.S.Narayan, M.Uma, J.Srikanth, S.Vidyanand, Uma Dayashankar, D.V.Rama, B.S.Sudha, A.S.Vinaya, P.Ashalakshmi, A.Sharda, S.Rajesh, N.Isharath, S.S.Srikanta.  Published in Diabetes Bulletin.  International Journal of Diabetes in Developing Countries).
  498. Foot Self Care (FSC) in Diabetes: Health Knowledge (HK) Behavior (HB) and Foot Status (FS). N.Ishrath, M.Uma, S.Rajesh, A.H.Mamatha, J.Srikanth, S.Vidyanand, U.Dayashankar, B.S.Sudha, G.S.Narayan, P.Ashalakshmi, A.S.Vinaya, S.Krishnaiengar, A.Sharda, S.S.Srikanta. Published in Diabetes Bulletin: International journal of Diabetes in Developing Countries).
  499. Deleterious Effect of Diabetic Nephropathy (DN) on Dyslpidemia (DL) is Further Grossly Amplified by Non Vegetarian Diet: Additional Plea for Vegetarianism. M.Uma, N.Ishrath, M.Uma, S.Rajesh, A.H.Mamatha, J.Srikanth, S.Vidyanand, U.Dayashankar, B.S.Sudha, G.S.Narayan, P.Ashalakshmi, A.S.Vinaya, S.Krishnaiengar, S.Sharda, S.S.Srikanta.
  500. M.G.Mamatha, J.Srikanth, B.S.Sudha, G.S.Narayan, P.Ashalakshmi, A.S.Vinaya, S.Krishnamurthy, D.V.Rama, S.Nagabhushan, P.Hegde, N.Nagesh, S.Colaco, S.Suresh, A.Sharda, S.S.Srikanta. Samatvam: Endocrinology Diabetes Center, Bangalore. India.Diabetes “Teaching Guides” Versus “Magazines”: Need for a Developing Country?
  501. M.G.Mamatha, J.Srikanth, B.S.Sudha, G.S.Narayan, P.Ashalakshmi, A.S.Vinaya, S.Krishnamurthy, D.V.Rama, S.Nagabhushan, P.Hegde, N.Nagesh, S.Colaco, S.Suresh, A.Sharda, S.S.Srikanta. Samatvam: Endocrinology Diabetes Center, Bangalore. India. Is Vegetarian Protein Diet (VRD) Renoprotective?
  502. M.G.Mamatha, J.Srikanth, B.S.Sudha, G.S.Narayan, P.Ashalakshmi, A.S.Vinaya, S.Krishnamurthy, D.V.Rama, S.Nagabhushan, P.Hegde, N.Nagesh, S.Colaco, S.Suresh, A.Sharda, S.S.Srikanta. Samatvam: Endocrinology Diabetes Center, Bangalore. India. Diabetes patient and community Health Education /Training Programs in a Developing Country.
  503. Type 1 diabetes in “have not” children in India: Project DISHA and the free “insulin lifeline” program in the State of Karnataka, India. Prathima Krishnamurthy and S S Srikanta, for the Diabetes Collaborative Study Group, 35th Annual Meeting of the International Society for Pediatric and Adolescent Diabetes ISPAD, Ljubljana, Slovenia, 2009.
  504. Type 1 diabetes in “have” children in India – experience and future of the insulin pump therapy program in the state of Karnataka, India: successes, failures and social engineering. Bina Naik and S S Srikanta, for the Diabetes Collaborative Study Group,  35th Annual Meeting of the International Society for Pediatric and Adolescent Diabetes ISPAD, Ljubljana, Slovenia, 2009.
  505. Type 1 diabetes in “have not” children in India: Project DISHA and the free “insulin lifeline” program in the State of Karnataka, India. Prakruthi Lakshman, Prathima Krishnamurthy, Usha Rangaraj, and S S Srikanta, for the Diabetes Collaborative Study Group, World Diabetes Congress, International Diabetes Federation, Montreal, Canada, 2009.
  506. Type 1 diabetes in “have” children in India – experience and future of the insulin pump therapy program in the state of Karnataka, India: successes, failures and social engineering. Madan Gopal Ramarajan, Bina Naik, Usha Rangaraj and S S Srikanta, for the Diabetes Collaborative Study Group, [], World Diabetes Congress, International Diabetes Federation, Montreal, Canada, 2009.
  507. Health economics and social engineering in diabetes care – an Indian experience. Ramesh Karmegam and  S S Srikanta, for the Diabetes Collaborative Study Group, World Diabetes Congress, International Diabetes Federation, Montreal, Canada, 2009.
  508. “Rationed SHBGM” – Limited Self Home Blood Glucose Monitoring In Improving Metabolic Control In Economically Disadvantaged Children With Type 1 Diabetes In India: Discipline “Compensation” For Poverty.  S Geetha Rao, Prathima Krishnamurthy, Usha Rangaraj, Bina Naik, S Srikanta,  Tejeswini Deepak and A Sharda, for the Diabetes Collaborative Study Group. 36th Annual Meeting of the International Society for Pediatric and Adolescent Diabetes ISPAD, Buenos Aires, Argentina, 2010.
  509. Insulin ”Plus” Education In Type 1 Diabetes Children In India: Transforming Helpless “Insulin Beggars” To Productive And Self Supporting Citizens Of The Nation ???   S Geetha Rao, Prathima Krishnamurthy, Usha Rangaraj, Bina Naik, S Srikanta,  Tejeswini Deepak and A Sharda, for the Diabetes Collaborative Study Group, Jnana Sanjeevini Medical Center, Bangalore, India,  36th Annual Meeting of the International Society for Pediatric and Adolescent Diabetes ISPAD, Buenos Aires, Argentina, 2010.
  510. Insulin Pump Therapy In Type 1 Diabetes Children And Youth In India:  Dream Towards Lower Cost Insulin Pump[s] And Wider Application For Developing Countries. Prathima Krishnamurthy, S Geetha Rao, Usha Rangaraj, Bina Naik, S Srikanta,  Tejeswini Deepak and A Sharda, for the Diabetes Collaborative Study Group, Samatvam Endocrinology Diabetes Center, Bangalore, India.   36th Annual Meeting of the International Society for Pediatric and Adolescent Diabetes ISPAD, Buenos Aires, Argentina, 2010.
  511. Early detection of diabetic autonomic neuropathy with a new device.  M Fevre-Genoulaz1, MJ Lafitte1, S Srikanta2, L Punitha2 & S Vidyanand2,1Dyansys Clinical Research Unit, Geneva, Switzerland; 2Samatvam Endocrinology Diabetes Centre, Bangalore, India. Endocrine Abstracts (2006) 11 P197 European Congress of Endocrinology 2006, Glasgow, UK, 01 April 2006 – 05 April 2006, European Society of Endocrinology, British Endocrine Societies
  512. 500 heart beats for assessing diabetic autonomic neuropathy.   MJ Lafitte1, M Fèvre-Genoulaz1, S Srikanta2, L Punitha2, S Vidyanand2,  1 Dyansys Clinical Research Unit, Burlingame, CA, United States, 2 Samatvam Endocrinology Diabetes Centre, Bangalore, India, Int J Diab Dev Ctries 2005;25:113-117
  513. Insulin pump therapy in t1dm : dream towards lower cost insulin pump[s] for developing countries —-   N. Srinivas1, R. Krishna1, S. Manjunath1, U. Dayashankar1, G. For Diabetes Collaborative Study Group1. 1Jnana Sanjeevini Medical Center, Endocrinology Diabetes Center, Bangalore, India——D-0758. World Diabetes Congress, International Diabetes Federation at Dubai- 4 to 8 December 2011.
  514. Correlates of insulin secretion, insulin resistance and body fat in T2DM in Asian Indians —   P. Krishnamurthy1, R. patel1, S. Srikanta1, S. For Diabetes collaborative study1. 1Jnana Sanjeevini Medical Center, Endocrinology Diabetes, Bangalore, India.— D-1040World Diabetes Congress, International Diabetes Federation at Dubai- 4 to 8 December 2011.
  515.  Healthy market competition can promote “lower” cost insulin pump therapy [IPT] for middle class Indians with T1DM —  L. Reddy1, A. Gill1, S. Srikanta1.1Jnana Sanjeevini Medical Center, Endocrinology and Diabetology, Bangalore, India.—D-1124World Diabetes Congress, International Diabetes Federation at Dubai- 4 to 8 December 2011.
  516. “Sufferers” as great “Healers”: Experiences with people with T1DM as health care providers [“Inside” and “Outside” of diabetes] —  S. Manjunath1, R. Krishnan1, U. Dayashankar1, S. For Diabetes Collaborative Study Group1.1Jnana Sanjeevini Medical Center, Endocrinology and Diabetology, Bangalore, India.—D-0702.World Diabetes Congress, International Diabetes Federation at Dubai- 4 to 8 December 2011.
  517. Determination of levels of tryptophan metabolites in saliva and correlation with oral changes in T2DM patients.—  K. Chandrika1, K. Rishab1, R. Vandana1, T. Kamala1, S. For Diabetes Collaborative Study Group1.1Jnana Sanjeevini Medical Center, Endocrinology and Diabetology, Bangalore, India.—-D-1028.World Diabetes Congress, International Diabetes Federation at Dubai- 4 to 8 December 2011.
  518. Tumor necrosis factor-alpha (TNF-a) in the gingival crevicular fluid(GCF) of T2DM patients with periodontal disease.—-  S. Siddhanthi1, J. Sharadha1, A. Gill1, K. Thummula1.
    1Jnana Sanjeevini Medical Center, Endocrinology and Diabetology, Bangalore, India.—-D-1029.World Diabetes Congress, International Diabetes Federation at Dubai- 4 to 8 December 2011.
  519. Hypovitaminosis D, secondary hyperparathyroidism and femoral bone mineral density in Type 2 Diabetes in India—-  R. Ashok1, G. Rao1, S.K. Sujatha1.1Jnana Sanjeevini Medical Center, Endocrinology and Diabetology, Bangalore, India.—-D-1045.World Diabetes Congress, International Diabetes Federation at Dubai- 4 to 8 December 2011.
  520. Determinants of visual prognosis after vitreous / retinal surgery in type 2 diabetes: An Indian experience—  V. Raj1, G. Vijayshree1, E. Gill1, K. Thummula1, S. Srikanta1.1Jnana Sanjeevini Medical Center, Endocrinology and Diabetology, Bangalore, India.—D-0852World Diabetes Congress, International Diabetes Federation at Dubai- 4 to 8 December 2011.
  521. Fasting insulin and HOMA-calculated insulin resistance in Indian type II diabetics after integrated yoga – a controlled study—  D. Rajan1, R. Nagarathna2, S. Srikanta3.1Real Medicine Foundation, Coordinator Global Projects, Bangalore, India.2Swami Vivekananda Yoga Research Foundation (SVYASA), Division of Yoga and Life Sciences, Bangalore, India.3Samatvam Endocrinology Diabetes Center, Endocrinologist, Bangalore, India.—- P-1177  World Diabetes Congress, International Diabetes Federation at Dubai- 4 to 8 December 2011.
  522. Salivary cortisol levels in Indian type II diabetics after integrated yoga – a controlled study— D. Rajan1, S. Vidyanand2, R. Nagarathna3, S. Srikanta4.1Real Medicine Foundation, Coordinator Global Projects, Bangalore, India.2Samatvam Endocrinology Diabetes Center, Physician, Bangalore, India.3Swami Vivekananda Yoga Research Foundation (SVYASA), Division of Yoga and Life-Sciences, Bangalore, India.4Samatvam Endocrinology Diabetes Center, Endocrinologist, Bangalore, India.—- P-1182.World Diabetes Congress, International Diabetes Federation at Dubai- 4 to 8 December 2011.
  523. Free 24 hour diabetes helplines: Successes, shortcomings and future [1994-2011] —  B. Naik1, N. Srinivas1, U. Dayashankar1, S. For Diabetes Collaborative Study Group1.1Jnana Sanjeevini Medical Center, Endocrinology Diabetes, Bangalore, India.— P-1728World Diabetes Congress, International Diabetes Federation at Dubai- 4 to 8 December 2011.
  524. Lens Opacities Classification System [LOCS] III in diabetes: a longitudinal quantitative marker during annual monitoring in diabetes— E. Gill Amit1, V. Raut1, P. Murthy1, G. For Diabetes Collaborative Study Group1.1Jnana Sanjeevini Medical Center, Endocrinology and Diabetology, Bangalore, India.—-P-1731.World Diabetes Congress, International Diabetes Federation at Dubai- 4 to 8 December 2011.
  525. Determinants of visual prognosis after cataract surgery in type 2 diabetes: An Indian experience — V. G.S1, E. Gill Amit1, S. Satyanarayana1, G. For Diabetes Collaborative Study Group1.1Jnana Sanjeevini Medical Center, Endocrinology Diabetes Center, Bangalore, India.—P-1787World Diabetes Congress, International Diabetes Federation at Dubai- 4 to 8 December 2011.
  526. Prevalence of Childhood obesity: In school going children—  S. Vidyanand1, E. Gill1, K. Thummula1, N. Srinavas1.1Jnana Sanjeevini Medical Center, Endocrinology and Diabetiology, Bangalore, India.— P-1800World Diabetes Congress, International Diabetes Federation at Dubai- 4 to 8 December 2011.
  527. Correlates of 24 hour blood glucose profiles and beta cell function in Type 2 diabetes – Multiple meal tolerance testing—R. Patel1, L. Reddy1, R. Ashok1, U. Dayashankar1, G. For Diabetes Collaborative Study Group1.1Jnana Sanjeevini Medical Center, Endocrinology and Diabetology, Bangalore, India.—- P-1316.World Diabetes Congress, International Diabetes Federation at Dubai- 4 to 8 December 2011.
  528. Continuous glucose monitoring in Type 2 diabetes: Initial experiences with iPro —  P. Lakshman1, P. Krishnamurthy1, N. Dr.Vasanthi1, S. For Diabetes Collaborative Study Group1.
    1Jnana Sanjeevini Medical Center, Endocrinology and Diabetology, Bangalore, India. — P-1481.World Diabetes Congress, International Diabetes Federation at Dubai- 4 to 8 December 2011.
  529. Patient parent support groups for T1DM in India: Successes, failures and future?   O-0460 Presenting Author:  R. Krishna, India For Diabetes Collaborative Study Group1.1Jnana Sanjeevini Medical Center, Endocrinology and Diabetology, Bangalore, India. — World Diabetes Congress, International Diabetes Federation at Dubai- 4 to 8 December 2011.
  530. Therapeutic Foot Wear (TFW) in Diabetes: DiaFootCare an Indian enterprise and  experience  O-0536 Presenting Author:  K. Thummala, India  For Diabetes Collaborative Study Group1. 1Jnana Sanjeevini Medical Center, Endocrinology and Diabetology, Bangalore, India. — World Diabetes Congress, International Diabetes Federation at Dubai- 4 to 8 December 2011.
  531. “Rationed SHBGM” – combined with more”Liberal SHUGM”– Desperation and Success O-0537  Presenting Author:  C. Chethana, India  For Diabetes Collaborative Study Group1. 1Jnana Sanjeevini Medical Center, Endocrinology and Diabetology, Bangalore, India. — World Diabetes Congress, International Diabetes Federation at Dubai- 4 to 8 December 2011.
  532. Androgen secreting ovarian tumor: Localisation by functional [FDG PET] and not anatomical [MRI/ CT/Ultrasound] imagingReddy, Lakshmi; Kamala, Thummala; Nath, Vasanthi; Sujatha, M.; Chandraprabha; Bhargava, Rina; Ravikumar, Pushpa; Sumathi, M.; Chandrika, K. M.; Thyagaraj, Babitha D.; Kallikot, Priyanka; Shivayogi, Preethi; Chitra, M.; Deepak, Tejeswini; Sharda, Ardanareswaran; Srikanta, Sri, at 23rd Annual Scientific and Clinical Congress, AACE, Las Vegas, USA, 2014.
  533. Carney Complex [CC]: Unique endocrine and non-endocrine diagnostic – therapeutic challenges and biologic mystery.Thummala, Kamala; Reddy, Lakshmi; Reddy, Kadapalakere; Prakruthi, Lakshman; Kg, Kallur; Nath, Vasanthi; Sujatha, M.; Krish, Lakshman; Krishna, Muralidhara; Siddalingappa, Chandraprabha; Bhargava, Rina; Ravikumar, Pushpa; Sumathi, M; Chandrika, K. M; Thyagaraj, Babitha D; Kallikot, Priyanka; Shivayogi, Preethi; Chitra, .M; Deepak, Tejeswini; Sharda, Ardanareswaran; Srikanta S at 23rd Annual Scientific and Clinical Congress AACE, Las Vegas, USA 2014. 
  534. Insulin, love and care”: “Poor response” subset in a “have-not” FREE type 1 diabetes clinic [DISHA] in India.  U. Dayashankar, S.G. Rao, U. Rangaraj, V. Shivaraj, E.E. Little, A. Hegde, P. Krishnamurthy, H.K. Vasanthalakshmi, R. Ashok, N. Jayaram, K.N. Ashwini, S.K. Lokanathan, M.K. Cavale, B. Prasannakumar, V. Krishnaswamy, K.M. Chandrika, L.V. Reddy, R. Harsha, V. Nath, M. Krishna, R. Kasiviswanath, T. Deepak, A. Sharda, S. Srikanta, G. Other Investigators, for Diabetes Endocrinology Study Group: Jnana Sanjeevini Diabetes Hospital and Medical Center, Samatvam Endocrinology Diabetes Center, Bangalore, India   Oral Presentation O22. 40th Annual Conference of the International Society for Pediatric and Adolescent Diabetes, to be held in Toronto, Canada, 2014
  535. Insulin autoimmune syndrome and hypoglycemia: Insulin immunoassay variabilities, continuous glucose monitoring, glucose intolerance and glucocorticoid immunotherapy.  Chandrika KM, Sumathi K,  Pushpa Ravikumar, Reshma Harsha, Babitha Devi ,Sunitha, Rajiv Kasiviswanath, Muralidhara Krishna, Tejeswini Deepak, Sharda A .Srikanta S at 24thScientific and Clinical Congress AACE, Nashville, USA. 2015
  536. “Silent pregnancy associated very severe hypertriglyceridemia and prompt remission postpartum” Chandrika KM, Sumathi K,  Pushpa Ravikumar, Reshma Harsha, Babitha Devi ,Sunitha, Rajiv Kasiviswanath, Muralidhara Krishna, Tejeswini Deepak, Sharda A .Srikanta Sat 24thScientific and Clinical Congress AACE, Nashville, USA. 2015
  537. Severe hypoinsulinemic hypoglycaemia in Beckwith-Widemann syndrome (BWS): Potential mechanisms and therapeutic implications Chandrika KM, Sumathi K,  Pushpa Ravikumar, Reshma Harsha, Babitha Devi ,Sunitha, Rajiv Kasiviswanath, Muralidhara Krishna, Tejeswini Deepak, Sharda A .Srikanta Sat 24thScientific and Clinical Congress AACE, Nashville, USA, 2015
  538. Isolated ACTH deficiency and acquired lipodystrophy (ALD) associated with multiple endocrine and nonendocrine autoimmunity.    Kalleshwar Chandrika, Sumathi K., Thummala Kamala, Vasanthi Nath, Siddalingappa Chandraprabha, Pushpa Ravikumar, Babitha Thyagaraj, Reshma V., MD Chitra, N Jyothi, CS Muralidhara Krishna, Rajiv Kasiviswanath, B Sunitha, Tejeswini Deepak, Ardhanareeshwaran Sharda, Lakshmi Reddy, Priyanka Somasundar, Prakruthi Lakshman, R Madan Gopal, Preethi Shivayogi, Sri Srikanta Samatvam Endocrinology Diabetes Center, Jnana Sanjeevini Diabetes Hospital and Medical Center.  24th Scientific and Clinical Congress AACE, Nashville, USA, 2015
  539. Growth characteristics and development in economically underprivileged type diabetes children in India.S. Bourgonde, V. Ashish Rao, U. Dayashankar, U. Rangaraj, R. Manjunath, B. Naik, K. Chetana, S.G. Rao, H.K. Vasanthalakshmi, N. Jayaram, N. Srinivas, R. Ashok, S.M. Owais, A. Hegde, V. Shivaraj, T. Kamala, M.D. Chitra, N. Jyothi, L. Deepesh, B.V. Reshma, B.D. Thyagaraj, P. Ravikumar, C.S. Muralidhara Krishna, R. Kasiviswanath, S. Chandraprabha, L. Reddy, K.M. Chandrika, K. Sumathi, T. Deepak, A. Sharda, S. Srikanta, Diabetes Endocrinology Study Group – Samatvam Jnana Sanjeevini, International Society of Pediatric and Adolescent Endocrinology – ISPAD Brisbane, Australia, 2015.
  540. Type 1 diabetes, growth retardation and diabetic cheiroarthropathy: story, disappearance and update S. Bourgonde, V. Ashish Rao, U. Dayashankar, U. Rangaraj, R. Manjunath, B. Naik, K. Chetana, S.G. Rao, H.K. Vasanthalakshmi, N. Jayaram, N. Srinivas, R. Ashok, S.M. Owais, A. Hegde, V. Shivaraj, T. Kamala, M.D. Chitra, N. Jyothi, L. Deepesh, B.V. Reshma, B.D. Thyagaraj, P. Ravikumar, C.S. Muralidhara Krishna, R. Kasiviswanath, S. Chandraprabha, L. Reddy, K.M. Chandrika, K. Sumathi, T. Deepak, A. Sharda, S. Srikanta, Diabetes Endocrinology Study Group – Samatvam Jnana Sanjeevini. International Society of Pediatric and Adolescent Endocrinology – ISPAD Brisbane, Australia, 2015.
  541. Glycemic Control and Quality of Life in Type 1 Diabetes Children: Crucial Role of Parental Bonding and Family Involvement, Despite Poverty. U. Dayashankar, K.M. Chandrika, K. Sumathi, L. Reddy, P Ravikumar, T. Deepak, A. Sharda, S. Srikanta,  V. Ashish Rao, S. Bourgonde, T. Kamala, V. Nath, S.M. Owais, V. Shivaraj, R. Ashok, A. Hegde, S.G. Rao, U. Rangaraj, N. Srinivas, H.K. Vasanthalakshmi, N. Jayaram, Diabetes Endocrinology Study Group – Samatvam Jnana Sanjeevini Diabetes Hospital and Endocrinology Center, Bangalore, India.   International Society of Pediatric and Adolescent Endocrinology – ISPAD Brisbane, Australia, 2015.
  542. Poverty Associated Childhood Diabetes In India: Clinical Profile, Complications, Comorbidities and Challenges  (1987 – 2011 – 2015)V. Ashish Rao, S. Bourgonde, T. Kamala, V. Nath, S.M. Owais, V. Shivaraj, R. Ashok, A. Hegde, S.G. Rao, U. Rangaraj, N. Srinivas, H.K. Vasanthalakshmi, N. Jayaram, U. Dayashankar, K.M. Chandrika, K. Sumathi, L. Reddy, T. Deepak, A. Sharda, S. Srikanta,  Diabetes Endocrinology Study Group – Samatvam Jnana Sanjeevini,  Jnana Sanjeevini Diabetes Hospital and Medical Center and Samatvam Endocrinology Diabetes Center, Diabetes Endocrinology, Bangalore, India.  International Society of Pediatric and Adolescent Endocrinology – ISPAD Brisbane, Australia, 2015.
  543. Complications and Comorbidities in Poverty associated Childhood Diabetes in India.  Bhargava, Rina; Srikanta, Sri S.; Kamala, Thummala; Ravikumar, Pushpa; Reddy, Lakshmi V.; Rao, Vibha A.; V, Reshma B.; Nath, Vasanthi; Thyagaraj, Babitha D; Narendran, Lekshmi and Diabetes Endocrinology Collaborative Study Group: Jnana Sanjeevini Diabetes Hospital and Medical Center and Samatvam Endocrinology Diabetes Center, Diabetes Endocrinology, Bangalore, India.  American Association Of Clinical Endocrinologists (AACE) 25th Annual Scientific and Clinical Congress, Orlando, Florida2016
  544. Familial Vs Sporadic Encapsulated Follicular Variant of Papillary Thyroid Carcinoma
    Need For More Aggressive Therapy?   Pushpa Ravikumar, Kalleshwar Chandrika, Sumathi K., Thummala Kamala, Vasanthi Nath, Siddalingappa Chandraprabha, Babitha Thyagaraj, Reshma BV, MD Chitra, N Jyothi, CS Muralidhara Krishna, Rajiv Kasiviswanath, B Sunitha, Tejeswini Deepak, Ardhanareeshwaran Sharda, Lakshmi Reddy, Priyanka Somasundar, R Bhargava, K Muniraj, L Deepesh, Preethi Shivayogi, Sri Srikanta, Endocrinology Diabetes Study Group, Samatvam Endocrinology Diabetes Center, Jnana Sanjeevini Diabetes Hospital and Medical Center.  American Association Of Clinical Endocrinologists (AACE) 25th Annual Scientific and Clinical Congress, Orlando, Florida2016
  545. Primary Hyperparathyroidism Presenting with Secondary Hypokalemic Periodic Paralysis and Severe Multiple Life Threatening Dyselectrolytemia [Hyperparathyroid Crisis].   Priyanka Somasundar, Pushpa Ravikumar, Kalleshwar Chandrika, Sumathi K., Thummala Kamala, Vasanthi Nath, Siddalingappa Chandraprabha, Babitha Thyagaraj, Reshma BV, MD Chitra, N Jyothi, CS Muralidhara Krishna, Rajiv Kasiviswanath, B Sunitha, Tejeswini Deepak, Ardhanareeshwaran Sharda, Lakshmi Reddy, R Bhargava, K Muniraj, L Deepesh, Preethi Shivayogi, Sri Srikanta, Endocrinology Diabetes Study Group.  Manjunath Shastry, Rangadore Memorial Hospital.American Association Of Clinical Endocrinologists (AACE) 25th Annual Scientific and Clinical Congress, Orlando, Florida 2016
  546. Diabetes and mental health: the INTERPRET-DD study. C.E. Lloyd, A. Nouwen, N. Sartorius, [Principal Investigator India: S Srikanta; Co Investigators: Reshma BV, Babitha D Thyagaraj, Vasanthi Nath] Faculty of Health & Social Care, The Open University, Milton Keynes, 2Department of Psychology, Middlesex University, London, 3Association for the Improvement of Mental Health Programmes, Geneva, Switzerland. || Abstract #817.  52nd Annual Meeting of the European Association for the Study of Diabetes 2016 in Munich, Germany.
  547. Hypergonadotrophic hypogonadism in 2 siblings with DIDMOAD syndrome and its associations.   Ashish Rao,  Akshya Hegde,  Ashwini KJ,  Owais Haqq,  Rajeshwari Ashok,  Marimuthu B,  Geetha Rao,  Nandini Jayaram,  Uma Dayashankhar,  Reshma Harsha,  Babithadevi T,  Chandrika KM,  Kamala T,  Sumathi K,  Lakshmi Reddy,  Chandraprabha S,  Vasanthi Nath,  Tejeswini D,  Sharda A,  Srikanta S.  Diabetes Endocrinology Collaborative Study Group: Samatvam Endocrinology Diabetes Center and Jnana Sanjeevini Diabetes Hospital and Medical Center.   Abstract NO.:1953. 17th International Congress of Endocrinology (ICE) and 15th Annual Conference of Chinese Society of Endocrinology (CSE), Beijing, China2016
  548. Utility of DEXA and CT body fat analysis and endocrine correlates in profiling and therapy of type 2 diabetes in Asian Indians.      Akshaya Hegde,  Vibha Rao,  ASHWINI KJ,  Rajeshwari A,  Owais Haqq,  Marimuttu B,  Geetha Rao,  KM Chandrika,  Sumati Madiazaghan,  Lakshmi Reddy,  Chandraprabha Siddlingappa,  Priyanka Somasundar,  Pushpa Ravikumar,  Babitha Thyagaraj,  Reshma Harsha,  Vasanthi Nath,  Kamala T,  Tejaswini Deepak,  Sharada a,  Srikanta SDiabetes Endocrinology Collaborative Study Group: Samatvam Endocrinology Diabetes Center and Jnana Sanjeevini Diabetes Hospital and Medical Center. Abstract NO.:1503.  17th International Congress of Endocrinology (ICE) and 15th Annual Conference of Chinese Society of Endocrinology (CSE), Beijing, China2016
  549. Community Diabetes Care Physician Manpower Development: Experiences from India’s largest Regional Center.  Ashwini K J,  Akshaya Hegde,  Vibha Ashish Rao,  Marimuttu B,  Rajesshwari A,  Owais Haqq,  Nandini Jayaram,  Chitra MD,  Murali M,  Chandrika KM,  Lakshmi Reddy,  Vasanthi Nath,  Reshma Harsha,  Babitha Thyagaraj,  Sumathi M,  kamala T,  Chandraprabha S,  Tejaswini Deepak,  Sharada A,  Srikanta S.Diabetes Endocrinology Collaborative Study Group: Samatvam Endocrinology Diabetes Center and Jnana Sanjeevini Diabetes Hospital and Medical Center. Abstract NO.:1656. 17th International Congress of Endocrinology (ICE) and 15th Annual Conference of Chinese Society of Endocrinology (CSE), Beijing, China2016
  550. Psychosocial profile, glycemic control and wellbeing in poverty associated type 1 diabetes mellitus adolescents in India.  OWAIS HAQQ,  Sanjana Malhotra,  Rajiv K,  Sunitha B,  Muralidhar Krishna,  Kamala T,  Vasanthi Nath,  Vibha Rao,  Reshma Harsha,  Akshaya Hegde,  Mari Muthu,  Owais Haqq,  Ashwini KJ,  Babitha Rani,  Sharda A,  Tejeswini Deepak,  Chandrika KM,  Chandraprabha P,  Geetha Rao,  S Srikanta   Diabetes Endocrinology Collaborative Study Group: Samatvam Endocrinology Diabetes Center and Jnana Sanjeevini Diabetes Hospital and Medical Center. Abstract NO.:1659. 17th International Congress of Endocrinology (ICE) and 15th Annual Conference of Chinese Society of Endocrinology (CSE), Beijing, China2016
  551. Profile of bone health in postmenopausal Asian Indian women: Community based Bone Mineral Density [BMD] and radiographic Vertebral Fracture Assessment [VFA]. Akshaya Hegde,  Rajeshwari A,  Owais Haqq,  Ashwini KJ,  Vibha Ashish Rao,  Marimuttu B,  Geetha Rao,  Uma Dayashanker,  Chandraprabha s,  Pushpa Ravikumar,  Kamala T,  Reshma Harsha,  Lakshmi Reddy,  Sumati M,  Babitha Thyagaraj,  Muralidhara CS,  Vasanthi Nath,  Tejaswini Deepak,  Sharda A,  Srikanta S  Diabetes Endocrinology Collaborative Study Group: Samatvam Endocrinology Diabetes Center and Jnana Sanjeevini Diabetes Hospital and Medical Center.Abstract NO.:1667. 17th International Congress of Endocrinology (ICE) and 15th Annual Conference of Chinese Society of Endocrinology (CSE), Beijing, China. 2016
  552. Addisons disease and pregnancy: Severe intrapartum hypotension due to cerebellar tonsillar herniation, but not Addisonian crisis.  Rajeshwari ashok,  Akshya hegde,  Owais Haqq,  Vibha Ashish Rao,  Marimuttu B,  Ashwini KJ,  Nandini Jayaram,  Geetha Rao,  Latha Venkatraman,  Babitha Thyagaraj,  Reshma Harsha,  Priyanka S,  Vasanthi Nath,  Chandrika KM,  Lakshmi Reddy,  Chandraprabha S,  Kamala T,  Tejaswini Deepak,  sharada A,  Srikanta S Diabetes Endocrinology Collaborative Study Group: Samatvam Endocrinology Diabetes Center and Jnana Sanjeevini Diabetes Hospital and Medical Center.  Abstract NO.:1699.  17th International Congress of Endocrinology (ICE) and 15th Annual Conference of Chinese Society of Endocrinology (CSE), Beijing, China2016
  553. Poverty associated childhood diabetes in India: Complications, comorbidities and challenges. Vibha Ashish Rao,  Akshaya Hegde,  Ashwini Kj,  Owais Haqq,  Marimuthu B,  Rajeshwari Ashok,  Nandini Jayaram,  Geetha Rao,  Uma Dayashankhar,  Usha Rangaraj,  Vasanthalakshmi H K,  Kamala T,  Vasanthi Nath,  Reshma Harsha,  Chandrika Km,  Rajeev K,  Muralidhara Krishna,  Tejeswini Deepak,  Sharda A,  Srikanta S.  Diabetes Endocrinology Collaborative Study Group: Samatvam Endocrinology Diabetes Center and Jnana Sanjeevini Diabetes Hospital and Medical Center.Abstract NO.:1701.  17th International Congress of Endocrinology (ICE) and 15th Annual Conference of Chinese Society of Endocrinology (CSE), Beijing, China2016
  554. Severe Hypoinsulinemic Hypoglycaemia in Beckwith-Wiedemann Syndrome (BWS): Potential Mechanisms and Therapeutic Implications. Rajeshwari Ashok,  Vibha Rao,  Owais Haqq,  Reshma Harsha,  Mari Muthu,  Babitha Rani,  Muralidhar Krishna,  Chandraprabha P,  Akshaya Hegde,  Geetha Rao,  Usha Rangarajan,  Chandrika KM,  Vasanthi Nath,  Uma Dayashankar,  Sharda A,  Sunitha B,  Tejeswini Deepak,  Nandhini Jayaram,  Bina naik,  Srikanta S.  Diabetes Endocrinology Collaborative Study Group: Samatvam Endocrinology Diabetes Center and Jnana Sanjeevini Diabetes Hospital and Medical Center. Abstract NO.:1702.  17th International Congress of Endocrinology (ICE) and 15th Annual Conference of Chinese Society of Endocrinology (CSE), Beijing, China2016
  555. Drug Induced Fanconis Syndrome and Metabolic Bone Disease (Hypophosphatemic Osteomalacia) due to Nucleotide Reverse Transcriptase Inhibitors: Need for Increased awareness and Prospective Surveillance. Vibha Ashish Rao,  Owais Haqq,  Akshaya Hegde,  Ashwini Kj,  Marimuthu B,  Rajeshwari Ashok,  Geetha Rao,  Usha Rangaraj,  Mahalakshmi H,  Kamala T,  Vasanthi Nath,  Lakshmi Reddy,  Reshma Harsha,  Babitha Devi T,  Chandrika Km,  Chandraprabha S,  Sumathi M,  Tejeswini D,  Sharda A,  Srikanta S. Diabetes Endocrinology Collaborative Study Group: Samatvam Endocrinology Diabetes Center and Jnana Sanjeevini Diabetes Hospital and Medical Center.Abstract NO.:1706. 17th International Congress of Endocrinology (ICE) and 15th Annual Conference of Chinese Society of Endocrinology (CSE), Beijing, China2016
  556. Thyroid dysfunction, celiac disease, economic impoverishment and childhood diabetes in India.  Ashwini K J,  Owais Haqq,  Akshya Hegade,  VibhaAshish Rao,  Rajeshwari A,  Marimuttu B,  Usha Rangaraj,  Geetha Ra0,  vasanthalakshmi HK,  Kavitha M,  Babitha Thyagaraj,  Muralidhara CS,  Chandraprabha S,  Reshma Harsha,  Sunitha Vidhyanand,  Vasanthi Nath,  Kamala T,  Tejaswini Deepak,  Sharada A,  Srikanta S.  Diabetes Endocrinology Collaborative Study Group: Samatvam Endocrinology Diabetes Center and Jnana Sanjeevini Diabetes Hospital and Medical Center.  Abstract NO.:1825. 17th International Congress of Endocrinology (ICE) and 15th Annual Conference of Chinese Society of Endocrinology (CSE), Beijing, China2016
  557. Bone mineral density and metabolic bone indices in Asian Indian postmenopausal women with and without diabetes. Rajeshwari Ashok,  Akshya Hegde,  Aswini KJ,  Owais Haqq,  Vibha ashish Rao,  Marimuttu B,  geetha Rao,  Uma Dayashanker,  Pushpa Ravikumar,  Chandraprabha S,  Babitha Thyagaraj,  Vasanthi Nath,  Reshma Harsha,  Muralidahara CS,  Rajeev k,  Chitra MD,  Kamala t,  Tejaswini Deepak,  Sharada A,  Srikanta S. Diabetes Endocrinology Collaborative Study Group: Samatvam Endocrinology Diabetes Center and Jnana Sanjeevini Diabetes Hospital and Medical Center.Abstract NO.:1840. 17th International Congress of Endocrinology (ICE) and 15th Annual Conference of Chinese Society of Endocrinology (CSE), Beijing, China.2016
  558. Carney Complex [CC]: Unique and desperate [endocrine and non-endocrine] diagnostic – therapeutic challenges and biologic mystery.Akshaya Hegde,  Vibha Ashish Rao,  Owais Haqq,  Ashwini KJ,  Marimuttu B,  Rajeshwari A,  Uma Dayashanker,  Rajeev K,  Chandraprabha S,  Chitra MD,  Lakshmi Reddy,  Sumathi K,  Chandrika KM,  Babitha Thyagaraj,  Vasanthi Nath,  Reshma Harsha,  Kamala T,  Tejaswini Deepak,  Sharada A,  Srikanta S. Diabetes Endocrinology Collaborative Study Group: Samatvam Endocrinology Diabetes Center and Jnana Sanjeevini Diabetes Hospital and Medical Center.Abstract NO.:1848. 17th International Congress of Endocrinology (ICE) and 15th Annual Conference of Chinese Society of Endocrinology (CSE), Beijing, China2016
  559. Mandatory need of screening for mental health disorders in Diabetes Clinics: Potential for improved diabetes and health outcomes.   OWAIS HAQQ,  Vibha Rao,  Rajeshwari Ashok,  Mari Muthu,  Akshaya Hegde,  Ashwini KJ,  Kamala T,  Roshan Sutar,  Vasanthi Nath,  Babitha Rani,  Sanjana Malhotra,  Chandrika KM,  Tejeswini Deepak,  Sharda A,  Chandraprabha P,  Santosh Chaturvedi,  Geetha Rao,  Usha Rangarajan,  Reshma Harsha,  Srikanta S. Diabetes Endocrinology Collaborative Study Group: Samatvam Endocrinology Diabetes Center and Jnana Sanjeevini Diabetes Hospital and Medical Center.Abstract NO.:1858. 17th International Congress of Endocrinology (ICE) and 15th Annual Conference of Chinese Society of Endocrinology (CSE), Beijing, China.2016
  560. Bromocriptine: An orphan grossly underutilized and neglected diabetes medication with cardiovascular benefits? Owais Haqq,  Vibha Ashish Rao,  Akshaya Hegde,  Ashwini K J,  Rajeshwari Ashok,  Marimuthu B,  Uma Dayashankar,  Geetha Rao,  Nandini Jayaram,  Babitha T,  Kavitha M,  Kamala T,  Reshma Harsha,  Vasanthi Nath,  Chandraprabha S,  Sumathi M,  Lakshmi Reddy,  Tejeswini Deepak,  Sharda A,  Srikanta S. Diabetes Endocrinology Collaborative Study Group: Samatvam Endocrinology Diabetes Center and Jnana Sanjeevini Diabetes Hospital and Medical Center.Abstract NO.:1889. 17th International Congress of Endocrinology (ICE) and 15th Annual Conference of Chinese Society of Endocrinology (CSE), Beijing, China2016
  561. Places of worship as fertile locations for community diabetes awareness and screening: “One day at the gates of a temple”.  Marimuthu B,  Vibha Ashish Rao,  Ashwini K J,  Owais Haqq,  Rajshwari Ashok,  Akshaya Hegde,  Geetha Rao,  Usha Rangaraj,  Vasanthalakshmi Hk,  Uma Dayashankhar,  Nandini Jayaram,  Reshma Harsha,  Babitha T,  Rajeev K,  Murlidhara Cs,  Vasanthi Nath,  Sunitha V,  Tejeswini Deepak,  Sharada A,  Srikanta S.  Diabetes Endocrinology Collaborative Study Group: Samatvam Endocrinology Diabetes Center and Jnana Sanjeevini Diabetes Hospital and Medical Center.Abstract NO.:1892. 17th International Congress of Endocrinology (ICE) and 15th Annual Conference of Chinese Society of Endocrinology (CSE), Beijing, China2016
  562. Clinical utility of coronary artery calcium [CAC] scores as good markers of preclinical atherosclerosis and need for aggressive therapy in diabetes. VIBHA ASHISH RAO,  Akshaya Hegde,  ASHWINI K, J,  MARIMUTHU B,  OWAIS HAQQ,  RAJESHWARI ASHOK,  Babithadevi T,  Geetha Rao,  Nandini Jayaram,  Reshma Harsha,  Vasanthi Nath,  Kamala T,  Chandraprabha S,  Pushpa Ravikumar,  Lakshmi Reddy,  Sumathi M,  Chandrika KM,  Tejeswini D,  Sharda A,  Srikanta S.  Diabetes Endocrinology Collaborative Study Group: Samatvam Endocrinology Diabetes Center and Jnana Sanjeevini Diabetes Hospital and Medical Center.Abstract NO.:2066.  17th International Congress of Endocrinology (ICE) and 15th Annual Conference of Chinese Society of Endocrinology (CSE), Beijing, China2016
  563. Type 2 Diabetes and coexistent Cardiovascular disease: Profile and trends of renal dysfunction and medication dosing.  MARIMUTHU B,  Akshaya Hegde,  Rajeshwari Ashok,  VIBHA ASHISH RAO,  Owais Haqq,  Ashwini KN,  Nandini Jayaram,  Uma Dayashankhar,  Usha Rangaraj,  Reshma Harsha,  BabithaDevi T,  Vasanthi Nath,  Lakshmi Reddy,  Sumathi M,  Kamala T,  Priyanka S,  Chandraprabha S,  Tejeswini Deepak,  Sharda A,  Srikanta S.  Diabetes Endocrinology Collaborative Study Group: Samatvam Endocrinology Diabetes Center and Jnana Sanjeevini Diabetes Hospital and Medical Center.Abstract NO.:2073. 17th International Congress of Endocrinology (ICE) and 15th Annual Conference of Chinese Society of Endocrinology (CSE), Beijing, China2016
  564. Acquired post-partum severe (but reversible) renal tubular dysfunction with periodic paralysis (hypokalemia, hypophosphatemia) and nephrogenic diabetes insipidus.  Akshaya Hegde,  Vibha Ashish Rao,  Ashwini K J,  Owais Haqq,  Rajeshwari Ashok,  Marimuthu B,  Reshma H,  Geetha Rao,  Uma Dayashankhar,  Usha Rangaraj,  Nandini Jayaram,  Vasanthi Nath,  BabithaDevi T,  Kamala T,  Lakshmi Reddy,  Sumathi M,  Chandrika KM,  Tejeswini Deepak,  Sharda A,  Srikanta S. Diabetes Endocrinology Collaborative Study Group: Samatvam Endocrinology Diabetes Center and Jnana Sanjeevini Diabetes Hospital and Medical Center. Abstract NO.:2075.  17th International Congress of Endocrinology (ICE) and 15th Annual Conference of Chinese Society of Endocrinology (CSE), Beijing, China2016
  565. Initial experiences and learnings from the unique “first country in the world – India” novel libre pro continuous glucose monitoring [CGM] system: plea for approval in pediatric diabetes.  R. Manjunath, V.A. Rao, S. Srikanta, L. Reddy, A. Sharda, T. Deepak, A. Hegde, B.D. Thyagaraj, B. Reshma, R. Ashok, S. Madiazaghan, K.L. Chetana, U. Dayashankar, U. Rangaraj, Diabetes Collaborative Study Group: Jnana Sanjeevini Diabetes Hospital and Medical Center and Samatvam Endocrinology Diabetes Center, Bangalore, India Poster number P041.  42nd Annual Conference of the International Society for Pediatric and Adolescent Diabetes (ISPAD), Valencia, Spain.2016
  566. Thyroid dysfunction, celiac disease, economic impoverishment and childhood type 1 diabetes [T1DM] in India. R. Manjunath, S. Malhotra, S. Srikanta, V.A. Rao, L. Reddy, T. Kamala, K.L. Chetana, B.D. Thyagaraj, A. Hegde, R. Ashok, C.S. Muralidhara Krishna, K. Rajiv, T. Deepak, A. Sharda, Diabetes Collaborative Study Group: Jnana Sanjeevini Diabetes Hospital and Medical Center and Samatvam Endocrinology Diabetes Center, Bangalore, IndiaPoster number P032.  42nd Annual Conference of the International Society for Pediatric and Adolescent Diabetes (ISPAD), Valencia, Spain.2016
  567. “Psychosocial profile, glycemic control and well-being in poverty associated type 1 diabetes mellitus [T1DM] adolescents in India.  R. Manjunath, S. Malhotra, V.A. Rao, L. Reddy, S. SRIKANTA, Diabetes Collaborative Study Group: Jnana Sanjeevini Diabetes Hospital and Medical Center and Samatvam Endocrinology Diabetes Center, Bangalore, India.   Poster number P348. 42nd Annual Conference of the International Society for Pediatric and Adolescent Diabetes (ISPAD), Valencia, Spain.2016
  568. Hypergonadotropic hypogonadism in 2 siblings with DIDMOAD (Wolfram Syndrome – WFS) syndrome and its associations. R. Manjunath, V.A. Rao, K. Chandrika, G.S. Rao, A. Sharda, T. Deepak, L. Reddy, B. Reshma, S. Srikanta, V. Nath, Diabetes Collaborative Study Group: Samatvam Endocrinology Diabetes Center and Jnana Sanjeevini Medical Center, Bangalore, India Posternumber P106.  42nd Annual Conference of the International Society for Pediatric and Adolescent Diabetes (ISPAD), Valencia, Spain. 2016
  569. Coronary Artery Calcium [CAC] Scores and Early Stage Diabetic Kidney Disease [Dkd]: Good Markers of Preclinical Atherosclerosis and Need For Aggressive Therapy in Diabetes. S. Srikanta1, U. Anandh2, T. Kamala1, B. Thyagaraj1, R. Bananki1, V. Nath1, K. Muniraj1, R. Kasiviswanath1, M. Chikkamogha Siddaiah1, Chitra. M D1.Abstract Number:  WCN17-0690, ISN 2017 World Congress of Nephrology, Mexico City, Mexico.
  570. Community Preventive Nephrology   – A Small Step Towards:  Diabetes And Hypertension Awareness And Screening: “One Day At The Gates Of A Temple”. S. Srikanta1, U. Anandh2, T. Kamala1, B. Tyagaraj1, R. Bananki1, V. Nath1, K. Muniraj1, R. Kasivishwanath1, M. Chikkamoga Siddaiah1, A. Sinha1.
     Abstract Number:  WCN17- 0696, ISN 2017 World Congress of Nephrology, Mexico City, Mexico.
  571. Diabetic Kidney Disease [DKD] In Poverty Associated Childhood Diabetes in India: Prevalence Correlates and Challenges. S. Srikanta1, U. Anandh2, T. Kamala1, B. Reshma1, B. Thyagaraj1, V. Nath1, K. Muniraj1, R. Kasiviswanath1, M. Chikkamoga Siddaiah1, C. Siddalingappa1. Abstract Number:  WCN17- 0697, ISN 2017 World Congress of Nephrology, Mexico City, Mexico.
  572. Spectrum and Longitudinal Trends of Renal Dysfunction in Type 2 Diabetes with Coexistent Cardiovascular Disease: Relevance to Medication Dosing and Titrations. S. Srikanta1, U. Anandh2, T. Kamala1, R. Bananki1, B. Thyagaraj1, V. Nath1, K. Muniraj1, R. Kasivishwanath1, M. Chikkamoga Siddaiah1, Chitra. M D1 Abstract Number:  WCN17- 0693, ISN 2017 World Congress of Nephrology, Mexico City, Mexico.
  573. Validation of point of care device for urine microalbumin/creatinine, serum albumin and HbA1c: correlations and applications in diabetic kidney disease. V. Kumar, N. Bhat, P. Krishnaswamy, S. Panwar, R. Kalam, S. R, S. Prasad, K. T., S. Srikanta, U. Anandh. Abstract Number: WCN17-0408, ISN 2017 World Congress of Nephrology, Mexico City, Mexico.
  574. Self-Blood Glucose Monitoring [SMBG] in Poverty associated childhood type 1 diabetes: Achievement of high quality accuracy and improved health outcomes possible? K. Chethana, S. Srikanta, H. Reshma, N. Vasanthi, K. Muralidhar, K. Rajeev, T.Babitadevi, S. Amitkumar, S. Vasudha, M.D. Chitra, A. Sumitra, M. Sapna, R. Vibha, H.Akshaya, T. Jayalakshmi, M. Kavitha, S. Chandraprabha, Samatvam Jnana Sanjeevini Diabetes Collaborave Study Group. International Society for Pediatric and Adolescent Diabetes (ISPAD) 2017-Innsburg, Austria.
  575.  Childhood and youth onset diabetes in India: Profile, challenges, progress and future? [1970s – 2010s]. K.Chethana ,S.Srikanta, H.Reshma, N.Vasanthi, K.Muralidhar, K.Rajeev, T.Babitadevi, S Amitkumar, S.Vasudha, M.D.Chitra, A.Sumitra, M.Sapna, R.Vibha, H.Akshaya, T. Jayalakshmi, M. Kavitha, S.Chandraprabha, Samatvam Jnana Sanjeevini Diabetes Collaborave Study Group. International Society for Pediatric and Adolescent Diabetes (ISPAD) 2017-Innsburg, Austria.
  576. Dyslipidemia and Diabec Kidney Disease [DKD] in poverty associated childhood diabetes in India: Prevalence correlates and challenges. K.Chethana, S.Srikanta, H.Akshaya, S.Amitkumar, T.Babitadevi, M.D.Chitra, K.Muralidhar, K.Rajeev, H Reshma, M.Sapna, A.Sumitra, N.Vasanthi, S.Vasudha, R.Vibha, T.Jayalakshmi, M.Kavitha, Samatvam Jnana Sanjeevini Collaborave Study Group. International Society for Pediatric and Adolescent Diabetes (ISPAD) 2017-Innsburg, Austria.
  577. Point of Care [POC] Biosensors for Diabetes Biomarkers: Clinical and Community applicaons in Diabetes Care [Type 1 and 2]. K.Chethana, S.Srikanta, H.Akshaya, H.Reshma, K.Muralidhar, T.Babitadevi, S.Amitkumar, N.Vasanthi, K.Rajeev, M.D.Chitra, A.Sumitra, M.Sapna, R Vibha, N.Bhat, V.Chauhan, U.Anandh, M.Kavitha, S.Chandraprabha, Samatvam Jnana Sanjeevini Diabetes Collaborave Study Group. International Society for Pediatric and Adolescent Diabetes (ISPAD) 2017-Innsburg, Austria.
  578. Peers for Health: Community health worker led diabetes hypertension screening awareness program for rural and urban poor. Mahesh Manjunath , S Srikanta, Ashwini K J, Mary Priya , Srilatha BK, Harsha A S,Amit Kumar Shina , Akshaya Hegde , Vibha Rao , Kavitha Muniraju, Muralidhar Krishna C S, Kavitha Vhalve and the Diabetes Collaborative Study Group. Jnana Sanjeevini Diabetes Hospital and Medical Center and Samatvam Endocrinology Diabetes Center, Diabetes Endocrinology, Bangalore, India. Poster number-0085, International Diabetes Federation (IDF) Congress 2017, Abu Dhabi, UAE
  579. Childhood and youth onset diabetes in India: Profile, challenges, progress and future? [1970s – 2010s] Mary Priya, S Srikanta, Amit Kumar Sinha, Srilatha Chandrashekar, Ashwini K J,Mahesh Manjunath, Akshaya Hegde, Kavitha Muniraj, Muralidhar Krishna C S, Kavitha Vhavle , Vibha Rao and the Diabetes Collaborative Study Group. Jnana Sanjeevini Diabetes Hospital and Medical Center and Samatvam Endocrinology Diabetes Center, Diabetes Endocrinology, Bangalore, India. Poster number-0771, International Diabetes Federation (IDF) Congress 2017, Abu Dhabi, UAE
  580. Bone Mineral Density and Metabolic Bone Indices in Asian Indian Postmenopausal Women With and Without Diabetes, Ashwini Kuntikana, S Srikanta, Mary Priya , Srilatha BK, Harsha A S, Amit Kumar Shina, Mahesh Manjunath, Akshaya Hegde , Vibha Rao, Muralidhar Krishna C S and
    the Diabetes Collaborative Study Group Jnana Sanjeevini Diabetes Hospital and Medical Center and Samatvam Endocrinology Diabetes Center, Bangalore, India, Poster number-1013, International Diabetes Federation (IDF) Congress 2017, Abu Dhabi, UAE
  581. Coronary artery calcium and diabetic kidney disease: Markers of preclinical atherosclerosis and aggressive therapy need Amit Kumar Sinha , S Srikanta, Mary Priya , Srilatha B K, Harsha A S, Mahesh Manjunath, Ashwini KJ, Akshaya Hegde, Vibha Rao, Kavitha V P, Kavitha Muniraju and the Diabetes Collaborative Study Group. Jnana Sanjeevini Diabetes Hospital and Medical Center and Samatvam Endocrinology Diabetes Center, Diabetes Endocrinology, Bangalore, India, Poster number-0025, International Diabetes Federation (IDF) Congress 2017, Abu Dhabi, UAE
  582. Community Preventive Diabetology – a small step towards: Diabetes and hypertension awareness and screening: “One day at the gates of a temple”, Kavitha V P, S Sathyanarayana, Mahesh Manjunath, Harsha Ananthaswamy, Mary Priya, Srilatha B K, Amit Kumar Sinha, Ashwini K J, Akshaya Hegade, Muralidhara Krishna C S and the Diabetes Collaborative Study Group. Jnana Sanjeevini Diabetes Hospital and Medical Center and Samatvam Endocrinology Diabetes Center, Diabetes Endocrinology, Bangalore, India, Poster number-0141, International Diabetes Federation (IDF) Congress 2017, Abu Dhabi, UAE
  583. Growth and Development Trends In Economically Underprivileged Type 1 Diabetes Children In India, Amit Kumar Shina, S. Srikanta , Mary Priya, Srilatha B K, Harsha Ananthaswamy, Mahesh Manjunath, Ashwini K J, Akshaya Hegde, Vibha Rao, Kavitha V P, Reshma B V and the Diabetes Collaborative Study Group. Jnana Sanjeevini Diabetes Hospital and Medical Center and Samatvam Endocrinology Diabetes Center, Diabetes Endocrinology, Bangalore, India. Poster number-0777, International Diabetes Federation (IDF) Congress 2017, Abu Dhabi, UAE
  584. Novel user friendly Libre Pro continuous glucose monitoring [CGM]: Exclusive India initial experiences and learnings, Mahesh Manjunath, S Srikanta, Mary Priya, Srilatha B K, Harsha A S, Ashwini K J, Amit Kumar Shina, Akshya Hegde, Kavitha Muniraju, Vibha Rao, Kavitha Vhavle
    and the Diabetes Collaborative Study Group. Jnana Sanjeevini Diabetes Hospital and Medical Center and Samatvam Endocrinology Diabetes Center, Diabetes Endocrinology, Bangalore, India. Poster number-1218, International Diabetes Federation (IDF) Congress 2017, Abu Dhabi, UAE
  585. Mega “Pulse” Diabetes Awareness Program: Design, implementation, experiences, challenges, and “model” replication. Harsha A S, S Srikanta, Ashwini K J, Mahesh Manjunath, Mary Priya , Srilatha BK, Amit Kumar Shina , Akshaya Hegde , Vibha Rao , Reshma B V, Kavitha Vhalve,
    Muralidhara Krishna C S and the Diabetes Collaborative Study Group. Jnana Sanjeevini Diabetes Hospital and Medical Center and Samatvam Endocrinology Diabetes Center, Diabetes Endocrinology, Bangalore, India. Poster number-0155, International Diabetes Federation (IDF) Congress 2017, Abu Dhabi, UAE
  586. Tackling diabetes epidemic through focused Primary Care Provider training: India’s largest Regional Center’s experience. Ashwini K J, S Srikanta, Mary Priya , Mahesh Manjunath, Srilatha BK, Harsha A S, Amit Kumar Shina , Akshaya Hegde , Vibha Rao , Kavitha Muniraju, Muralidhar Krishna C S, Kavitha Vhalve and the Diabetes Collaborative Study Group Jnana Sanjeevini Diabetes Hospital and Medical Center and Samatvam Endocrinology Diabetes Center, Bangalore, India. Poster number-0175, International Diabetes Federation (IDF) Congress 2017, Abu Dhabi, UAE
  587. Diabetic Kidney Disease [DKD] in poverty associated childhood diabetes in India: Prevalence correlates and challenges. Mary Priya , S Srikanta, Srilatha B K, Harsha A, Mahesh Manjunath, Amit Kumar Sinha , Ashwini K J, Akshaya Hegde, Vibha Rao, Kavitha Muniraj , Babitha Devi Thyagaraj and the Diabetes Collaborative Study Group. Jnana Sanjeevini Diabetes Hospital and Medical Center and Samatvam Endocrinology Diabetes Center, Diabetes Endocrinology, Bangalore, India. Poster number-0946, International Diabetes Federation (IDF) Congress 2017, Abu Dhabi, UAE
  588. Type 2 diabetes care in a resource limited setting in India [1994-2017] – Towards success of Berlin Declaration. Harsha Ananathaswamy, S Srikanta, Srilatha B K, Mahesha M, Mary Priya, Ashwini
    K J, Amit Kumar Sinha, Akshaya Hegade, Vibha Rao, K. Muniraj, Chitra M D and the Diabetes Collaborative Study Group.Jnana Sanjeevini Diabetes Hospital and Medical Center and Samatvam
    Endocrinology Diabetes Center, Diabetes Endocrinology, Bangalore, India. Poster number-1180, International Diabetes Federation (IDF) Congress 2017, Abu Dhabi, UAE
  589. Anxiety, depression, glycemic control and wellbeing in poverty associated type 1 diabetes mellitus adolescents in India. Mary Priya , S Srikanta, Srilatha B K, Harsha A, Mahesh Manjunath, Amit Kumar Sinha , Ashwini K J, Akshaya Hegde, Vasanthi Nath, Kavitha Muniraj , Reshma B V and the Diabetes Collaborative Study Group Jnana Sanjeevini Diabetes Hospital and Medical Center and Samatvam Endocrinology Diabetes Center, Bangalore, India. Poster number-0123, International Diabetes Federation (IDF) Congress 2017, Abu Dhabi, UAE
  590. Thyroid dysfunction, celiac disease, economic impoverishment and childhood diabetes in India. Mary Priya , S Srikanta, Srilatha B K, Harsha A, Mahesh Manjunath, Amit Kumar Sinha , Ashwini K J, Akshaya Hegde, Chitra M D, Muralidhara Krishna C S, Rajiv K and the Diabetes Collaborative Study Group Jnana Sanjeevini Diabetes Hospital and Medical Center and Samatvam Endocrinology Diabetes Center, Bangalore, India. Poster number-0776, International Diabetes Federation (IDF) Congress 2017, Abu Dhabi, UAE
  591.  Hypergonadotrophic Hypogonadism In 2 Siblings With DIDMOAD Syndrome and Its Associations. Amit Kumar Shina S Srikanta, Mary Priya , Srilatha B K, Ashwini K J, Mahesh Manjunath, Harsha A S, Akshaya Hegde , Vibha Rao , Kavitha Vhalve , Vasanthi Nath and the Diabetes Collaborative Study Group. Samatvam Endocrinology Diabetes Center and Jnana Sanjeevini Medical Center, Bangalore, India. Poster number-0572, International Diabetes Federation (IDF) Congress 2017, Abu Dhabi, UAE
  592. Point of care biosensor for urine albumin: creatinine measurement: clinical and community applications in diabetes care. Mahesh Manjunath, Vinay Kumar, Suraj hebbar, Navakantha Bhat, S
    Sathyanarayana, Urmila Anand, Harsha A S, Vibha Rao, Ashwini K J, Akshaya Hegde and the Diabetes Collaborative Study Group. Jnana Sanjeevini Diabetes Hospital and Medical Center and Samatvam
    Endocrinology Diabetes Center, Diabetes Endocrinology, Bangalore, India. Poster number-0192, International Diabetes Federation (IDF) Congress 2017, Abu Dhabi, UAE
  593. Point of care biosensor for urine albumin: creatinine measurement: clinical and community applications in diabetes care. Mahesh Manjunath, Vinay Kumar, Suraj hebbar, Navakantha Bhat, S
    Sathyanarayana, Urmila Anand, Harsha A S, Vibha Rao, Ashwini K J, Akshaya Hegde and the Diabetes Collaborative Study Group. Jnana Sanjeevini Diabetes Hospital and Medical Center and Samatvam
    Endocrinology Diabetes Center, Diabetes Endocrinology, Bangalore, India. Poster number-1218, International Diabetes Federation (IDF) Congress 2017, Abu Dhabi, UAE.
  594. Point of care biosensor for glycated hemoglobin measurement: clinical and community applications in diabetes care. Vibha Rao, Vinay Kumar, KPR, S Hebbar, A Bhat, S Sathyanarayana, Mahesh Manjunath, Harsha A S, Mary Priya, Akshaya Hegde, Urmila Anand and the Diabetes Collaborative Study Group. Jnana Sanjeevini Diabetes Hospital and Medical Center and Samatvam
    Endocrinology Diabetes Center, Diabetes Endocrinology, Bangalore, India. International Diabetes Federation (IDF) Congress 2017, Abu Dhabi, UAE.
  595.  
  596. “Mental Health” challenges in people with diabetes: Mandatory screening to improve quality of life and health outcomes. Akshaya Hegde, S Srikanta, M. Priya , Srilatha B K, Harsha A S, Mahesh Manjunath, Amit Kumar Sinha, Ashwini K J, Vibha Rao , Kavitha V P, Reshma B V and the Diabetes Collaborative Study Group. Jnana Sanjeevini Diabetes Hospital and Medical Center and Samatvam
    Endocrinology Diabetes Center, Diabetes Endocrinology, Bangalore, India. International Diabetes Federation (IDF) Congress 2017, Abu Dhabi, UAE.
  597. “Health care at doorsteps of rural and urban poor”: An innovative “piggy back” paradigm for Preventive Diabetology. Akshaya Hegde, S Srikanta, Amit Kumar Sinha, Mary Priya, Harsha A S, Srilatha B K, Kavitha V P, Ashwini K J, Kavitha Muniraj, Reshma B V, Rajiv K and the Diabetes Collaborative Study Group. Jnana Sanjeevini Diabetes Hospital and Medical Center and Samatvam
    Endocrinology Diabetes Center, Diabetes Endocrinology, Bangalore, India. International Diabetes Federation (IDF) Congress 2017, Abu Dhabi, UAE.
  598.  Dyslipidemia in childhood type 1 diabetes in India: prevalence, correlates and management challenges in a resource limited setting.  A. Govind , S. Chandrashekar , M.S. Vaishnav , S. Manjunath , S. Geetha Rao , S.Srikanta. Diabetes Collaborative Study Group. Samatvam: Science and Research for Human Welfare Trust, Endocrinology Diabetes Medicine, BENGALURU, India, Jnana Sanjeevini Medical Center and Diabetes Hospital, Diabetes Endocrinology Medicine, Bangalore, India, Jnana Sanjeevini Medical Center and Diabetes Hospital, Endocrinology, Diabetes, Bangalore, India, Samatvam: Science and Research for Human Welfare Trust, Endocrinology Diabetes Medicine, Bangalore, India. Poster number P266. 44nd Annual Conference of the International Society for Pediatric and Adolescent Diabetes (ISPAD)2018, Hyderabad, India.
  599. “Bridging the Gap”? Diabetic Kidney Disease [DKD] in poverty associated type 1 childhood diabetes in India: prevalence, correlates and challenges.  A. Govind , M.S. Vaishnav , S. Chandrashekar , R. Bananki Vijay , S. Srikanta , U. Dayashankar , G. Rao , U. Rangaraj , H.K. Vasanthalakshmi , R. Ashok , A. Hegde , N. Jayaram , K. Muniraj , V. Nath , L. Reddy , K.M. Chandrika , C.S. Muralidhara krishna , S. Chandraprabha , B.D. Thyagaraj , M.D. Chitra , P. Jayalakshmi , N.S. Vijayalakshmi , K.M. Sumathi , B.M. Bhatt , T. Kamala , P. Ravikumar , T. Deepak , R. Manjunath , K.L. Chethana , B. Naik , P. Srinivas , S. Manjunath , N. Rayas , R. Kasiviswanath , S. Dinesha , V. Srikanth , N. Srinivas , A. Sharda . Diabetes Collaborative Study Group. Samatvam: Science and Research for Human Welfare Trust, Endocrinology Diabetes Medicine, BENGALURU, India, Jnana Sanjeevini Medical Center and Diabetes Hospital, Diabetes Endocrinology Medicine, Bangalore, India, Jnana Sanjeevini Medical Center and Diabetes Hospital, Endocrinology, Diabetes, Bangalore, India, Samatvam: Science and Research for Human Welfare Trust, Endocrinology Diabetes Medicine, Bangalore, India.  poster number P262. 44nd Annual Conference of the International Society for Pediatric and Adolescent Diabetes (ISPAD)2018, Hyderabad, India.
  600. “Reaching the Unreached??” in Childhood Diabetes Patient – Family Health Education
    and Counselling: Three Decades Challenges, Failures and Successes from India [DISHA CDIC – LFAC].
  601. Bananki Vijay , A. Govind , S. Chandrashekar , S. Geetha Rao , M.S. Vaishnav , S. Chugh ,
    P. Dinakaran , S. Srikanta , S. Manjunath , B.D. Thyagaraj , S. Chandraprabha , K. Muniraj , V.
    Nath , C.S. Muralidhara krishna , R. Kasiviswanath , P. Jayalakshmi , M.D. Chitra , V.
    Srikanta , S. Dinesha , U. Dayashankar , B.M. Bhatt , Diabetes Collaborative Study Group. Samatvam: Science and Research for Human Welfare Trust, Endocrinology Diabetes Medicine,
    Bangalore, India, Samatvam: Science and Research for Human Welfare Trust, Endocrinology
    Diabetes Medicine, BENGALURU, India, Changing Diabetes in Children Program, Novo
    Nordisk, India, Bangalore, India. .  Poster number . 44nd Annual Conference of the International Society for Pediatric and Adolescent Diabetes (ISPAD) 2018, Hyderabad, India
  602. Practical challenges in diagnosis and management of pediatric type 2 diabetes in India resource limited settings. R. Bananki Vijay , A. Govind , M.S. Vaishnav , S. Chandrashekar , V. Nath , L. Reddy , K.M. Chandrika , K. Muniraj , C.S. Muralidhara krishna , S. Chandraprabha , B.D. Thyagaraj , M.D.Chitra , P. Jayalakshmi , K.M. Sumathi , B.M. Bhatt , T. Kamala , P. Ravikumar , T. Deepak , A.
    Sharda , N. Srinivas , V. Srikanth , S. Dinesha , N. Rayas , S. Geetha Rao , U. Rangaraj , R. Kasiviswanath, H.K. Vasanthalakshmi , N. Jayaram , R. Ashok , S. Manjunath , U. Dayashankar , P. Srinivas , B. Naik , K.L. Chethana , R. Manjunath , S. Srikanta , A. Hegde , N.S. Vijayalakshmi , Diabetes Collaborative Study Group Samatvam: Science and Research for Human Welfare Trust, Endocrinology Diabetes Medicine,Bangalore, India, Samatvam: Science and Research for Human Welfare Trust, Endocrinology
    Diabetes Medicine, BENGALURU, India, Changing Diabetes in Children Program, Novo Nordisk, India, Bangalore, India. poster number . 44nd Annual Conference of the International Society for Pediatric and Adolescent Diabetes (ISPAD) 2018, Hyderabad, India.
  603. Bisphosphonate related atypical femoral fractures: Need for heightened awareness regarding diagnosis and therapy. Nidhi Garg, Kavitha Muniraj, Reshma B. Vijay, Vasanthi Nath, Chandraprabha S, Babitha D. T, Muralidhara Krishna, Jayalakshmi T, Apoorva Govind, Siddartha Dinesha, MD Chitra, Vasudha Srikanth, Nalini K Rayas, Keerthana Haridas, Monica Narayanaswamy, Sathvik Reddy C.B. Annual Scientific Conference of American Association of Clinical Endocrinologists, 2019, Los Angeles, USA.
  604. Community to clinic to bench: Biomarker associations for better diabetes health care – Foundation studies  Jayalakshmi T, Reshma B. Vijay, Vasanthi Nath, Muralidhara Krishna, Kavitha Muniraj, Babitha D. T, Chandraprabha S, Nidhi Garg, Apoorva Govind, Madhumati S Vaishnav, MD Chitra,Vasudha Srikanth, Monica Narayanaswamy, Namya Gaekwad, Nalini K Rayas,Keerthana Haridas. Annual Scientific Conference of American Association of Clinical Endocrinologists, 2019, Los Angeles, USA.
  605. Dyslipidemia in childhood type 1 diabetes in India: Prevalence correlates and management challenges in a resource limited setting.  Chandraprabha S, Jayalakshmi T, Reshma B. Vijay, Kavitha Muniraj, Muralidhara Krishna, Apoorva Govind, Madhumati S Vaishnav, Babitha D. T, Vasanthi Nath,Nidhi Garg, MD Chitra,Vasudha Srikanth, Monica Narayanaswamy, Namya Gaekwad, Nalini K Rayas,Keerthana Haridas. Annual Scientific Conference of American Association of Clinical Endocrinologists, 2019, Los Angeles, USA.
  606. Giant cell tumor – osteoclastoma of the spine as the inaugural presentation of primary hyperparathyroidism and giant parathyroid adenoma. Babitha D. T, Kavitha Muniraj, Reshma B. Vijay, Vasanthi Nath, Chandraprabha S, Muralidhara Krishna, Jayalakshmi T, Nidhi Garg, Apoorva Govind, MD Chitra, Siddartha Dinesha, Vasudha Srikanth, Sathvik Reddy C.B, Namya Gaekwad, Madhumati S Vaishnav,Keerthana Haridas. Annual Scientific Conference of American Association of Clinical Endocrinologists, 2019, Los Angeles, USA.
  607. Multiple germinomas of the brain: Clinical and endocrine challenges. Kavitha Muniraj, Muralidhara Krishna, Vasanthi Nath, Chandraprabha S, Babitha D. T, Jayalakshmi T, Nidhi Garg, Apoorva Govind, Reshma B. Vijay, MD Chitra, Vasudha Srikanth, Nalini K Rayas, , Siddartha Dinesha, Madhumati S Vaishnav,Monica Narayanaswamy,Keerthana Haridas. Annual Scientific Conference of American Association of Clinical Endocrinologists, 2019, Los Angeles, USA.
  608. Oncogenous osteomalacia due to benign mesenchymal tumor of right hip: Residual tumor – regrowth – repeat surgery – cure [20 years follow up]. Jayalakshmi T, Kavitha Muniraj, Reshma B. Vijay, Vasanthi Nath, Chandraprabha S, Babitha D. T, Muralidhara Krishna, Nidhi Garg, Apoorva Govind, Siddartha Dinesha, MD Chitra, Vasudha Srikanth, Sathvik Reddy C.B, Namya Gaekwad, Madhumati S Vaishnav, Keerthana Haridas. Annual Scientific Conference of American Association of Clinical Endocrinologists, 2019, Los Angeles, USA.
  609. Palpation/ traumatic thyroiditis following bilateral neck surgery for primary hyperparathyroidism. Chandraprabha S, Vasanthi Nath, Kavitha Muniraj, Reshma B. Vijay, Babitha D. T, Muralidhara Krishna,  Jayalakshmi T, Nidhi Garg, Apoorva Govind, Siddartha Dinesha, MD Chitra,Vasudha Srikanth, Sathvik Reddy C.B,, Nalini K Rayas,Monica Narayanaswamy,Namya Gaekwad. Annual Scientific Conference of American Association of Clinical Endocrinologists, 2019, Los Angeles, USA.
  610. Pituitary macroadenoma posted for transphenoidal surgery: Pituitary thyrotroph hyperplasia. Kavitha Muniraj, Babitha D. T, Vasanthi Nath, Chandraprabha S, Reshma B. Vijay, Muralidhara Krishna, Jayalakshmi T, Nidhi Garg, Apoorva Govind, Siddartha Dinesha, MD Chitra,Vasudha Srikanth, Sathvik Reddy C.B,, Namya Gaekwad,Monica Narayanaswamy, Madhumati S Vaishnav. Annual Scientific Conference of American Association of Clinical Endocrinologists, 2019, Los Angeles, USA.
  611. Puzzling thyroid functions tests: Euthyroid hypertriiodothyroninemia [and hyperthyroxinemia] due to multiple myeloma. Reshma B. Vijay, Kavitha Muniraj, Vasanthi Nath, Chandraprabha S, Babitha D. T, Muralidhara Krishna, Jayalakshmi T, Nidhi Garg, Apoorva Govind, MD Chitra, Vasudha Srikanth, Sathvik Reddy C.B, Siddartha Dinesha, Nalini K Rayas,Monica Narayanaswamy, Keerthana Haridas. Annual Scientific Conference of American Association of Clinical Endocrinologists, 2019, Los Angeles, USA.
  612. Type 2 diabetes and depression in India: Lessons from the international prevalence and treatment of diabetes and depression (interpret-dd) study, a collaborative study carried out in 14 countries. Muralidhara Krishna, Vasanthi Nath, Kavitha Muniraj, Chandraprabha S, Babitha D. T, Reshma B. Vijay, Jayalakshmi T,  Nidhi Garg, Madhumati S Vaishnav, Apoorva Govind, MD Chitra,Vasudha Srikanth, Sathvik Reddy C.B, Namya Gaekwad,Nalini K Rayas, Siddartha Dinesha. Annual Scientific Conference of American Association of Clinical Endocrinologists, 2019, Los Angeles, USA.
  613. Diabetes care, economics and health outcomes: Experiences from the 3 decade free diabetes clinic for the poor. Nidhi Garg, S Srikanta, CS Muralidhara Krishna, Reshma B. Vijay, Kavitha Muniraj, Vasanthi Nath, Chandraprabha S, Babitha D. T, Jayalakshmi T, Nidhi Garg, Apoorva Govind, MD Chitra, Vasudha Srikanth, Sathvik Reddy C.B, Siddartha Dinesha, Nalini K Rayas, Monica Narayanaswamy, Keerthana Haridas. Annual Scientific Conference of American Association of Clinical Endocrinologists, 2019, Los Angeles, USA.
  614. Long standing [7 years] Graves’ disease, with recent monstrous thyroid enlargement- Second pathology?  Vasanthi Nath, S Srikanta, CS Muralidhara Krishna, Ashim Sinha, Reshma B. Vijay, Kavitha Muniraj, Chandraprabha S, Babitha D. T, , Jayalakshmi T, Nidhi Garg, Apoorva Govind, MD Chitra, Vasudha Srikanth, Sathvik Reddy C.B, Siddartha Dinesha, Nalini K Rayas, Monica Narayanaswamy, Keerthana Haridas. Annual Scientific Conference of American Association of Clinical Endocrinologists, 2019, Los Angeles, USA.
  615. Giant parathyroid adenoma: Rarity, special features and management challenges. Vasanthi Nath, Reshma B. Vijay, Kavitha Muniraj, Chandraprabha S, Babitha D. T, Muralidhara Krishna, Jayalakshmi T, Nidhi Garg, Apoorva Govind, MD Chitra, Vasudha Srikanth, Sathvik Reddy C.B, Siddartha Dinesha, Nalini K Rayas, Monica Narayanaswamy, Keerthana Haridas. Annual Scientific Conference of American Association of Clinical Endocrinologists, 2019, Los Angeles, USA.
  616. “Insulin Akshayapatra” for childhood onset type diabetes in India: three decades [1987 – 2019] dreams, challenges, failures and successes from India. K. Haridas, M.S. Vaishnav, A. Govind, S. Reddy, N. Gaekwad, S. Dinesha, M. Narayanaswamy, R. Harsha, M. Chitra, J. Thimmaiah, N. Garg, R. Kashivishwanath, A. Hegde, Diabetes Endocrinology Study Group Samatvam Jnana Sanjeevini 1Jnana Sanjeevini Medical Center and Diabetes Hospital, Diabetes Endocrinology, Bangalore, India, 2Indian Institute of Science, Center for Nano Science and Engineering, Bangalore, India, 3Samatvam Endocrinology Diabetes Center, Diabetes Endocrinology, Bangalore, India, 4Samatvam Science and Research for Human Welfare Trust, Diabetes Endocrinology, Bangalore, India. 45th Annual Conference of the International Society for Pediatric and Adolescent Diabetes (ISPAD) 2019, Boston, USA. 
  617. Insulin edema in a 14 year poor adolescent girl with type 1 diabetes mellitus due to surreptitious [but not therapeutic] self-insulin use [project DISHA: receiving free medical care. K. Haridas, A. Govind, M.S. Vaishnav, S. Reddy, N. Gaekwad, S. Dinesha, R. Harsha, M. Narayanaswamy, M. Chitra, J. Thimmaiah, N. Garg, R. Kashivishwanath, A. Hegde, Diabetes Endocrinology Study Group Samatvam Jnana Sanjeevini 1Jnana Sanjeevini Medical Center and Diabetes Hospital, Diabetes Endocrinology, Bangalore, India, 2Indian Institute of Science, Center for Nano Science and Engineering, Bangalore, India, 3Samatvam Science and Research for Human Welfare Trust, Diabetes Endocrinology, Bangalore, India, 4Samatvam Endocrinology Diabetes Center, Diabetes Endocrinology, Bangalore, India. 45th Annual Conference of the International Society for Pediatric and Adolescent Diabetes (ISPAD) 2019, Boston, USA.
  618. Camps Man Mohan (= Mind Endearing) for type 1 diabetes children and youth: challenges, experiences and successes in resource limited settings (1987-2019-Future????) – (100% free to the beneficiaries). N. Gaekwad, M.S. Vaishnav, K. Haridas, A. Govind, S. Reddy, S. Dinesha, M. Narayanaswamy, M. Chitra, J. Thimmaiah, N. Garg, R. Kashivishwanath, P. Ravikumar, U. Dayashankar, V. Shivaraj, G. Ogle, S. Chugh, H. Dyamesh, Diabetes Endocrinology Study Group Samatvam Jnana Sanjeevini 1Samatvam: Science and Research for Human Welfare Trust, Endocrinology Diabetes, Bangalore, India, 2Indian Institute of Science, Center for Nano Science and Engineering, Bangalore, India, 3Samatvam: Science and Research for Human Welfare Trust, Diabetes Endocrinology, Bangalore, India, 4Jnana Sanjeevini Medical Center, Endocrinology Diabetes, Bangalore, India, 5Samatvam Endocrinology Diabetes, Endocrinology Diabetes, Bangalore, India, 6Jnana Sanjeevini Medical Center and Diabetes Hospital, Endocrinology Diabetes, Bangalore, India, 7Samatvam Endocrinology Diabetes Center, Endocrinology Diabetes, Bangalore, India, 8Life for a Child with Diabetes, Sydney, Australia, 9Changing Diabetes in Children, Bangalore, India, 10Sri Matha Swami Panditharadhya Shivacharya Swamiji, Spirituality Social Welfare Education, Sanehalli Village, Hosadurga, India. 45th Annual Conference of the International Society for Pediatric and Adolescent Diabetes (ISPAD) 2019, Boston, USA.
  619. SLC29A3 spectrum disorder associated monogenic / syndromic insulin dependent diabetes: multiple tragedies and herculean management challenges of an enigmatic multisystem pathology. N. Gaekwad, M.S. Vaishnav, S. Dinesha, S. Reddy3, K. Haridas, R. Harsha, A. Govind, M. Narayanaswamy, M.D. Chitra, J. Thimmaiah, N. Garg, R. Kashivishwanath, A. Hegde, Diabetes Endocrinology Study Group Samatvam Jnana Sanjeevini 1Samatvam Science and Research for Human Welfare Trust, Endocrinology Diabetes, Bangalore, India, 2Indian Institute of Science, Center for Nano Science and Engineering, Bangalore, India, 3Samatvam Endocrinology Diabetes Center, Endocrinology Diabetes, Bangalore, India, 4Jnana Sanjeevini Medical Center, Endocrinology Diabetes, Bangalore, India, 5Jnana Sanjeevini Medical Center and Diabetes Hospital, Endocrinology Diabetes, Bangalore, India. 45th Annual Conference of the International Society for Pediatric and Adolescent Diabetes (ISPAD) 2019, Boston, USA.
  620. Pre type 1 autoimmune diabetes presenting as childhood stress hyperglycaemia. S. Reddy, M.S. Vaishnav, S. Dinesha, K. Haridas, R. Harsha, A. Govind, M. Narayanaswamy, M.D. Chitra, J. Thimmaiah, N. Gaekwad, N. Garg, R. Kashivishwanath, A. Hegde, Diabetes Endocrinology Study Group Samatvam Jnana Sanjeevini 1Samatvam Endocrinology Diabetes Center, Endocrinology Diabetes, Bangalore, India, 2Indian Institute of Science, Center for Nano Science and Engineering, Bangalore, India, 3Jnana Sanjeevini Medical Center, Endocrinology Diabetes, Bangalore, India, 4Jnana Sanjeevini Medical Center and Diabetes Hospital, Endocrinology Diabetes, Bangalore, India, 5Samatvam Science and Research for Human Welfare Trust, Endocrinology Diabetes, Bangalore, India. 45th Annual Conference of the International Society for Pediatric and Adolescent Diabetes (ISPAD) 2019, Boston, USA.
  621. Helplessness, hopelessness and self-destruction situation in a type 1 diabetes poor village family: successful transformation story to a United Nations global art awardee, role model and a future doctor. S. Reddy, M.S. Vaishnav, S. Dinesha, M.D. Chitra, N. Gaekwad, A. Govind, K. Haridas, R. Harsha, M. Narayanaswamy, J. Thimmaiah, N. Garg, R. Kashivishwanath, A. Hegde, Diabetes Endocrinology Study Group Samatvam Jnana Sanjeevini 1Samatvam Endocrinology Diabetes Center, Diabetes Endocrinology, Bangalore, India, 2Indian Institute of Science, Center for Nano Science and Engineering, Bangalore, India, 3Jnana Sanjeevini Medical Center, Endocrinology Diabetes, Bangalore, India, 4Samatvam Science and Research for Human Welfare Trust, Endocrinology Diabetes, Bangalore, India, 5Jnana Sanjeevini Medical Center and Diabetes Hospital, Endocrinology Diabetes, Bangalore, India, 6Samatvam Endocrinology Diabetes Center, Endocrinology Diabetes, Bangalore, India. 45th Annual Conference of the International Society for Pediatric and Adolescent Diabetes (ISPAD) 2019, Boston, USA.
  622. Sarvodaya and Anthyodaya – diabetes and health care for all: 3 decades of Indian challenges, struggles and experience. M.S. Vaishnav, A. Govind, K. Haridas, S. Reddy, N. Gaekwad, S. Dinesha, R. Harsha, M. Narayanaswamy, M. Chitra, J. Thimmaiah, N. Garg, R. Kashivishwanath, A. Hegde, Diabetes Endocrinology Study Group Samatvam Jnana Sanjeevini 1Indian Institute of Science, Center for Nano Science and Engineering, Bangalore, India, 2Jnana Sanjeevini Medical Center and Diabetes Hospital, Diabetes Endocrinology, Bangalore, India, 3Samatvam Endocrinology Diabetes Center, Diabetes Endocrinology, Bangalore, India, 4Samatvam Science and Research for Human Welfare Trust, Diabetes Endocrinology, Bangalore, India. 45th Annual Conference of the International Society for Pediatric and Adolescent Diabetes (ISPAD) 2019, Boston, USA.
  623. SARVODAYA and ANTHYODAYA – Diabetes and Health Care for All: 3 decades of Indian challenges, struggles and experience. Monica Narayanaswamy1, Namya Gaekwad2, Apoorva Govind3, Madhumathi Shrikrushna Vaishnav4, Siddhartha Dinesha5, Keerthana Haridas6, Srikanta Sathyanarayana7, Chandrika .8, Reshma Bananki Vijay9, Kamala Thummala10, Chitra M D11, Samatvam Endocrinology Study Group12. International Diabetes Federation (IDF) Congress 2019, Busan, Korea.
  624. SLC29A3 spectrum disorder associated monogenic insulin dependent diabetes: Pathogenetic enigma and management challenges. Monica Narayanaswamy1, Namya Gaekwad2, Apoorva Govind3, Siddhartha Dinesha4, Keerthana Haridas5, Madhumathi Shrikrushna Vaishnav6, Reshma Bananki Vijay7, Pushpa Ravikumar8, Muralidhara Krishna9, Kamala Thummala10, Rajiv Kasivishvanath11, Samatvam Endocrinology Study Group12. International Diabetes Federation (IDF) Congress 2019, Busan, Korea
  625. Insulin edema in an adolescent with Type 1 Diabetes Mellitus due to surreptitious [but not therapeutic] insulin use. Apoorva Govind1, Keerthana Haridas2, Siddarth Dinesha3, Madhumati Shrikrushna Vaishnav4, Vasanthi Nath5, Reshma Bananki Vijay6, Sathyanaranaya Srikanta7. International Diabetes Federation (IDF) Congress 2019, Busan, Korea
  626. Revitalization of the use of Glycated Albumin as a “complimentary” marker for glycemic control in diabetes. Madhumati Shrikrushna Vaishnav1, Navakant Bhat2, Sathyanarayana Srikanta3, Apoorva Govind4, Sowmya Chandrashekhar5. International Diabetes Federation (IDF) Congress 2019, Busan, Korea
  627. HbA1c, Urine Albumin Creatinine Ratio and renal – cardiovascular health risk factors in a diabetes cohort from India. Madhumati Shrikrushna Vaishnav1, Navakant Bhat2, Sathyanarayana Srikanta3, Apoorva Govind4, Siddhartha Dinesha5, Monica Narayanaswamy6, Keertana Haridas7, Samtvam Endocrinology Study Group8. International Diabetes Federation (IDF) Congress 2019, Busan, Korea
  628. Type 2 diabetes and depression in India: Care, culture and science lessons from interpret-dd 14 country global study. Siddhartha Dinesha1, Sathvik Reddy C B2, Apoorva Govind3, Madhumathi Shrikrushna Vaishnav4, Monica Narayanaswamy5, Namya Gaekwad6, Keertana Haridas7, Kamala Thummala8, Muralidhara Krishna9, Sapna Manjunath10, Santhosh K Chathurvedi11, Samatvam Endocrinology Study Group12. International Diabetes Federation (IDF) Congress 2019, Busan, Korea
  629. Pre type 1 autoimmune diabetes presenting as childhood stress hyperglycaemia
  630. Siddhartha Dinesha1, Sathvik Reddy C B2, Apoorva Govind3, Samtvam Endocrinology Study Group4, Madhumathi Shrikrushna Vaishnav5, Monica Narayanaswamy6, Namya Gaekwad7, Keertana Haridas8, Sowmya Chandrashekar9, Kamala Thummala10, Pushpa Ravikumar11, Reshma banaki Vijay12Helplessness, hopelessness and self-destruction plan in Type 1 diabetes: Courage, determination and United Nations Award. International Diabetes Federation (IDF) Congress 2019, Busan, Korea
  631. Pediatric Type 2 Diabetes in India: Experiences from DISHA Free Diabetes Clinic for the Poor. Apoorva Govind1, Sathyanarayana Srikanta2, Monica Narayanaswamy3, Namya Gaekwad4, Siddartha Dinesha5, Madhumati Shrikrushna Vaishnav6, Reshma Bananki Vijay7, Keerthana Haridas8, Lakshmi Reddy9, Vasanthi Nath10, Kamala Thummala11, Chandrika K12. International Diabetes Federation (IDF) Congress 2019, Busan, Korea  
  632.  “Insulin Akshayapatra” for childhood onset diabetes in India: Three decades dreams, challenges, failures and successes. Sowmya Chandrashekhar1, Monica Narayanaswamy2, Keerthana Haridas3, Namya Gaekwad4, Siddhartha Dinesha5, Apoorva Govind6, Madhumathi Shrikrushna Vaishnav7, Kamala Thummala8, Pushpa Ravikumar9, Vasanthi Nath10, Kavitha Muniraj11, Samathvam Endocrinology Study Group12. International Diabetes Federation (IDF) Congress 2019, Busan, Korea
  633. Helplessness, hopelessness and self-destruction plan in Type 1 diabetes: Courage determination and United Nations Award.  Sowmya Chandrashekar1, Apoorva Govind2, Siddhartha Dinesha3, Sathvik Reddy C B4, Madhumathi Shrikrushna Vaishnav5, Monica Narayanaswamy6, Namya Gaekwad7, Keertana Haridas8, Kamala Thummala9, Pushpa Ravikumar10, Samtvam Endocrinology Study Group11 . Reshma banaki Vijay12. International Diabetes Federation (IDF) Congress 2019, Busan, Korea
  634. Insulin edema in Type 1 Diabetes Mellitus due to surreptitious self-insulin use.  Nidhi Garg, MD Chitra, Kavitha M, Sathvik Reddy, Siddhartha Dinesha,  Apoorva Govind, Keerthana Haridas, Prateek Hongal, Rajiv K, Chandraprabha S, Srikanta S, Jayalakshmi T, Madhumati Vaishnav, Kalpana Vajram, Reshma Vijay, Thummala Kamala,  Samatvam – Jnana Sanjeevini, Endocrinology Diabetes Study Group, Endocrine Practice, Vol 26, Suppl 2, 2020 
  635. Story of unpredictable “Thyroid Destiny”: Hashimotos and Graves overlap and interconversions. Siddalingappa, Chandraprabha, MD Chitra, Kavitha M, Sathvik Reddy, Siddhartha Dinesha, Nidhi Garg, Apoorva Govind, Keerthana Haridas, Prateek Hongal, Rajiv K, Srikanta S, Jayalakshmi T, Madhumati Vaishnav, Kalpana Vajram, Reshma Vijay, Thummala Kamala,  Samatvam – Jnana Sanjeevini, Endocrinology Diabetes Study Group, Endocrine Practice, Vol 26, Suppl 2, 2020
  636. Primary Hypothyroidism and Thyrotroph Hyperplasia progressing to Panhypopituitarism, Siddalingappa, Chandraprabha, MD Chitra, Kavitha M, Sathvik Reddy, Siddhartha Dinesha, Nidhi Garg, Apoorva Govind, Keerthana Haridas, Prateek Hongal, Rajiv K, Srikanta S, Jayalakshmi T, Madhumati Vaishnav, Kalpana Vajram, Reshma Vijay, Thummala Kamala,  Samatvam – Jnana Sanjeevini, Endocrinology Diabetes Study Group, Endocrine Practice, Vol 26, Suppl 2, 2020
  637. Monogenic Insulin Dependent Diabetes – SLC29a3 spectrum disorder associated Non-Autoimmune Beta Cell Dysfunction. Nidhi Garg, MD Chitra, Kavitha M, Sathvik Reddy, Siddhartha Dinesha, Apoorva Govind, Keerthana Haridas, Prateek Hongal, Rajiv K, Chandraprabha S, Srikanta S, Jayalakshmi T, Madhumati Vaishnav, Kalpana Vajram, Reshma Vijay, Thummala Kamala, Samatvam – Jnana Sanjeevini, Endocrinology Diabetes Study Group, Endocrine Practice, Vol 26, Suppl 2, 2020
  638. Bisphosphonate [BP] associated Osteonecrosis of the External Auditory Canal [ONE]: Presentation, challenges and prevention? Mandyam D Chitra, Kavitha M, Sathvik Reddy, Siddhartha Dinesha, Nidhi Garg, Apoorva Govind, Keerthana Haridas, Prateek Hongal, Rajiv K, Chandraprabha S, Srikanta S, Jayalakshmi T, Madhumati Vaishnav, Kalpana Vajram, Reshma Vijay, Thummala Kamala,  Samatvam – Jnana Sanjeevini, Endocrinology Diabetes Study Group, Endocrine Practice, Vol 26, Suppl 2, 2020
  639. “Refractory” Adrenal Crisis in “Subclinical” Hypopituitarism due to coincidental Viral Myocarditis – a masquerade? Mandyam D Chitra, Kavitha M, Sathvik Reddy, Siddhartha Dinesha, Nidhi Garg, Apoorva Govind, Keerthana Haridas, Prateek Hongal, Rajiv K, Chandraprabha S, Srikanta S, Jayalakshmi T, Madhumati Vaishnav, Kalpana Vajram, Reshma Vijay, Thummala Kamala, Samatvam – Jnana Sanjeevini, Endocrinology Diabetes Study Group, Endocrine Practice, Vol 26, Suppl 2, 2020
  640. Albumin Oxidation and Albumin Glycation Discordance During Type 2 Diabetes Therapy: Biological and Clinical Implications. Madhumati S Vaishnav, Namita Kumari, Kavitha Muniraj, Sathyanarayana Srikanta, Vinaya Simha, Patnam R Krishnaswamy, Padmanabhan Balaram, Navakanta Bhat. Abstract 700, 21st International Congress of Endocrinology, Dubai on 1-3 March 2024. 
  641. Truncated Albumins as Novel Surrogate Biomarkers in Diabetes: Epiphenomena and Potential Clinical Applications. Madhumati S Vaishnav, Lakshmi Reddy, Namita Kumari, Kavitha Muniraj, Sathyanarayana Srikanta, Vinaya Simha, Patnam R Krishnaswamy, Padmanabhan Balaram, Navakanta Bhat. Abstract 707, 21st International Congress of Endocrinology, Dubai 1-3 March 2024. 
  642. Differential Cys34 Albumin Di/Tri-Oxidation and Progressive Renal Dysfunction in Type 2 And Type 1 Diabetes: Novel Biological and Clinical Insights. Madhumati S Vaishnav, Namita Kumari, Kavitha Muniraj, Sathyanarayana Srikanta, Vinaya Simha, Patnam R Krishnaswamy, Padmanabhan Balaram, Navakanta Bhat. Abstract 715, 21st International Congress of Endocrinology, Dubai 1-3 March 2024. 
  643. Diabetes Care for The Bottom of The Socioeconomic Pyramid: Four Decades of Science, Medicine, Creativity and Empathy (Samatvam – India Model; 1987 – 2023). Sapna Manjunath, Madhumati S Vaishnav, Kavitha Muniraj, Sathyanarayana et.al; Abstract 723, 21st International Congress of Endocrinology, Dubai 1-3 March 2024. 
  644. Insulin Sensitivity and Secretion Biomarkers in Homozygote Vs Heterozygote Family Members for The Pathogenic WRN Gene Mutation (Werner Syndrome). Suvyaktha Simha, Madhumati S Vaishnav, Leena Lekkala, Kavitha Muniraj, Sathyanarayana Srikanta et.al. Abstract 770, 21st International Congress of Endocrinology, Dubai 1-3 March 2024.
  645. Congenital Generalised Lipodystrophy (CGL): This Nature’s Model Reaffirms Many Facets of The Molecular and Metabolic Signature of Insulin Resistance. Madhumati S Vaishnav, Suvyaktha Simha, Namita Kumari, Sathyanarayana Srikanta et.al. Abstract 771, 21st International Congress of Endocrinology, Dubai 1-3 March 2024.
  646. The “HAVE-NOTS” and the “HAVES” WITH TYPE 1 DIABETES: Universal Dream and Quest for Health Care Perfection (An Experience from India). Suvyaktha Simha, Sapna Manjunath, Madhumati S Vaishnav, Sathyanarayana Srikanta. Abstract 773, 21st International Congress of Endocrinology, Dubai 1-3 March 2024. 
  647. Diagnosis and Management of Diabetic Ketoacidosis (DKA) During Covid 19 Pandemic: Confusion, Chaos and Challenges (Two Contrasting Examples). Leena Lekkala, Kavitha Muniraj, Anirudh Krishnamurthy, Madhumati S Vaishnav, Sathyanarayana Srikanta. Abstract 787, 21st International Congress of Endocrinology, Dubai 1-3 March 2024. 
  648. Young-Onset Diabetes in Association with Insulin Receptor Substrate 2 (IRS 2) Mutation Suggests Novel Subtype of Monogenic Diabetes. Suvyaktha Simha, Anirudh Krishnamurthy, Yug Garg, Madhumati S Vaishnav, Sathyanarayana Srikanta. Abstract 795, 21st International Congress of Endocrinology, Dubai 1-3 March 2024. 
  649. Rare Case of Congenital Generalized Lipodystrophy in Association with Muscle Weakness and Poor Exercise Capacity. Diya Manjunath, Madhumati S Vaishnav, Suvyaktha Simha, Vinaya Simha, Sathyanarayana Srikanta. Abstract 834, 21st International Congress of Endocrinology, Dubai 1-3 March 2024. 
  650. Bringing Fully Closed-Loop Open-Source Automated Insulin Delivery (OS-AID) To India: Potential Model for Other Resource-Limited Settings (Peers-Led Star Clinic). Rahul Singh, Jamie Kurtzig, Madhumati S Vaishnav, Sathyanarayana Srikanta, Rayhan Lal. Abstract 872, 21st International Congress of Endocrinology, Dubai 1-3 March 2024. 
  651. Selectively Increased C-Terminal Albumin Truncation (HSA-L) In Diabetes Chronic Kidney Disease: An Indicator of Subclinical or Undiagnosed Pancreatitis. Madhumati S Vaishnav, Namita Kumari, Kavitha Muniraj, Sathyanarayana Srikanta, Vinaya Simha, Patnam R Krishnaswamy, Padmanabhan Balaram, Navakanta Bhat. Abstract 1213, 21st International Congress of Endocrinology, Dubai 1-3 March 2024.
  652. Hemoglobin, Serum Albumin and Serum Protein Glycation in Diabetes: Differential Biological Behaviour and Clinical Complementarity. Madhumati S Vaishnav, Namita Kumari, Sathyanarayana Srikanta, Vinaya Simha, Patnam R Krishnaswamy, Padmanabhan Balaram, Navakanta Bhat. Abstract 1214, 21st International Congress of Endocrinology, Dubai 1-3 March 2024.
  653. Glycation Gap and Its Determinants: Comparative Analysis and Implications in Type 2 Versus Type 1 Diabetes. Madhumati S Vaishnav, Kavitha Muniraj, Namita Kumari, Sathyanarayana Srikanta, Vinaya Simha, Patnam R Krishnaswamy, Padmanabhan Balaram, Navakanta Bhat. Abstract 1219, 21st International Congress of Endocrinology, Dubai 1-3 March 2024.
  654. Type 2 Diabetogenesis Continuum and Phenotypes: Insulin Resistance, Beta Cell Dysfunction, Inflammatory and Metabolic Biomarker Correlations. Madhumati S Vaishnav, Leena Lekkala, Kavitha Muniraj, Sathyanarayana Srikanta, Vinaya Simha, Navakanta Bhat. Abstract 1222, 21st International Congress of Endocrinology, Dubai 1-3 March 2024.
  655. Hemoglobin Versus Serum Protein Glycation in Diabetes: Differential Behavior, Biological Significance and Clinical Complementarity. Madhumati S Vaishnav, Lakshmi Reddy, Yug Garg, Reshma BV, Kavitha Muniraj, Leena Lekkala, Jayalakshmi Thimmaiah, Vinaya Simha8, Sathyanarayana Srikanta, Navakanta Bhat. Abstract 1223, 21st International Congress of Endocrinology, Dubai 1-3 March 2024.
  656. Multifactorial Determinants and Significance of Glycation Gap and Organ Damage in Diabetes: Role of Insulin Resistance and Beta Cell Dysfunction. Madhumati S Vaishnav, Kavitha Muniraj, Suvyaktha Simha, Yug Garg, Reshma BV, Vinaya Simha, Sathyanarayana Srikanta, Navakanta Bhat. Abstract 1224, 21st International Congress of Endocrinology, Dubai 1-3 March 2024.
  657. Diabetogenesis And Subclinical Exocrine Pancreatic Dysfunction: Determinants and Clinical Implications. Madhumati S Vaishnav, Siddhartha Dinesha, Yug Garg, Vinaya Simha, Kavitha Muniraj, Leena Lekkala, Reshma BV, Sathyanarayana Srikanta, Navakanta Bhat. Abstract 1226, 21st International Congress of Endocrinology, Dubai 1-3 March 2024.
  658. Clinical Utility of Serum C-Peptide Assay: Real Life Experience from A Speciality Diabetes Center and Lessons Learnt. Yug Garg, Madhumati S Vaishnav, Varenya Badarinath, Kavitha Muniraj, Sathyanarayana Srikanta. Abstract 1353, 21st International Congress of Endocrinology, Dubai 1-3 March 2024.
  659. Profile and Utility of C-Peptide Derived Homa Indices in Type 2 Diabetes (T2D) On Insulin Therapy. Yug Garg, Madhumati S Vaishnav, Varenya Badarinath, Kavitha Muniraj, Sathyanarayana Srikanta. Abstract 1356, 21st International Congress of Endocrinology, Dubai 1-3 March 2024.
  660. Mass Venous Blood Haemoglobin A1c Testing at Street-Camps for Enriched Community Prediabetes and Diabetes Screening and Care: A Unique First-In-World Social and Public Health Experiment. Ranjini Krishna, Madhumati S Vaishnav, Leena Lekkala, Rajeshwari Ashok, Sathyanarayana Srikanta, Bhanudev M Bhatt, Arokiaswamy Velumani. Abstract 1429, 21st International Congress of Endocrinology, Dubai 1-3 March 2024.
  661. Bone Turnover Marker (BTM) Measurements in Supporting Osteoporosis Treatment: Experience from A Speciality Endocrinology Center from India. Leena Lekkala, Rajeshwari Ashok, Sathyanarayana Srikanta, Nandini Jayaram, Madhumati S Vaishnav, Kavitha Muniraj, Reshma BV. Sathyanarayana Srikanta. Abstract 1433, 21st International Congress of Endocrinology, Dubai 1-3 March 2024.
  662. Comparison of Different C-Peptide Based Indices for Quantitation of Insulin Resistance (IR) And Beta-Cell Function (BCF) Towards Analysing T2D Pathogenetic Heterogeneity. Yug Garg, Madhumati S Vaishnav, Sathyanarayana Srikanta. Abstract 1455, 21st International Congress of 
  663. Endocrinology, Dubai 1-3 March 2024.
  664. Mitochondrial Cytopathy (M.3243A>G) With Diabetes Masquerading As “Late-Onset” Slowly Progressive Non-Autoimmune Type 1 Diabetes. Diya Manjunath, Kavitha Muniraj, Reshma BV, Suvyaktha Simha, Yug Garg, Madhumati S Vaishnav, Sapna Manjunath, Leena Lekkala, Sathyanarayana Srikanta. Abstract 1530, 21st International Congress of Endocrinology, Dubai 1-3 March 2024.
  665. A Novel Early-Onset Syndromic Diabetes Associated with Pancreatitis, Seizures and Hearing Impairment in An Asian Indian Family with Extensive Consanguinity. Diya Manjunath, Kavitha Muniraj, Reshma BV, Madhumati S Vaishnav, Sapna Manjunath, Suvyaktha Simha, Sathyanarayana Srikanta. Abstract 1536, 21st International Congress of Endocrinology, Dubai 1-3 March 2024.
  666. Glycated Serum Protein NBT Colorimetric Assay: Old Inexpensive Wine, Better Bottle and Potential for Greater Use. Madhumati S Vaishnav, Namita Kumari, Patnam R Krishnaswamy, Padmanabhan Balaram, Sathyanarayana Srikanta, Navakanta Bhat. Abstract 1549, 21st International Congress of Endocrinology, Dubai 1-3 March 2024.
  667. Primary Aldosteronism (PA) Screening in Resistant Hypertension (Rh): Experiences from A Speciality Endocrinology Diabetes Clinic (Should We Mark “Pre-Primary” Aldosteronism?). Siddhartha Dinesha, Kavitha Muniraj, Yug Garg, Reshma BV, Leena Lekkala, Madhumati S Vaishnav, Sathyanarayana Srikanta. Abstract 1598, 21st International Congress of Endocrinology, Dubai 1-3 March 2024.
  668. Challenging Case of Low-Grade Parathyroid Carcinoma with Coexisting Granulomatous Lymphadenitis Masquerading as Metastases. Yug Garg, Madhumati S Vaishnav, Kavitha Muniraj, Reshma BV, Siddhartha Dinesha, Leena Lekkala, Sathyanarayana Srikanta. Abstract 1607, 21st International Congress of Endocrinology, Dubai 1-3 March 2024.
  669. Resistant Metabolic Alkalosis and Hypokalemia During Severe Sepsis with Hyperlactatemia as The First Clue to Primary Aldosteronism (PA). Sathyanarayana Srikanta, Jayalakshmi Thimmaiah, Reshma BV, Kavitha Muniraj, Lakshmi Reddy, Siddhartha Dinesha, Madhumati S Vaishnav. Abstract 1620, 21st International Congress of Endocrinology, Dubai 1-3 March 2024. 
  670. “GIVING TREE: T1D-100”: Experiences from A Philanthropy Based Free Type 1 Diabetes Comprehensive Care Program in India (1987- Current).  Sameera Khanduri, Madhumati S Vaishnav, Uma Dayashankar, Sathyanarayana Srikanta. Abstract 1976, 21st International Congress of Endocrinology, Dubai 1-3 March 2024.